<div id="page0" style="width:595.3pt;height:793.7pt">
<p style="top:753.5pt;left:67.9pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">VOL. 100-B, No. 3, MARCH 2018</span></p>
<p style="top:753.5pt;left:549.1pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">271</span></p>
<p style="top:72.4pt;left:168.7pt;line-height:14.0pt"><span style="font-family:Wingdings,sans-serif;font-size:14.0pt;color:#424242">&#xf06e;</span><b><span style="font-family:Univers45Light,Bold,serif;font-size:14.0pt;color:#424242"> SYSTEMATIC REVIEW</span></b></p>
<p style="top:91.6pt;left:168.7pt;line-height:20.0pt"><b><span style="font-family:Sabon,Bold,serif;font-size:20.0pt">Biological augmentation of graft healing in </span></b></p>
<p style="top:115.6pt;left:168.7pt;line-height:20.0pt"><b><span style="font-family:Sabon,Bold,serif;font-size:20.0pt">anterior cruciate ligament reconstruction</span></b></p>
<p style="top:146.6pt;left:168.7pt;line-height:12.0pt"><span style="font-family:Sabon,serif;font-size:12.0pt">A SYSTEMATIC REVIEW</span></p>
<p style="top:189.9pt;left:67.9pt;line-height:10.0pt"><b><span style="font-family:Sabon,Bold,serif;font-size:10.0pt">A. T. Hexter,</span></b></p>
<p style="top:201.9pt;left:67.9pt;line-height:10.0pt"><b><span style="font-family:Sabon,Bold,serif;font-size:10.0pt">T. Thangarajah,</span></b></p>
<p style="top:213.9pt;left:67.9pt;line-height:10.0pt"><b><span style="font-family:Sabon,Bold,serif;font-size:10.0pt">G. Blunn,</span></b></p>
<p style="top:225.9pt;left:67.9pt;line-height:10.0pt"><b><span style="font-family:Sabon,Bold,serif;font-size:10.0pt">F. S. Haddad</span></b></p>
<p style="top:250.3pt;left:67.9pt;line-height:9.5pt"><i><span style="font-family:Sabon,Italic,serif;font-size:9.5pt">From University </span></i></p>
<p style="top:262.3pt;left:67.9pt;line-height:9.5pt"><i><span style="font-family:Sabon,Italic,serif;font-size:9.5pt">College Hospital, </span></i></p>
<p style="top:274.3pt;left:67.9pt;line-height:9.5pt"><i><span style="font-family:Sabon,Italic,serif;font-size:9.5pt">London, United </span></i></p>
<p style="top:286.3pt;left:67.9pt;line-height:9.5pt"><i><span style="font-family:Sabon,Italic,serif;font-size:9.5pt">Kingdom</span></i></p>
<p style="top:402.1pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Wingdings,sans-serif;font-size:6.0pt;color:#c0c0c0">&#xf06e;</span><span style="font-family:Univers55,serif;font-size:6.0pt"> A. T. Hexter, MBBS(Hons) </span></p>
<p style="top:410.0pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">BSc(Hons) PG Cert MRCS (Eng), </span></p>
<p style="top:418.0pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">NIHR Academic Clinical Fellow, </span></p>
<p style="top:426.1pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">Orthopaedic Specialist </span></p>
<p style="top:434.0pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">Registrar</span></p>
<p style="top:442.0pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Wingdings,sans-serif;font-size:6.0pt;color:#c0c0c0">&#xf06e;</span><span style="font-family:Univers55,serif;font-size:6.0pt"> T. Thangarajah, MbChB </span></p>
<p style="top:450.1pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">(Hons) MSc MRCS PhD, </span></p>
<p style="top:458.0pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">Orthopaedic Specialist </span></p>
<p style="top:466.0pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">Registrar</span></p>
<p style="top:474.1pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Wingdings,sans-serif;font-size:6.0pt;color:#c0c0c0">&#xf06e;</span><span style="font-family:Univers55,serif;font-size:6.0pt"> G. Blunn, BSc PhD, Professor </span></p>
<p style="top:482.0pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">of Bioengineering</span></p>
<p style="top:490.0pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">Institute of Orthopaedics and </span></p>
<p style="top:498.1pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">Musculoskeletal Science, </span></p>
<p style="top:506.0pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">Division of Surgery and </span></p>
<p style="top:514.0pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">Interventional Science, </span></p>
<p style="top:522.1pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">University College London, and </span></p>
<p style="top:530.0pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">Royal National Orthopaedic </span></p>
<p style="top:538.0pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">Hospital Brockley Hill, </span></p>
<p style="top:546.1pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">Stanmore, Middlesex HA7 4LP, </span></p>
<p style="top:554.0pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">UK.</span></p>
<p style="top:568.0pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Wingdings,sans-serif;font-size:6.0pt;color:#c0c0c0">&#xf06e;</span><span style="font-family:Univers55,serif;font-size:6.0pt"> F. S. Haddad, BSc MD (Res), </span></p>
<p style="top:576.1pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">FRCS (Tr&amp;Orth), Professor of </span></p>
<p style="top:584.0pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">Orthopaedic Surgery</span></p>
<p style="top:592.0pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">University College London </span></p>
<p style="top:600.1pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">Hospitals, 235 Euston Road, </span></p>
<p style="top:608.0pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">London, NW1 2BU, UK and </span></p>
<p style="top:616.0pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">NIHR University College </span></p>
<p style="top:624.1pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">London Hospitals Biomedical </span></p>
<p style="top:632.0pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">Research Centre, UK.</span></p>
<p style="top:646.0pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">Correspondence should be sent </span></p>
<p style="top:654.1pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">to A. Hexter; email: </span></p>
<p style="top:662.0pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">a.hexter@ucl.ac.uk</span></p>
<p style="top:677.7pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">&#xa9;2018 The British Editorial </span></p>
<p style="top:685.7pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">Society of Bone &amp; Joint </span></p>
<p style="top:693.7pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">Surgery</span></p>
<p style="top:701.7pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">doi:10.1302/0301-620X.100B3. </span></p>
<p style="top:709.7pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">BJJ-2017-0733.R2 $2.00</span></p>
<p style="top:725.4pt;left:67.9pt;line-height:6.0pt"><i><span style="font-family:Univers55,Italic,serif;font-size:6.0pt">Bone Joint J</span></i></p>
<p style="top:733.4pt;left:67.9pt;line-height:6.0pt"><span style="font-family:Univers55,serif;font-size:6.0pt">2018;100-B:271&#x2013;84.</span></p>
<p style="top:189.9pt;left:168.7pt;line-height:10.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:10.0pt;color:#424242">Aims</span></b></p>
<p style="top:202.0pt;left:168.7pt;line-height:9.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:9.0pt">The success of anterior cruciate ligament reconstruction (ACLR) depends on </span></b></p>
<p style="top:214.0pt;left:168.7pt;line-height:9.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:9.0pt">osseointegration at the graft-tunnel interface and intra-articular ligamentization. Our aim </span></b></p>
<p style="top:226.0pt;left:168.7pt;line-height:9.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:9.0pt">was to conduct a systematic review of clinical and preclinical studies that evaluated </span></b></p>
<p style="top:238.0pt;left:168.7pt;line-height:9.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:9.0pt">biological augmentation of graft healing in ACLR. </span></b></p>
<p style="top:261.4pt;left:168.7pt;line-height:10.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:10.0pt;color:#424242">Materials and Methods</span></b></p>
<p style="top:273.5pt;left:168.7pt;line-height:9.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:9.0pt">In all, 1879 studies were identified across three databases. Following assessment against </span></b></p>
<p style="top:285.5pt;left:168.7pt;line-height:9.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:9.0pt">strict criteria, 112 studies were included (20 clinical studies; 92 animal studies). </span></b></p>
<p style="top:308.9pt;left:168.7pt;line-height:10.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:10.0pt;color:#424242">Results</span></b></p>
<p style="top:321.0pt;left:168.7pt;line-height:9.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:9.0pt">Seven categories of biological interventions were identified: growth factors, biomaterials, </span></b></p>
<p style="top:333.0pt;left:168.7pt;line-height:9.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:9.0pt">stem cells, gene therapy, autologous tissue, biophysical/environmental, and </span></b></p>
<p style="top:345.0pt;left:168.7pt;line-height:9.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:9.0pt">pharmaceuticals. The methodological quality of animal studies was moderate in 97%, but </span></b></p>
<p style="top:357.0pt;left:168.7pt;line-height:9.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:9.0pt">only 10% used clinically relevant outcome measures. The most interventions in clinical trials </span></b></p>
<p style="top:369.0pt;left:168.7pt;line-height:9.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:9.0pt">target the graft-tunnel interface and are applied intraoperatively. Platelet-rich plasma is the </span></b></p>
<p style="top:381.0pt;left:168.7pt;line-height:9.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:9.0pt">most studied intervention, but the clinical outcomes are mixed, and the methodological </span></b></p>
<p style="top:393.0pt;left:168.7pt;line-height:9.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:9.0pt">quality of studies was suboptimal. Other biological therapies investigated in clinical trials </span></b></p>
<p style="top:405.0pt;left:168.7pt;line-height:9.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:9.0pt">include: remnant-augmented ACLR; bone substitutes; calcium phosphate-hybridized grafts; </span></b></p>
<p style="top:417.0pt;left:168.7pt;line-height:9.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:9.0pt">extracorporeal shockwave therapy; and adult autologus non-cultivated stem cells.</span></b></p>
<p style="top:440.4pt;left:168.7pt;line-height:10.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:10.0pt;color:#424242">Conclusion</span></b></p>
<p style="top:452.5pt;left:168.7pt;line-height:9.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:9.0pt">There is extensive preclinical research supporting the use of biological therapies to augment </span></b></p>
<p style="top:464.5pt;left:168.7pt;line-height:9.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:9.0pt">ACLR. Further clinical studies that meet the minimum standards of reporting are required to </span></b></p>
<p style="top:476.5pt;left:168.7pt;line-height:9.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:9.0pt">determine whether emerging biological strategies will provide tangible benefits in patients </span></b></p>
<p style="top:488.5pt;left:168.7pt;line-height:9.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:9.0pt">undergoing ACLR.</span></b></p>
<p style="top:505.5pt;left:168.7pt;line-height:9.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:9.0pt">Cite this article: </span></b><b><i><span style="font-family:Univers45Light,BoldItali,serif;font-size:9.0pt">Bone Joint J</span></i></b><b><span style="font-family:Univers45Light,Bold,serif;font-size:9.0pt"> 2018;100-B:271&#x2013;84.</span></b></p>
<p style="top:526.3pt;left:168.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">Injury to the anterior cruciate ligament (ACL)</span></p>
<p style="top:538.3pt;left:168.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">is common, with an estimated annual</span></p>
<p style="top:550.3pt;left:168.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">incidence of 200 000 in the United States.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">1</span></sup></p>
<p style="top:562.3pt;left:168.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">Anterior cruciate ligament reconstruction</span></p>
<p style="top:574.3pt;left:168.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">(ACLR) is the treatment of choice for young</span></p>
<p style="top:586.3pt;left:168.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">active </span></p>
<p style="top:586.3pt;left:203.6pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">patients,</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">2</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> </span></p>
<p style="top:586.3pt;left:253.2pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">with </span></p>
<p style="top:586.3pt;left:282.8pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">current </span></p>
<p style="top:586.3pt;left:323.5pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">evidence</span></p>
<p style="top:598.3pt;left:168.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">indicating autograft has superior outcomes</span></p>
<p style="top:610.3pt;left:168.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">compared with artificial ligament.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">3,4</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> While the</span></p>
<p style="top:622.3pt;left:168.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">technique of ACLR has evolved,</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">5,6</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> it remains</span></p>
<p style="top:634.3pt;left:168.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">imperfect, with patients rarely returning to</span></p>
<p style="top:646.3pt;left:168.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">baseline function.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">7</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> There is a risk of re-rupture</span></p>
<p style="top:658.3pt;left:168.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">and premature knee osteoarthritis.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">8-11</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt">The</span></p>
<p style="top:670.3pt;left:168.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">outcome of ACLR is thought to depend on the</span></p>
<p style="top:682.3pt;left:168.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">biological healing response referred to as</span></p>
<p style="top:694.3pt;left:168.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">&#x201c;graft healing&#x201d;,</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">12</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> which collectively refers to</span></p>
<p style="top:706.3pt;left:168.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">osseointegration at the graft-tunnel interface</span></p>
<p style="top:718.3pt;left:168.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">and remodelling of the intra-articular graft,</span></p>
<p style="top:730.3pt;left:168.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">called ligamentization. </span></p>
<p style="top:526.3pt;left:380.3pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">The native ACL inserts to bone through a</span></p>
<p style="top:538.3pt;left:370.3pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">direct fibrocartilaginous enthesis, which is</span></p>
<p style="top:550.3pt;left:370.3pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">characterized by a four-zone morphological</span></p>
<p style="top:562.3pt;left:370.3pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">structure with gradual transition from tendon</span></p>
<p style="top:574.3pt;left:370.3pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">to cartilage to mineralized cartilage to bone.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">13</span></sup></p>
<p style="top:586.3pt;left:370.3pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">Following ACLR the graft heals with an</span></p>
<p style="top:598.3pt;left:370.3pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">indirect enthesis formed of biomechanically</span></p>
<p style="top:610.3pt;left:370.3pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">inferior fibrovascular scar tissue.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">14</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> As a result,</span></p>
<p style="top:622.3pt;left:370.3pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">research is ongoing investigating interventions</span></p>
<p style="top:634.3pt;left:370.3pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">that can biologically augment graft healing</span></p>
<p style="top:646.3pt;left:370.3pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">after ACLR, and which may facilitate early</span></p>
<p style="top:658.3pt;left:370.3pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">aggressive rehabilitation and a faster return to</span></p>
<p style="top:670.3pt;left:370.3pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">physical activity.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">15</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> Platelet-rich plasma (PRP)</span></p>
<p style="top:682.3pt;left:370.3pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">and mesenchymal stem cells (MSCs) are two</span></p>
<p style="top:694.3pt;left:370.3pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">promising </span></p>
<p style="top:694.3pt;left:422.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">biological </span></p>
<p style="top:694.3pt;left:474.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">therapies </span></p>
<p style="top:694.3pt;left:522.3pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">used </span></p>
<p style="top:694.3pt;left:552.0pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">in</span></p>
<p style="top:706.3pt;left:370.3pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">musculoskeletal research, but concerns about</span></p>
<p style="top:718.3pt;left:370.3pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">inadequate reporting of scientific details</span></p>
<p style="top:730.3pt;left:370.3pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">critical to outcome led to a recent expert</span></p>


<img style="position:absolute;transform:matrix(.3200452,0,-0,.31638713,47.153337,979.88009)" src="data:image/png;base64,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">
<p style="top:49.8pt;left:52.1pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">272</span></p>
<p style="top:49.8pt;left:203.2pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">A. T. HEXTER, T. THANGARAJAH, G. BLUNN, F. S. HADDAD</span></p>
<p style="top:753.5pt;left:70.0pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">Follow us @BoneJointJ</span></p>
<p style="top:753.5pt;left:447.7pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">THE BONE &amp; JOINT JOURNAL</span></p>
<p style="top:322.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">consensus on the minimum reporting requirements for</span></p>
<p style="top:334.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">clinical studies evaluating PRP and MSCs.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">16</span></sup></p>
<p style="top:346.3pt;left:62.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">The objectives of this study were to: 1) perform a</span></p>
<p style="top:358.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">systematic review and categorize biological methods of</span></p>
<p style="top:370.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">augmentation of graft healing in ACLR; 2) to critically</span></p>
<p style="top:382.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">appraise studies against existing minimum reporting</span></p>
<p style="top:394.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">standards; 3) to identify the target site (graft-tunnel</span></p>
<p style="top:406.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">interface </span><i><span style="font-family:Sabon,Italic,serif;font-size:9.5pt">versus</span></i><span style="font-family:Sabon,serif;font-size:9.5pt"> ligamentization) and timing (intraoperative</span></p>
<p style="top:418.3pt;left:52.1pt;line-height:9.5pt"><i><span style="font-family:Sabon,Italic,serif;font-size:9.5pt">versus</span></i><span style="font-family:Sabon,serif;font-size:9.5pt"> postoperative) of biological interventions; and 4) to</span></p>
<p style="top:430.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">summarize progress of the different categories towards</span></p>
<p style="top:442.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">clinical translation and identify areas of future research.</span></p>
<p style="top:465.9pt;left:52.1pt;line-height:10.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:10.0pt;color:#424242">Materials and Methods</span></b></p>
<p style="top:478.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">We aimed to include all original studies evaluating</span></p>
<p style="top:490.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">biological interventions to augment graft healing after</span></p>
<p style="top:502.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">ACLR. We included studies using tendon autografts or</span></p>
<p style="top:514.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">synthetic ligament. We included clinical trials and animal</span></p>
<p style="top:526.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">studies of ACLR which used objective outcome measures of</span></p>
<p style="top:538.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">graft healing; these included animal studies reporting</span></p>
<p style="top:550.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">histological examination of the interface or clinical studies</span></p>
<p style="top:562.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">with radiological or clinical assessment of graft integrity.</span></p>
<p style="top:574.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">We excluded studies evaluating ACL repair, or treatment of</span></p>
<p style="top:586.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">partial ACL lesions or overstretch-injury. Animal studies</span></p>
<p style="top:598.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">reporting </span><i><span style="font-family:Sabon,Italic,serif;font-size:9.5pt">in vitro</span></i><span style="font-family:Sabon,serif;font-size:9.5pt"> results without </span><i><span style="font-family:Sabon,Italic,serif;font-size:9.5pt">in vivo</span></i><span style="font-family:Sabon,serif;font-size:9.5pt"> results, or those</span></p>
<p style="top:610.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">using extra-articular models of tendon-bone healing were</span></p>
<p style="top:622.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">excluded as were studies evaluating interventions without a</span></p>
<p style="top:634.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">biological component; studies focusing on augmentation of</span></p>
<p style="top:646.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">healing at the harvest site or surrounding muscles; studies</span></p>
<p style="top:658.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">without a control group or lacking adequate information</span></p>
<p style="top:670.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">for data extraction. If two studies were published </span><span style="font-family:Sabon,serif;font-size:14.0pt">u</span><span style="font-family:Sabon,serif;font-size:9.5pt">sing the</span></p>
<p style="top:682.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">same data the larger study was included. </span></p>
<p style="top:694.3pt;left:62.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">A literature search of three databases (MEDLINE,</span></p>
<p style="top:706.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">EMBASE and Web of Science) was undertaken in February</span></p>
<p style="top:718.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">2017 by one author (AH). No date of publication or</span></p>
<p style="top:730.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">language restriction was applied. Search strings were:</span></p>
<p style="top:322.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">(&#x201c;Anterior Cruciate Ligament&#x201d; OR ACL); AND (&#x201c;Tendon-</span></p>
<p style="top:334.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">bone healing&#x201d; OR &#x201c;Biological therapy&#x201d; OR&#x201c;Stem cells&#x201d;</span></p>
<p style="top:346.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">OR &#x201c;Tissue Scaffolds&#x201d; OR &#x201c;Growth factor&#x201d; OR &#x201c;Bone</span></p>
<p style="top:358.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">morphogenic protein&#x201d; OR &#x201c;Platelet-rich plasma&#x201d; OR</span></p>
<p style="top:370.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">&#x201c;Calcium </span></p>
<p style="top:370.3pt;left:364.4pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">phosphate </span></p>
<p style="top:370.3pt;left:427.4pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">cement&#x201d; </span></p>
<p style="top:370.3pt;left:482.6pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">OR </span></p>
<p style="top:370.3pt;left:518.5pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">&#x201c;Bone</span></p>
<p style="top:382.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">substitutes&#x201d; OR &#x201c;Gene therapy&#x201d;). Additional studies were</span></p>
<p style="top:394.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">added by screening bibliographies. Studies underwent title</span></p>
<p style="top:406.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">and abstract screening against inclusion/exclusion criteria</span></p>
<p style="top:418.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">and after initial screening, full manuscript review was</span></p>
<p style="top:430.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">undertaken. </span></p>
<p style="top:430.3pt;left:363.2pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">Data </span></p>
<p style="top:430.3pt;left:393.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">extraction </span></p>
<p style="top:430.3pt;left:445.6pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">and </span></p>
<p style="top:430.3pt;left:471.4pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">measurement </span></p>
<p style="top:430.3pt;left:535.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">of</span></p>
<p style="top:442.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">methodological quality was undertaken by two authors (AH</span></p>
<p style="top:454.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">and TT) using tools developed by the Cochrane</span></p>
<p style="top:466.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">collaboration. Randomized controlled trials were assessed</span></p>
<p style="top:478.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">using the Risk of Bias (RoB) tool</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">17</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> and non-randomized</span></p>
<p style="top:490.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">studies were assessed using the Risk Of Bias In Non-</span></p>
<p style="top:502.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">randomized Studies of Interventions (ROBINS-I) tool,</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">18</span></sup></p>
<p style="top:514.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">which both score risk of bias across seven domains.</span></p>
<p style="top:526.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">Minimum reporting standards</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">16</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> have been published for</span></p>
<p style="top:538.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">PRP (a 23 point checklist) and MSCs (a 25 point checklist);</span></p>
<p style="top:550.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">clinical studies evaluating PRP or MSCs were assessed to see</span></p>
<p style="top:562.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">how well they met the criteria.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">16</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> The methodological quality</span></p>
<p style="top:574.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">of animal studies was assessed using an eight point scoring</span></p>
<p style="top:586.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">system</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">19,20</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> (Table I) and the quality of the outcome</span></p>
<p style="top:598.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">measures used in animal studies were ranked using a</span></p>
<p style="top:610.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">previously published scale on the basis of their relevance to</span></p>
<p style="top:622.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">clinical practice.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">20</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> The ranks were: A, quantitative clinical</span></p>
<p style="top:634.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">outcome measures similar to those used in human trials; B,</span></p>
<p style="top:646.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">biomechanical testing of graft; C, quantitative biochemical</span></p>
<p style="top:658.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">measurements; D, semi-quantitative histological analysis or</span></p>
<p style="top:670.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">quantitative imaging; and E, simple qualitative histological</span></p>
<p style="top:682.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">or imaging analysi</span><span style="font-family:Sabon,serif;font-size:9.5pt">s.</span></p>
<p style="top:705.9pt;left:304.1pt;line-height:10.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:10.0pt;color:#424242">Results</span></b></p>
<p style="top:718.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">Our search strategy identified 1879 studies. After removal</span></p>
<p style="top:730.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">of duplicates, 1422 studies underwent screening by title. Of</span></p>
<p style="top:73.4pt;left:53.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Table I. Criteria for assessing methodological quality of animal studies</span></p>
<p style="top:88.2pt;left:53.3pt;line-height:7.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:7.0pt">Criteria</span></b></p>
<p style="top:88.2pt;left:200.7pt;line-height:7.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:7.0pt">Score</span></b></p>
<p style="top:88.2pt;left:309.3pt;line-height:7.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:7.0pt">Comments</span></b></p>
<p style="top:99.4pt;left:53.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Unit of sample</span></p>
<p style="top:99.4pt;left:200.8pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Unilateral 1/Bilateral 0</span></p>
<p style="top:99.4pt;left:309.4pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Unilateral operations are generally considered superior to bilateral </span></p>
<p style="top:107.4pt;left:309.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">operations </span></p>
<p style="top:117.4pt;left:53.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Standardization of surgical procedure</span></p>
<p style="top:117.4pt;left:200.7pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Yes 1/No 0</span></p>
<p style="top:117.4pt;left:309.2pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Details of graft harvest, surgical approach, drilling tunnels and fixation </span></p>
<p style="top:125.4pt;left:309.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">are provided</span></p>
<p style="top:135.4pt;left:53.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Description of surgical complications </span></p>
<p style="top:135.4pt;left:200.7pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Yes 1/No 0</span></p>
<p style="top:135.4pt;left:309.2pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Details such as general performance, perioperative morbidity and </span></p>
<p style="top:143.4pt;left:309.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">wound infection </span></p>
<p style="top:153.4pt;left:53.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Biomechanical testing reported</span></p>
<p style="top:153.4pt;left:200.8pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Yes 1/No 0</span></p>
<p style="top:153.4pt;left:309.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Mechanical testing is a useful outcome when assessing tendon-bone </span></p>
<p style="top:161.4pt;left:309.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">healing</span></p>
<p style="top:171.4pt;left:53.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Variation (ratio of standard deviation to </span></p>
<p style="top:179.4pt;left:53.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">the mean)</span></p>
<p style="top:171.4pt;left:200.8pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">&lt; 50%/ 1/&gt; 50% 0</span></p>
<p style="top:171.4pt;left:309.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Large standard deviations indicate poor precision or large intra-group </span></p>
<p style="top:179.4pt;left:309.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">variability</span></p>
<p style="top:189.4pt;left:53.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Statistical method</span></p>
<p style="top:189.4pt;left:200.8pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Appropriate 1/Inappropriate 0</span></p>
<p style="top:189.4pt;left:309.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Appropriate statistical tests and measures of variation are used </span></p>
<p style="top:199.4pt;left:53.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Description of tendon-bone interface</span></p>
<p style="top:199.4pt;left:200.7pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Yes 1/No 0</span></p>
<p style="top:199.4pt;left:309.2pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Description of sampling of the region of interest is given during </span></p>
<p style="top:207.4pt;left:309.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">histological analyses</span></p>
<p style="top:217.4pt;left:53.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Semi-quantitative histological analysis</span></p>
<p style="top:217.4pt;left:200.9pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Yes 1/No 0</span></p>
<p style="top:217.4pt;left:309.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">During histological analysis the use of scoring systems indicate better </span></p>
<p style="top:225.4pt;left:309.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">study quality</span></p>
<p style="top:235.4pt;left:53.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Table adapted from system first described by Fu et al</span><sup><span style="font-family:Univers55,serif;font-size:4.9pt">20</span></sup></p>


<p style="top:49.8pt;left:138.0pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">BIOLOGICAL AUGMENTATION OF GRAFT HEALING IN ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION</span></p>
<p style="top:49.8pt;left:549.0pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">273</span></p>
<p style="top:753.5pt;left:67.9pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">VOL. 100-B, No. 3, MARCH 2018</span></p>
<p style="top:478.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">the 154 studies that underwent full manuscript review</span></p>
<p style="top:490.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">42 studies did not meet the required criteria (Fig. 1). The</span></p>
<p style="top:502.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">remaining 112 studies (92 animal studies and 20 clinical</span></p>
<p style="top:514.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">trials) met the inclusion criteria (Tables II and III). The</span></p>
<p style="top:526.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">interventions studied fell into seven broad categories (Table</span></p>
<p style="top:538.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">IV).</span></p>
<p style="top:551.1pt;left:67.9pt;line-height:8.5pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:8.5pt;color:#424242">Animal studies. </span></b><span style="font-family:Sabon,serif;font-size:9.5pt">The rabbit was the most common animal</span></p>
<p style="top:562.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">model (55 studies), followed by rodent (12 studies), sheep</span></p>
<p style="top:574.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">(eight studies), goat and pig (six studies each) and dog (five</span></p>
<p style="top:586.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">studies). The number of animals used ranged from six to</span></p>
<p style="top:598.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">176, with a median of 36. Follow-up ranged from three</span></p>
<p style="top:610.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">weeks to 72 weeks, with a median of 12 weeks. Different</span></p>
<p style="top:622.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">ACLR graft types were used: the three most common were</span></p>
<p style="top:634.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">hamstring tendon (n = 25), flexor tendon of the lower limb</span></p>
<p style="top:646.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">(n = 18) and extensor tendon (n = 15). Two studies</span></p>
<p style="top:658.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">investigated both hamstring and flexor tendon grafts. A</span></p>
<p style="top:670.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">total of 15 studies used synthetic scaffolds; the two most</span></p>
<p style="top:682.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">common </span></p>
<p style="top:682.3pt;left:114.6pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">were </span></p>
<p style="top:682.3pt;left:144.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">silk </span></p>
<p style="top:682.3pt;left:169.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">scaffolds </span></p>
<p style="top:682.3pt;left:216.6pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">(eight </span></p>
<p style="top:682.3pt;left:250.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">studies) </span></p>
<p style="top:682.3pt;left:292.6pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">and</span></p>
<p style="top:694.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">polyethylene terephthalate (PET, seven studies). The grafts</span></p>
<p style="top:706.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">were investigated in one limb (unilaterally) in 45 studies</span></p>
<p style="top:718.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">and in both limbs (bilaterally) in 47 studies. The graft-</span></p>
<p style="top:730.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">tunnel interface was the target of biological intervention in</span></p>
<p style="top:478.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">63 studies (68%), whereas ligamentization was the target in</span></p>
<p style="top:490.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">20 studies; nine studies examined both sites. The most</span></p>
<p style="top:502.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">commonly </span></p>
<p style="top:502.3pt;left:377.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">investigated </span></p>
<p style="top:502.3pt;left:441.2pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">categories </span></p>
<p style="top:502.3pt;left:496.6pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">of </span></p>
<p style="top:502.3pt;left:519.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">biological</span></p>
<p style="top:514.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">intervention were biomaterials (29 studies) and growth</span></p>
<p style="top:526.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">factors (24 studies). The remaining categories were seen in</span></p>
<p style="top:538.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">the following frequencies: stem cells (13 studies),</span></p>
<p style="top:550.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">autologous tissue (ten studies), gene therapy (nine studies,</span></p>
<p style="top:562.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">of which seven concerned genetically modified stem cells),</span></p>
<p style="top:574.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">pharmaceuticals (six studies), and biophysical interventions</span></p>
<p style="top:586.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">(four studies). Seven studies combined different categories</span></p>
<p style="top:598.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">of intervention in the same study. The most common</span></p>
<p style="top:610.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">growth factors evaluated were bone morphogenic proteins</span></p>
<p style="top:622.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">(eight studies) and PRP (four studies). Of the animal</span></p>
<p style="top:634.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">studies, positive findings were seen in 86/92 studies (92%),</span></p>
<p style="top:646.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">negative findings in two (both investigating growth factors)</span></p>
<p style="top:658.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">and no difference in five (two studies of growth factors, two</span></p>
<p style="top:670.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">of autologous tissue, and one study of gene therapy).</span></p>
<p style="top:683.1pt;left:319.9pt;line-height:8.5pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:8.5pt;color:#424242">Study quality. </span></b><span style="font-family:Sabon,serif;font-size:9.5pt">The methodological quality scores for</span></p>
<p style="top:694.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">animal studies ranged from 4/8 to 8/8 (Table II), with 89/92</span></p>
<p style="top:706.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">of studies (97%) having a score of at least five points</span></p>
<p style="top:718.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">(considered </span></p>
<p style="top:718.3pt;left:378.4pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">to </span></p>
<p style="top:718.3pt;left:398.3pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">be </span></p>
<p style="top:718.3pt;left:419.4pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">the </span></p>
<p style="top:718.3pt;left:443.5pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">threshold </span></p>
<p style="top:718.3pt;left:493.6pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">for </span></p>
<p style="top:718.3pt;left:517.2pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">acceptable</span></p>
<p style="top:730.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">methodological quality). Excellent inter-rater reliability</span></p>
<p style="top:86.2pt;left:168.3pt;line-height:6.0pt"><span style="font-family:UniversCE,serif;font-size:6.0pt">Initial results of publication searches (n = 1879)</span></p>
<p style="top:95.5pt;left:208.3pt;line-height:6.0pt"><span style="font-family:UniversCE,serif;font-size:6.0pt">MEDLINE (n = 243)</span></p>
<p style="top:105.2pt;left:209.2pt;line-height:6.0pt"><span style="font-family:UniversCE,serif;font-size:6.0pt">EMBASE (n = 343)</span></p>
<p style="top:114.7pt;left:199.5pt;line-height:6.0pt"><span style="font-family:UniversCE,serif;font-size:6.0pt">Web of science (n =1289)</span></p>
<p style="top:124.3pt;left:204.7pt;line-height:6.0pt"><span style="font-family:UniversCE,serif;font-size:6.0pt">Bibliographies (n = 4)</span></p>
<p style="top:197.1pt;left:196.2pt;line-height:6.0pt"><span style="font-family:UniversCE,serif;font-size:6.0pt">Results screened (n = 1422)</span></p>
<p style="top:121.9pt;left:128.6pt;line-height:6.0pt"><span style="font-family:UniversCE,serif;font-size:6.0pt">Identification</span></p>
<p style="top:206.2pt;left:128.6pt;line-height:6.0pt"><span style="font-family:UniversCE,serif;font-size:6.0pt">Screening</span></p>
<p style="top:294.0pt;left:128.6pt;line-height:6.0pt"><span style="font-family:UniversCE,serif;font-size:6.0pt">Eligibility</span></p>
<p style="top:381.5pt;left:128.6pt;line-height:6.0pt"><span style="font-family:UniversCE,serif;font-size:6.0pt">Included</span></p>
<p style="top:165.6pt;left:339.3pt;line-height:6.0pt"><span style="font-family:UniversCE,serif;font-size:6.0pt">Duplicates removed (n = 457)</span></p>
<p style="top:225.6pt;left:343.9pt;line-height:6.0pt"><span style="font-family:UniversCE,serif;font-size:6.0pt">Excluded according to selection criteria (n = 1268)</span></p>
<p style="top:274.8pt;left:340.6pt;line-height:6.0pt"><span style="font-family:UniversCE,serif;font-size:6.0pt">Full-text articles (n = 42) excluded due to:</span></p>
<p style="top:293.4pt;left:359.7pt;line-height:6.0pt"><span style="font-family:UniversCE,serif;font-size:6.0pt">&#x2013; Bio-enhanced repair (n = 15)</span></p>
<p style="top:303.3pt;left:359.7pt;line-height:6.0pt"><span style="font-family:UniversCE,serif;font-size:6.0pt">&#x2013; Full text unavailable (n = 11)</span></p>
<p style="top:312.4pt;left:359.7pt;line-height:6.0pt"><span style="font-family:UniversCE,serif;font-size:6.0pt">&#x2013; No control group (n = 8)</span></p>
<p style="top:322.3pt;left:359.7pt;line-height:6.0pt"><span style="font-family:UniversCE,serif;font-size:6.0pt">&#x2013; Not ACLR (extra-articular model) (n = 4)</span></p>
<p style="top:331.6pt;left:359.7pt;line-height:6.0pt"><span style="font-family:UniversCE,serif;font-size:6.0pt">&#x2013; Same study population in two studies (n = 2)</span></p>
<p style="top:340.8pt;left:359.7pt;line-height:6.0pt"><span style="font-family:UniversCE,serif;font-size:6.0pt">&#x2013; Duplicate studies in Chinese/English (n = 1)</span></p>
<p style="top:349.9pt;left:359.7pt;line-height:6.0pt"><span style="font-family:UniversCE,serif;font-size:6.0pt">&#x2013; Outcome was muscle atrophy (n = 1)</span></p>
<p style="top:254.0pt;left:167.0pt;line-height:6.0pt"><span style="font-family:UniversCE,serif;font-size:6.0pt">Full-text articles assessed for eligibility (n = 154)</span></p>
<p style="top:370.9pt;left:198.2pt;line-height:6.0pt"><span style="font-family:UniversCE,serif;font-size:6.0pt">Studies included (n = 112)</span></p>
<p style="top:389.8pt;left:206.5pt;line-height:6.0pt"><span style="font-family:UniversCE,serif;font-size:6.0pt">Clinical trials, n = 20</span></p>
<p style="top:399.3pt;left:203.5pt;line-height:6.0pt"><span style="font-family:UniversCE,serif;font-size:6.0pt">Animal studies, n = 92</span></p>
<p style="top:420.6pt;left:306.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Fig. 1</span></p>
<p style="top:443.7pt;left:175.9pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">A flowchart outlining the selection of studies for inclusion in this systematic review.</span></p>


<img style="position:absolute;transform:matrix(.3200452,0,-0,.31638713,47.153337,979.88009)" src="data:image/png;base64,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">
<p style="top:49.8pt;left:52.1pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">274</span></p>
<p style="top:49.8pt;left:203.2pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">A. T. HEXTER, T. THANGARAJAH, G. BLUNN, F. S. HADDAD</span></p>
<p style="top:753.5pt;left:70.0pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">Follow us @BoneJointJ</span></p>
<p style="top:753.5pt;left:447.7pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">THE BONE &amp; JOINT JOURNAL</span></p>
<p style="top:694.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">was seen between the two authors (intraclass correlation</span></p>
<p style="top:706.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">coefficient, ICC 0.910; 95% confidence interval 0.799 to</span></p>
<p style="top:718.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">0.952). Most (71/92) of the studies had outcome measures</span></p>
<p style="top:730.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">ranked at &#x2018;B&#x2019; (Table II).</span></p>
<p style="top:695.1pt;left:304.1pt;line-height:8.5pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:8.5pt;color:#424242">Clinical studies. </span></b><span style="font-family:Sabon,serif;font-size:9.5pt">Follow-up ranged from three to 36 months</span></p>
<p style="top:706.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">(median 12). The number of patients ranged from ten to</span></p>
<p style="top:718.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">150 (median 50). A total of 15 studies (80%) evaluated</span></p>
<p style="top:730.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">growth factors, all of which were in the form of platelet</span></p>
<p style="top:74.6pt;left:53.9pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Table II. Animal studies (n = 92) (see Table II continued on next page)</span></p>
<p style="top:95.6pt;left:53.9pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Author</span></b></p>
<p style="top:89.6pt;left:106.1pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Biological </span></b></p>
<p style="top:95.6pt;left:106.1pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">modulation</span></b></p>
<p style="top:89.6pt;left:151.1pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Category of</span></b></p>
<p style="top:95.6pt;left:151.1pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">intervention</span></b></p>
<p style="top:89.6pt;left:196.0pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Animal </span></b></p>
<p style="top:95.6pt;left:196.0pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">model</span></b></p>
<p style="top:95.6pt;left:221.5pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">n</span></b></p>
<p style="top:95.6pt;left:247.0pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">ACLR graft (uni/bi) Site of action</span></b></p>
<p style="top:95.6pt;left:337.1pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Groups (n)</span></b></p>
<p style="top:89.6pt;left:366.8pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Follow-up </span></b></p>
<p style="top:95.6pt;left:366.8pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">min to max</span></b></p>
<p style="top:95.6pt;left:398.4pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Outcome measures</span></b></p>
<p style="top:95.6pt;left:462.2pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Finding</span></b></p>
<p style="top:89.6pt;left:497.6pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Evidence </span></b></p>
<p style="top:95.6pt;left:497.6pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">level</span></b></p>
<p style="top:89.6pt;left:522.7pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Quality </span></b></p>
<p style="top:95.6pt;left:522.7pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">score</span></b></p>
<p style="top:104.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Wang et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">66</span></sup></p>
<p style="top:104.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Mg-based </span></p>
<p style="top:110.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interference screw</span></p>
<p style="top:104.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biomaterial</span></p>
<p style="top:104.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:104.9pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">112</span></p>
<p style="top:104.9pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Extensor (Bi)</span></p>
<p style="top:104.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:110.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:104.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:104.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3 wks to</span></p>
<p style="top:110.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">16 wks</span></p>
<p style="top:104.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical, </span></p>
<p style="top:110.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">imaging (pQCT)</span></p>
<p style="top:104.9pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:104.9pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:104.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:118.8pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Zhang et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">112</span></sup></p>
<p style="top:118.8pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Simvastatin</span></p>
<p style="top:118.8pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Pharmaceutical</span></p>
<p style="top:118.8pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:118.8pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">36</span></p>
<p style="top:118.8pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PET (Uni)</span></p>
<p style="top:118.8pt;left:293.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:124.8pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:118.8pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3</span></p>
<p style="top:118.8pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4 wks to </span></p>
<p style="top:124.8pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8 wks</span></p>
<p style="top:118.8pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC), </span></p>
<p style="top:124.8pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical</span></p>
<p style="top:118.8pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:118.8pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:118.8pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:132.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Zhang et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">112</span></sup></p>
<p style="top:132.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">ADSC - Runx2 </span></p>
<p style="top:138.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">transfected</span></p>
<p style="top:132.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Gene therapy </span></p>
<p style="top:138.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(Stem cell)</span></p>
<p style="top:132.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:132.9pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">30</span></p>
<p style="top:132.9pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring (Uni)</span></p>
<p style="top:132.9pt;left:293.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:138.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:132.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3</span></p>
<p style="top:132.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to</span></p>
<p style="top:138.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">52 wks</span></p>
<p style="top:132.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical, </span></p>
<p style="top:138.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">imaging (3D CT)</span></p>
<p style="top:132.9pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:132.9pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:132.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8</span></p>
<p style="top:146.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Teuschl et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">96</span></sup></p>
<p style="top:146.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">ADSC - seeded </span></p>
<p style="top:152.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">silk scaffold</span></p>
<p style="top:146.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Stem Cell</span></p>
<p style="top:146.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Sheep</span></p>
<p style="top:146.9pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">33</span></p>
<p style="top:146.9pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Silk (Uni)</span></p>
<p style="top:146.9pt;left:293.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Ligamentization</span></p>
<p style="top:146.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:146.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">26 wks to</span></p>
<p style="top:152.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">52 wks</span></p>
<p style="top:146.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology</span></p>
<p style="top:146.9pt;left:462.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:146.9pt;left:497.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">E</span></p>
<p style="top:146.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">5</span></p>
<p style="top:160.8pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Teng et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">21</span></sup></p>
<p style="top:160.8pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PRP, BMSC</span></p>
<p style="top:160.8pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor </span></p>
<p style="top:166.8pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Stem Cell</span></p>
<p style="top:160.8pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:160.8pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">30</span></p>
<p style="top:160.8pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring (Uni)</span></p>
<p style="top:160.8pt;left:293.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:166.8pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:160.8pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3</span></p>
<p style="top:160.8pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8 wks</span></p>
<p style="top:160.8pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical, </span></p>
<p style="top:166.8pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">imaging (microCT)</span></p>
<p style="top:160.8pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:160.8pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:160.8pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:174.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Takahashi et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">124</span></sup></p>
<p style="top:174.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Augmented </span></p>
<p style="top:180.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">remnant repair</span></p>
<p style="top:174.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Autologous</span></p>
<p style="top:180.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">tissue</span></p>
<p style="top:174.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Sheep</span></p>
<p style="top:174.9pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">42</span></p>
<p style="top:174.9pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring (Uni)</span></p>
<p style="top:174.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Ligamentization</span></p>
<p style="top:174.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:174.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4 wks to </span></p>
<p style="top:180.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:174.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Laxity testing Histology, </span></p>
<p style="top:180.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical</span></p>
<p style="top:174.9pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:174.9pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">A</span></p>
<p style="top:174.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8</span></p>
<p style="top:188.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Song et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">125</span></sup></p>
<p style="top:188.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Augmented </span></p>
<p style="top:194.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">remnant repair</span></p>
<p style="top:188.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Autologous </span></p>
<p style="top:194.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">tissue</span></p>
<p style="top:188.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:188.9pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">60</span></p>
<p style="top:188.9pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring (Uni)</span></p>
<p style="top:188.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Ligamentization</span></p>
<p style="top:188.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:188.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">24 wks</span></p>
<p style="top:188.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical</span></p>
<p style="top:188.9pt;left:462.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No difference B</span></p>
<p style="top:188.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8</span></p>
<p style="top:202.8pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Mutsuzaki 2016</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">86</span></sup></p>
<p style="top:202.8pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">CaP-hybridised </span></p>
<p style="top:208.8pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">tendon</span></p>
<p style="top:202.8pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biomaterial</span></p>
<p style="top:202.8pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Goat</span></p>
<p style="top:202.8pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">10</span></p>
<p style="top:202.8pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Flexor (Uni)</span></p>
<p style="top:202.8pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:208.8pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:202.8pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:202.8pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">24 wks</span></p>
<p style="top:202.8pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Laxity testing, Histology, </span></p>
<p style="top:208.8pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical, Imaging </span></p>
<p style="top:214.8pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(CT)</span></p>
<p style="top:202.8pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:202.8pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">A</span></p>
<p style="top:202.8pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">7</span></p>
<p style="top:222.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Li et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">99</span></sup></p>
<p style="top:222.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">BMSC-seeded</span></p>
<p style="top:228.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">silk scaffold</span></p>
<p style="top:222.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">tem Cell</span></p>
<p style="top:222.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:222.9pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">27</span></p>
<p style="top:222.9pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Silk (Bi)</span></p>
<p style="top:222.9pt;left:293.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:228.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:222.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:222.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">24 wks</span></p>
<p style="top:222.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical, </span></p>
<p style="top:228.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">imaging (microCT)</span></p>
<p style="top:222.9pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:222.9pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:222.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:236.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Kouroupis 2016</span></p>
<p style="top:236.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">hAT-MSCs and </span></p>
<p style="top:242.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">hiPSC-MSC</span></p>
<p style="top:236.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Stem Cell</span></p>
<p style="top:236.9pt;left:196.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Pig</span></p>
<p style="top:236.9pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:236.9pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Bioscaffold (Uni)</span></p>
<p style="top:236.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Ligamentization</span></p>
<p style="top:236.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3</span></p>
<p style="top:236.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">16 wks</span></p>
<p style="top:236.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC)</span></p>
<p style="top:236.9pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:236.9pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">C</span></p>
<p style="top:236.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">5</span></p>
<p style="top:250.8pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Kosaka et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">97</span></sup></p>
<p style="top:250.8pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">ADSC</span></p>
<p style="top:250.8pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Stem Cell</span></p>
<p style="top:250.8pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:250.8pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">80</span></p>
<p style="top:250.8pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring (Uni)</span></p>
<p style="top:250.8pt;left:293.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:256.8pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:250.8pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:250.8pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to </span></p>
<p style="top:256.8pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:250.8pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical</span></p>
<p style="top:250.8pt;left:462.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:250.8pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:250.8pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8</span></p>
<p style="top:264.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Kawakami</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">113</span></sup></p>
<p style="top:264.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">ACL CD34+ - BMP2 </span></p>
<p style="top:270.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">transfected</span></p>
<p style="top:264.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Gene therapy </span></p>
<p style="top:270.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(Stem cell)</span></p>
<p style="top:264.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rat</span></p>
<p style="top:264.9pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">48 (96)</span></p>
<p style="top:264.9pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Flexor (Bi)</span></p>
<p style="top:264.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:270.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:264.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4</span></p>
<p style="top:264.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to </span></p>
<p style="top:270.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8 wks</span></p>
<p style="top:264.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC), </span></p>
<p style="top:270.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical</span></p>
<p style="top:264.9pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:264.9pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:264.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">5</span></p>
<p style="top:278.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Jin et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">61</span></sup></p>
<p style="top:278.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hydroxyapatite-</span></p>
<p style="top:284.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">BMP coating</span></p>
<p style="top:278.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biomaterial, </span></p>
<p style="top:284.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:278.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:278.9pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">24</span></p>
<p style="top:278.9pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Silk (Bi)</span></p>
<p style="top:278.9pt;left:293.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:284.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:278.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4</span></p>
<p style="top:278.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">1 wks to </span></p>
<p style="top:284.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3 wks</span></p>
<p style="top:278.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC)</span></p>
<p style="top:278.9pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:278.9pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">C</span></p>
<p style="top:278.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">5</span></p>
<p style="top:292.8pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Dai et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">131</span></sup></p>
<p style="top:292.8pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Periosteum</span></p>
<p style="top:298.8pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">patch</span></p>
<p style="top:292.8pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Autologous </span></p>
<p style="top:298.8pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">tissue</span></p>
<p style="top:292.8pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Goat</span></p>
<p style="top:292.8pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12</span></p>
<p style="top:292.8pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PET (Uni)</span></p>
<p style="top:292.8pt;left:293.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:298.8pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:292.8pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:292.8pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">52 wks</span></p>
<p style="top:292.8pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical, </span></p>
<p style="top:298.8pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Imaging (CT, MRI)</span></p>
<p style="top:292.8pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:292.8pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:292.8pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">7</span></p>
<p style="top:306.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Chou et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">68</span></sup></p>
<p style="top:306.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PLGA/collagen </span></p>
<p style="top:312.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">nanofiber and </span></p>
<p style="top:318.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PLA bolt</span></p>
<p style="top:306.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biomaterial</span></p>
<p style="top:306.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:306.9pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">48</span></p>
<p style="top:306.9pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Extensor (Uni)</span></p>
<p style="top:306.9pt;left:293.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:312.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:306.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:306.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8 wks to</span></p>
<p style="top:312.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">16 wks</span></p>
<p style="top:306.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, mechanical</span></p>
<p style="top:306.9pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:306.9pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:306.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">5</span></p>
<p style="top:326.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Cheng et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">67</span></sup></p>
<p style="top:326.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Mg-based interfer-</span></p>
<p style="top:332.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">ence screw</span></p>
<p style="top:326.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biomaterial</span></p>
<p style="top:326.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:326.9pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">60</span></p>
<p style="top:326.9pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring (Uni)</span></p>
<p style="top:326.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:332.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:326.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:326.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3 wks to</span></p>
<p style="top:332.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">9 wks</span></p>
<p style="top:326.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC),</span></p>
<p style="top:332.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical, imaging </span></p>
<p style="top:338.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(microCT)</span></p>
<p style="top:326.9pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:326.9pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:326.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:346.8pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Chen et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">114</span></sup></p>
<p style="top:346.8pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">BMSC - bFGF/</span></p>
<p style="top:352.8pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">BMP2 transfected</span></p>
<p style="top:346.8pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Gene therapy </span></p>
<p style="top:352.8pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(Stem cell)</span></p>
<p style="top:346.8pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:346.8pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">32</span></p>
<p style="top:346.8pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring (Bi)</span></p>
<p style="top:346.8pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:352.8pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:346.8pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4</span></p>
<p style="top:346.8pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4 wks to</span></p>
<p style="top:352.8pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:346.8pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical, </span></p>
<p style="top:352.8pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">imaging (microCT)</span></p>
<p style="top:346.8pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:346.8pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:346.8pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">7</span></p>
<p style="top:360.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Takayama et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">115</span></sup></p>
<p style="top:360.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">ACL CD34+ -VEGF </span></p>
<p style="top:366.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">transfected</span></p>
<p style="top:360.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Gene therapy </span></p>
<p style="top:366.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(Stem cell)</span></p>
<p style="top:360.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rat</span></p>
<p style="top:360.9pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">60</span></p>
<p style="top:360.9pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Flexor (Bi)</span></p>
<p style="top:360.9pt;left:293.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Ligamentization</span></p>
<p style="top:360.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">5</span></p>
<p style="top:360.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to</span></p>
<p style="top:366.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8 wks</span></p>
<p style="top:360.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC),</span></p>
<p style="top:366.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical</span></p>
<p style="top:360.9pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No difference B</span></p>
<p style="top:360.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:374.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Li et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">120</span></sup></p>
<p style="top:374.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Augmented rem-</span></p>
<p style="top:380.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">nant repair</span></p>
<p style="top:374.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Autologous </span></p>
<p style="top:380.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">tissue</span></p>
<p style="top:374.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Goat</span></p>
<p style="top:374.9pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12</span></p>
<p style="top:374.9pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PET (Bi)</span></p>
<p style="top:374.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Ligamentization</span></p>
<p style="top:374.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:374.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">24 wks to</span></p>
<p style="top:380.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">52 wks</span></p>
<p style="top:374.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC)</span></p>
<p style="top:374.9pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:374.9pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">C</span></p>
<p style="top:374.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">5</span></p>
<p style="top:388.8pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Leong et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">22</span></sup></p>
<p style="top:388.8pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">bFGF</span></p>
<p style="top:388.8pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:388.8pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rat</span></p>
<p style="top:388.8pt;left:221.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">44</span></p>
<p style="top:388.8pt;left:246.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PCL (Uni)</span></p>
<p style="top:388.8pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Ligamentization</span></p>
<p style="top:388.8pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4</span></p>
<p style="top:388.8pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8 wks to </span></p>
<p style="top:394.8pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">16 wks</span></p>
<p style="top:388.8pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC), </span></p>
<p style="top:394.8pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical</span></p>
<p style="top:388.8pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:388.8pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:388.8pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8</span></p>
<p style="top:402.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Jang et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">101</span></sup></p>
<p style="top:402.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">hUCB-MSCs</span></p>
<p style="top:402.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Stem cell</span></p>
<p style="top:402.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:402.9pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">30</span></p>
<p style="top:402.9pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring (Uni)</span></p>
<p style="top:402.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:408.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:402.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:402.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4 wks to</span></p>
<p style="top:408.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:402.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC), imaging </span></p>
<p style="top:408.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(microCT)</span></p>
<p style="top:402.9pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:402.9pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:402.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:416.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hensler et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">23</span></sup></p>
<p style="top:416.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Fibrin clot</span></p>
<p style="top:416.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:416.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Goat</span></p>
<p style="top:416.9pt;left:221.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8</span></p>
<p style="top:416.9pt;left:246.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Achilles (Uni)</span></p>
<p style="top:416.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Ligamentization</span></p>
<p style="top:416.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:416.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:416.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC), biome-</span></p>
<p style="top:422.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">chanical, Imaging (MRI)</span></p>
<p style="top:416.9pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:416.9pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:416.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8</span></p>
<p style="top:430.8pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Han et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">75</span></sup></p>
<p style="top:430.8pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PCL/nHAp/Col- </span></p>
<p style="top:436.8pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">wrapped tendon</span></p>
<p style="top:430.8pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biomaterial</span></p>
<p style="top:430.8pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:430.8pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">24</span></p>
<p style="top:430.8pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring (Uni)</span></p>
<p style="top:430.8pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:436.8pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:430.8pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:430.8pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4 wks to</span></p>
<p style="top:436.8pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8 wks</span></p>
<p style="top:430.8pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical</span></p>
<p style="top:430.8pt;left:462.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:430.8pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:430.8pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:444.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Fleming et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">24</span></sup></p>
<p style="top:444.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PRP-ECM scaffold Growth factor</span></p>
<p style="top:444.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Mini-pig</span></p>
<p style="top:444.9pt;left:221.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">55</span></p>
<p style="top:444.9pt;left:246.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PET (Bi)</span></p>
<p style="top:444.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Ligamentization</span></p>
<p style="top:444.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">5</span></p>
<p style="top:444.9pt;left:366.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">15 wks</span></p>
<p style="top:444.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Laxity testing Histology, </span></p>
<p style="top:450.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical</span></p>
<p style="top:444.9pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:444.9pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">A</span></p>
<p style="top:444.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8</span></p>
<p style="top:458.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Bi et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">73</span></sup></p>
<p style="top:458.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Collagen matrix</span></p>
<p style="top:458.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biomaterial</span></p>
<p style="top:458.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:458.9pt;left:221.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">20</span></p>
<p style="top:458.9pt;left:246.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Silk (Uni)</span></p>
<p style="top:458.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Both</span></p>
<p style="top:458.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:458.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4 wks to</span></p>
<p style="top:464.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">16 wks</span></p>
<p style="top:458.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC), </span></p>
<p style="top:464.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical, imaging </span></p>
<p style="top:470.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(microCT)</span></p>
<p style="top:458.9pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:458.9pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:458.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">7</span></p>
<p style="top:478.8pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Song et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">121</span></sup></p>
<p style="top:478.8pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Augmented </span></p>
<p style="top:484.8pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">remnant repair</span></p>
<p style="top:478.8pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Autologous</span></p>
<p style="top:484.8pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">tissue</span></p>
<p style="top:478.8pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:478.8pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">50</span></p>
<p style="top:478.8pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring (Uni)</span></p>
<p style="top:478.8pt;left:293.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Ligamentization</span></p>
<p style="top:478.8pt;left:337.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:478.8pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:478.8pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Laxity testing, </span></p>
<p style="top:484.8pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical</span></p>
<p style="top:478.8pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No difference A</span></p>
<p style="top:478.8pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8</span></p>
<p style="top:492.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Shen et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">74</span></sup></p>
<p style="top:492.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Collagen matrix</span></p>
<p style="top:492.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biomaterial</span></p>
<p style="top:492.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:492.9pt;left:221.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">15 (30)</span></p>
<p style="top:492.9pt;left:246.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Silk (Bi)</span></p>
<p style="top:492.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Both</span></p>
<p style="top:492.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:492.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8 wks to </span></p>
<p style="top:498.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">72 wks</span></p>
<p style="top:492.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC),</span></p>
<p style="top:498.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical, imaging </span></p>
<p style="top:504.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(microCT)</span></p>
<p style="top:492.9pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:492.9pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:492.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:512.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Lui et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">102</span></sup></p>
<p style="top:512.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">TDSC sheet </span></p>
<p style="top:518.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">wrapped tendon</span></p>
<p style="top:512.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Stem cell</span></p>
<p style="top:512.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rat</span></p>
<p style="top:512.9pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">97</span></p>
<p style="top:512.9pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Flexor (Uni)</span></p>
<p style="top:512.9pt;left:293.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Both</span></p>
<p style="top:512.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:512.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to</span></p>
<p style="top:518.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:512.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC), </span></p>
<p style="top:518.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical, imaging </span></p>
<p style="top:524.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(microCT)</span></p>
<p style="top:512.9pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:512.9pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:512.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:532.8pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Li et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">25</span></sup></p>
<p style="top:532.8pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">TCP/PEEK anchor Biomaterial</span></p>
<p style="top:532.8pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Pig</span></p>
<p style="top:532.8pt;left:221.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">14</span></p>
<p style="top:532.8pt;left:246.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Silk (Uni)</span></p>
<p style="top:532.8pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:538.8pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:532.8pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:532.8pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks to </span></p>
<p style="top:538.8pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">24 wks</span></p>
<p style="top:532.8pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, </span></p>
<p style="top:538.8pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical</span></p>
<p style="top:532.8pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:532.8pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:532.8pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">7</span></p>
<p style="top:546.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Li et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">44</span></sup></p>
<p style="top:546.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Human fibronec-</span></p>
<p style="top:552.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">tin coating</span></p>
<p style="top:546.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:546.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rat</span></p>
<p style="top:546.9pt;left:221.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">20</span></p>
<p style="top:546.9pt;left:246.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PET (Uni)</span></p>
<p style="top:546.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Ligamentization</span></p>
<p style="top:546.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:546.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4 wks</span></p>
<p style="top:546.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC) Imaging </span></p>
<p style="top:552.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(SEM)</span></p>
<p style="top:546.9pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:546.9pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">C</span></p>
<p style="top:546.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">7</span></p>
<p style="top:560.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Kuang et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">87</span></sup></p>
<p style="top:560.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Sr-CPC and</span></p>
<p style="top:566.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">CPC</span></p>
<p style="top:560.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biomaterial</span></p>
<p style="top:560.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:560.9pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">15 (30)</span></p>
<p style="top:560.9pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Achilles (Bi)</span></p>
<p style="top:560.9pt;left:293.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:566.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:560.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:560.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3 wks to</span></p>
<p style="top:566.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">24 wks</span></p>
<p style="top:560.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (HM)</span></p>
<p style="top:560.9pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:560.9pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">C</span></p>
<p style="top:560.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">5</span></p>
<p style="top:574.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hsu et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">76</span></sup></p>
<p style="top:574.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">DBM</span></p>
<p style="top:574.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Bone substitute</span></p>
<p style="top:574.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:574.9pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">10</span></p>
<p style="top:574.9pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Extensor (Uni)</span></p>
<p style="top:574.9pt;left:293.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:580.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:574.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:574.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4 wks to </span></p>
<p style="top:580.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:574.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC), </span></p>
<p style="top:580.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Radiographs</span></p>
<p style="top:574.9pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:574.9pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">C</span></p>
<p style="top:574.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8</span></p>
<p style="top:588.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Bi et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">138</span></sup></p>
<p style="top:588.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PTH (injection)</span></p>
<p style="top:588.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Pharmaceutical</span></p>
<p style="top:588.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rat</span></p>
<p style="top:588.9pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">20</span></p>
<p style="top:588.9pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Flexor (Uni)</span></p>
<p style="top:588.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone </span></p>
<p style="top:594.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:588.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:588.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4 wks</span></p>
<p style="top:588.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC), </span></p>
<p style="top:594.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical, imaging </span></p>
<p style="top:600.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(microCT)</span></p>
<p style="top:588.9pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:588.9pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:588.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:608.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Zhu et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">100</span></sup></p>
<p style="top:608.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">BMSC-seeded </span></p>
<p style="top:614.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PLGA scaffold</span></p>
<p style="top:608.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Stem cell</span></p>
<p style="top:608.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:608.9pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">48</span></p>
<p style="top:608.9pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring (Bi)</span></p>
<p style="top:608.9pt;left:293.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:614.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:608.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3</span></p>
<p style="top:608.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4 wks to </span></p>
<p style="top:614.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:608.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical, </span></p>
<p style="top:614.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">imaging (microCT)</span></p>
<p style="top:608.9pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:608.9pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:608.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">7</span></p>
<p style="top:622.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Zhai et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">62</span></sup></p>
<p style="top:622.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PRP, DBP</span></p>
<p style="top:622.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor, </span></p>
<p style="top:628.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Bone substitute</span></p>
<p style="top:622.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:622.9pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">48</span></p>
<p style="top:622.9pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring (Bi)</span></p>
<p style="top:622.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:628.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:622.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4</span></p>
<p style="top:622.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to</span></p>
<p style="top:628.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:622.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical, </span></p>
<p style="top:628.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">imaging (microCT)</span></p>
<p style="top:622.9pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:622.9pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:622.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:636.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Weimin et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">26</span></sup></p>
<p style="top:636.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">CaP cement,</span></p>
<p style="top:642.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">RBX</span></p>
<p style="top:636.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biomaterial, Bone </span></p>
<p style="top:642.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">substitute</span></p>
<p style="top:636.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:636.9pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">90</span></p>
<p style="top:636.9pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Extensor (Bi)</span></p>
<p style="top:636.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:642.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:636.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3</span></p>
<p style="top:636.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6 wks to</span></p>
<p style="top:642.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">24 wks</span></p>
<p style="top:636.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical, </span></p>
<p style="top:642.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">imaging (microCT)</span></p>
<p style="top:636.9pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:636.9pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:636.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">5</span></p>
<p style="top:650.9pt;left:53.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Vaquette et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">72</span></sup></p>
<p style="top:650.9pt;left:106.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PolyNaSS</span></p>
<p style="top:650.9pt;left:151.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biomaterial</span></p>
<p style="top:650.9pt;left:196.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Sheep</span></p>
<p style="top:650.9pt;left:221.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">51</span></p>
<p style="top:650.9pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">LARS (Uni)</span></p>
<p style="top:650.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:656.9pt;left:293.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:650.9pt;left:337.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:650.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks to</span></p>
<p style="top:656.9pt;left:366.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">52 wks</span></p>
<p style="top:650.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical, </span></p>
<p style="top:656.9pt;left:398.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">imaging (microCT)</span></p>
<p style="top:650.9pt;left:462.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:650.9pt;left:497.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:650.9pt;left:522.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8</span></p>


<p style="top:49.8pt;left:138.0pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">BIOLOGICAL AUGMENTATION OF GRAFT HEALING IN ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION</span></p>
<p style="top:49.8pt;left:549.0pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">275</span></p>
<p style="top:753.5pt;left:67.9pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">VOL. 100-B, No. 3, MARCH 2018</span></p>
<p style="top:694.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">concentrates, such as PRP; the remainder studied platelet</span></p>
<p style="top:706.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">rich fibrin matrix, autologous serum, platelet leucocyte gel</span></p>
<p style="top:718.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">and autologous platelet concentrate. All interventions were</span></p>
<p style="top:730.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">administered at the time of surgery except four studies</span></p>
<p style="top:694.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">which </span></p>
<p style="top:694.3pt;left:355.3pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">included </span></p>
<p style="top:694.3pt;left:400.6pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">post-operative </span></p>
<p style="top:694.3pt;left:469.8pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">interventions. </span></p>
<p style="top:694.3pt;left:536.2pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">These</span></p>
<p style="top:706.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">included one study evaluating postoperative extracorporeal</span></p>
<p style="top:718.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">shockwave therapy (ESWT)</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">147</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> and three studies evaluating</span></p>
<p style="top:730.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">post-operative joint injections of growth factors in the form</span></p>
<p style="top:77.2pt;left:68.8pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Table II. Animal studies (n = 92) (cont.)</span></p>
<p style="top:98.2pt;left:68.8pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Author</span></b></p>
<p style="top:92.2pt;left:122.2pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Biological </span></b></p>
<p style="top:98.2pt;left:122.2pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">modulation</span></b></p>
<p style="top:92.2pt;left:167.2pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Category of </span></b></p>
<p style="top:98.2pt;left:167.2pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">intervention</span></b></p>
<p style="top:92.2pt;left:208.4pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Animal </span></b></p>
<p style="top:98.2pt;left:208.4pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">model</span></b></p>
<p style="top:98.2pt;left:233.8pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">n</span></b></p>
<p style="top:98.2pt;left:259.2pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">ACLR graft (uni/bi) Site of action</span></b></p>
<p style="top:98.2pt;left:348.9pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Groups (n)</span></b></p>
<p style="top:92.2pt;left:381.5pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Follow-up </span></b></p>
<p style="top:98.2pt;left:381.5pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">min to max Outcome measures</span></b></p>
<p style="top:98.2pt;left:486.6pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Finding</span></b></p>
<p style="top:92.2pt;left:514.4pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Evidence </span></b></p>
<p style="top:98.2pt;left:514.4pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">level</span></b></p>
<p style="top:92.2pt;left:539.6pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Quality </span></b></p>
<p style="top:98.2pt;left:539.6pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">score</span></b></p>
<p style="top:107.4pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Sun et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">122</span></sup></p>
<p style="top:107.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Augmented</span></p>
<p style="top:113.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">remnant repair</span></p>
<p style="top:107.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Autologous</span></p>
<p style="top:107.4pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:107.4pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">48 (96)</span></p>
<p style="top:107.4pt;left:259.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Achilles (Bi)</span></p>
<p style="top:107.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Both</span></p>
<p style="top:107.4pt;left:348.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:107.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4 wks to</span></p>
<p style="top:113.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:107.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical</span></p>
<p style="top:107.4pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:107.4pt;left:514.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:107.4pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:121.4pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Sun et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">123</span></sup></p>
<p style="top:121.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Muscle remnant </span></p>
<p style="top:127.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(SMDSC)</span></p>
<p style="top:121.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Autologous </span></p>
<p style="top:127.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">tissue</span></p>
<p style="top:121.4pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:121.4pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">40</span></p>
<p style="top:121.4pt;left:259.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Achilles (Bi)</span></p>
<p style="top:121.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Ligamentization</span></p>
<p style="top:121.4pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:121.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to</span></p>
<p style="top:127.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8 wks</span></p>
<p style="top:121.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Laxity/Gait Histology,</span></p>
<p style="top:127.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical</span></p>
<p style="top:121.4pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:121.4pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">A</span></p>
<p style="top:121.4pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">7</span></p>
<p style="top:135.5pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Pan et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">149</span></sup></p>
<p style="top:135.5pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">ICPC-RBX, BMP</span></p>
<p style="top:135.5pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biomaterial, </span></p>
<p style="top:141.5pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:135.5pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:135.5pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">90 (180)</span></p>
<p style="top:135.5pt;left:259.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Extensor (Bi)</span></p>
<p style="top:135.5pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone </span></p>
<p style="top:141.5pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:135.5pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3</span></p>
<p style="top:135.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6 wks to</span></p>
<p style="top:141.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">24 wks</span></p>
<p style="top:135.5pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical, </span></p>
<p style="top:141.5pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">imaging (microCT)</span></p>
<p style="top:135.5pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:135.5pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:135.5pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:149.4pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Oka et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">139</span></sup></p>
<p style="top:149.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Simvastatin</span></p>
<p style="top:149.4pt;left:167.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Drug</span></p>
<p style="top:149.4pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:149.4pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">42</span></p>
<p style="top:149.4pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring (Bi)</span></p>
<p style="top:149.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:155.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:149.4pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:149.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to</span></p>
<p style="top:155.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8 wks</span></p>
<p style="top:149.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC), biomechani-</span></p>
<p style="top:155.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">cal, imaging (microCT)</span></p>
<p style="top:149.4pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:149.4pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:149.4pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">5</span></p>
<p style="top:163.4pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Murray et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">27</span></sup></p>
<p style="top:163.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Autologous </span></p>
<p style="top:169.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">blood-ECM </span></p>
<p style="top:175.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">scaffold</span></p>
<p style="top:163.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:163.4pt;left:208.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Mini-pig</span></p>
<p style="top:163.4pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">64</span></p>
<p style="top:163.4pt;left:259.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Patella (Uni)</span></p>
<p style="top:163.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Ligamentization</span></p>
<p style="top:163.4pt;left:348.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4</span></p>
<p style="top:163.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">24 wks to 52 </span></p>
<p style="top:169.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">wks</span></p>
<p style="top:163.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Laxity Histology (IHC),</span></p>
<p style="top:169.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical</span></p>
<p style="top:163.4pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No</span></p>
<p style="top:169.4pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">difference</span></p>
<p style="top:163.4pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">A</span></p>
<p style="top:163.4pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">7</span></p>
<p style="top:183.5pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Mifune et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">103</span></sup></p>
<p style="top:183.5pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">ACL-derived cell </span></p>
<p style="top:189.5pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">sheet</span></p>
<p style="top:183.5pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Stem cell</span></p>
<p style="top:183.5pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rat</span></p>
<p style="top:183.5pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">27</span></p>
<p style="top:183.5pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Flexor (Bi)</span></p>
<p style="top:183.5pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Both</span></p>
<p style="top:183.5pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3</span></p>
<p style="top:183.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to</span></p>
<p style="top:189.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8 wks</span></p>
<p style="top:183.5pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical</span></p>
<p style="top:183.5pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:183.5pt;left:514.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:183.5pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">7</span></p>
<p style="top:197.4pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Lui et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">136</span></sup></p>
<p style="top:197.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Alendronate</span></p>
<p style="top:203.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(local)</span></p>
<p style="top:197.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Pharmaceutical</span></p>
<p style="top:197.4pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rat</span></p>
<p style="top:197.4pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">72</span></p>
<p style="top:197.4pt;left:259.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Flexor (Uni)</span></p>
<p style="top:197.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:203.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:197.4pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3</span></p>
<p style="top:197.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to </span></p>
<p style="top:203.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6 wks</span></p>
<p style="top:197.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical, </span></p>
<p style="top:203.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">imaging (CT)</span></p>
<p style="top:197.4pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:197.4pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:197.4pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">7</span></p>
<p style="top:211.4pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Lui et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">137</span></sup></p>
<p style="top:211.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Alendronate</span></p>
<p style="top:217.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(systemic)</span></p>
<p style="top:211.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Pharmaceutical</span></p>
<p style="top:211.4pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rat</span></p>
<p style="top:211.4pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">84</span></p>
<p style="top:211.4pt;left:259.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Flexor (Uni)</span></p>
<p style="top:211.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone </span></p>
<p style="top:217.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:211.4pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3</span></p>
<p style="top:211.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to</span></p>
<p style="top:217.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6 wks</span></p>
<p style="top:211.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical, </span></p>
<p style="top:217.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">imaging (CT)</span></p>
<p style="top:211.4pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:211.4pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:211.4pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8</span></p>
<p style="top:225.5pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Cho et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">71</span></sup></p>
<p style="top:225.5pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Gelatin and</span></p>
<p style="top:231.5pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">hyaluronic</span></p>
<p style="top:237.5pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">acid coating</span></p>
<p style="top:225.5pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biomaterial</span></p>
<p style="top:225.5pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Pig</span></p>
<p style="top:225.5pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:225.5pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PET (Uni)</span></p>
<p style="top:225.5pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:231.5pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:225.5pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:225.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:225.5pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, imaging</span></p>
<p style="top:231.5pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(microCT)</span></p>
<p style="top:225.5pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:225.5pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">C</span></p>
<p style="top:225.5pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">5</span></p>
<p style="top:245.4pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Mutsuzaki et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">89</span></sup></p>
<p style="top:245.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">CaP-hybridised </span></p>
<p style="top:251.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">tendon graft</span></p>
<p style="top:245.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biomaterial</span></p>
<p style="top:245.4pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Goat</span></p>
<p style="top:245.4pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12</span></p>
<p style="top:245.4pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring, Flexor</span></p>
<p style="top:245.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:251.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:245.4pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:245.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">24 wks</span></p>
<p style="top:245.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical, </span></p>
<p style="top:251.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">imaging (microCT)</span></p>
<p style="top:245.4pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:245.4pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:245.4pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">7</span></p>
<p style="top:259.4pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Mifune et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">104</span></sup></p>
<p style="top:259.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">ACL-derived CD34+ </span></p>
<p style="top:265.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">cells (injected)</span></p>
<p style="top:259.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Stem cell</span></p>
<p style="top:259.4pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rat</span></p>
<p style="top:259.4pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">40</span></p>
<p style="top:259.4pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Flexor (Bi)</span></p>
<p style="top:259.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:265.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:259.4pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4</span></p>
<p style="top:259.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to</span></p>
<p style="top:265.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8 wks</span></p>
<p style="top:259.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC) biomechanical, </span></p>
<p style="top:265.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">imaging (microCT)</span></p>
<p style="top:259.4pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:259.4pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:259.4pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:273.5pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Matsumoto et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">119</span></sup></p>
<p style="top:273.5pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Augmented</span></p>
<p style="top:279.5pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">remnant repair</span></p>
<p style="top:273.5pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Autologous</span></p>
<p style="top:273.5pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Dog</span></p>
<p style="top:273.5pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">20 (40)</span></p>
<p style="top:273.5pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Flexor (Bi)</span></p>
<p style="top:273.5pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:279.5pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:273.5pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:273.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to</span></p>
<p style="top:279.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4 wks</span></p>
<p style="top:273.5pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC), biomechani-</span></p>
<p style="top:279.5pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">cal, imaging (microCT)</span></p>
<p style="top:273.5pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:273.5pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:273.5pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">5</span></p>
<p style="top:287.4pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Lovric et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">78</span></sup></p>
<p style="top:287.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">DBM</span></p>
<p style="top:287.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Bone substitute</span></p>
<p style="top:287.4pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rat</span></p>
<p style="top:287.4pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">56</span></p>
<p style="top:287.4pt;left:259.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Flexor (Uni)</span></p>
<p style="top:287.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone </span></p>
<p style="top:293.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:287.4pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:287.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to</span></p>
<p style="top:293.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6 wks</span></p>
<p style="top:287.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC), biomechani-</span></p>
<p style="top:293.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">cal, imaging (microCT)</span></p>
<p style="top:287.4pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:287.4pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:287.4pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8</span></p>
<p style="top:301.4pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Li 2012</span></p>
<p style="top:301.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Bioactive glass</span></p>
<p style="top:301.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biomaterial</span></p>
<p style="top:301.4pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:301.4pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">30</span></p>
<p style="top:301.4pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PET (Bi)</span></p>
<p style="top:301.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:307.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:301.4pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:301.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3 wks to </span></p>
<p style="top:307.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:301.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC),</span></p>
<p style="top:307.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical</span></p>
<p style="top:301.4pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:301.4pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:301.4pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:315.5pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Lee et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">28</span></sup></p>
<p style="top:315.5pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PRP</span></p>
<p style="top:315.5pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:315.5pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:315.5pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">20</span></p>
<p style="top:315.5pt;left:259.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">SIS (Uni)</span></p>
<p style="top:315.5pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:321.5pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:315.5pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:315.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">1 wks to</span></p>
<p style="top:321.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8 wks</span></p>
<p style="top:315.5pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC),</span></p>
<p style="top:321.5pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical, imaging (MRI)</span></p>
<p style="top:315.5pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Negative</span></p>
<p style="top:315.5pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:315.5pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8</span></p>
<p style="top:329.4pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Kadonishi et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">79</span></sup></p>
<p style="top:329.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Enamel matrix </span></p>
<p style="top:335.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">derivative</span></p>
<p style="top:329.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Bone subsitute l Rat</span></p>
<p style="top:329.4pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">30</span></p>
<p style="top:329.4pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Flexor (Bi)</span></p>
<p style="top:329.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:335.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:329.4pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:329.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4 wks to </span></p>
<p style="top:335.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:329.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical</span></p>
<p style="top:329.4pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:329.4pt;left:514.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:329.4pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:343.4pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Dong et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">116</span></sup></p>
<p style="top:343.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">BMSC-BMP2 </span></p>
<p style="top:349.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Transfected</span></p>
<p style="top:343.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Gene therapy </span></p>
<p style="top:349.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(Stem cell)</span></p>
<p style="top:343.4pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:343.4pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">30</span></p>
<p style="top:343.4pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Gastroc (Bi)</span></p>
<p style="top:343.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone </span></p>
<p style="top:349.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:343.4pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3</span></p>
<p style="top:343.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4 wks to </span></p>
<p style="top:349.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8 wks</span></p>
<p style="top:343.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical</span></p>
<p style="top:343.4pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:343.4pt;left:514.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:343.4pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:357.5pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Chen et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">29</span></sup></p>
<p style="top:357.5pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">VEGF-released</span></p>
<p style="top:363.5pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">system</span></p>
<p style="top:357.5pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:357.5pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:357.5pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">45</span></p>
<p style="top:357.5pt;left:259.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Patella (Bi)</span></p>
<p style="top:357.5pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Ligamentization</span></p>
<p style="top:357.5pt;left:348.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4</span></p>
<p style="top:357.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to</span></p>
<p style="top:363.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8 wks</span></p>
<p style="top:357.5pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical</span></p>
<p style="top:357.5pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:357.5pt;left:514.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:357.5pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:371.4pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Zhang et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">30</span></sup></p>
<p style="top:371.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">BMP, RBX</span></p>
<p style="top:371.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor, </span></p>
<p style="top:377.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Bone substitute</span></p>
<p style="top:371.4pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:371.4pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">51</span></p>
<p style="top:371.4pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Flexor (Bi)</span></p>
<p style="top:371.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone </span></p>
<p style="top:377.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:371.4pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3</span></p>
<p style="top:371.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6 wks to </span></p>
<p style="top:377.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:371.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical, </span></p>
<p style="top:377.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">imaging (microCT)</span></p>
<p style="top:371.4pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:371.4pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:371.4pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">5</span></p>
<p style="top:385.4pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Wei et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">31</span></sup></p>
<p style="top:385.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">TGF-b/VEGF </span></p>
<p style="top:391.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">transfected MSC</span></p>
<p style="top:385.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Gene therapy </span></p>
<p style="top:391.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(Stem cell)</span></p>
<p style="top:385.4pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:385.4pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">176</span></p>
<p style="top:385.4pt;left:259.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Achilles (Uni)</span></p>
<p style="top:385.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Ligamentization</span></p>
<p style="top:385.4pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4</span></p>
<p style="top:385.4pt;left:381.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3 wks to</span></p>
<p style="top:391.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">24 wks</span></p>
<p style="top:385.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC)</span></p>
<p style="top:391.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">, biomechanical</span></p>
<p style="top:385.4pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:385.4pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:385.4pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:399.5pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Pan et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">32</span></sup></p>
<p style="top:399.5pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">BMP, CPC </span></p>
<p style="top:405.5pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(injected) Fibrin </span></p>
<p style="top:411.5pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">sealant (inj.)</span></p>
<p style="top:399.5pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor, </span></p>
<p style="top:405.5pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomaterial</span></p>
<p style="top:399.5pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:399.5pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">51 (102)</span></p>
<p style="top:399.5pt;left:259.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Extensor (Bi)</span></p>
<p style="top:399.5pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:405.5pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:399.5pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3</span></p>
<p style="top:399.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to</span></p>
<p style="top:405.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:399.5pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC), biomechani-</span></p>
<p style="top:405.5pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">cal, imaging (microCT)</span></p>
<p style="top:399.5pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:399.5pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:399.5pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:419.4pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Mutsuzaki et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">90</span></sup></p>
<p style="top:419.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">CaP-hybridized </span></p>
<p style="top:425.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">tendon graft</span></p>
<p style="top:419.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biomaterial</span></p>
<p style="top:419.4pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Goat</span></p>
<p style="top:419.4pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">18</span></p>
<p style="top:419.4pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring, Flexor </span></p>
<p style="top:425.4pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(Uni)</span></p>
<p style="top:419.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:425.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:419.4pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3</span></p>
<p style="top:419.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">52 wks</span></p>
<p style="top:419.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Laxity Histology, biomechani-</span></p>
<p style="top:425.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">cal, imaging (microCT)</span></p>
<p style="top:419.4pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:419.4pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">A</span></p>
<p style="top:419.4pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">7</span></p>
<p style="top:433.4pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hashimoto et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">33</span></sup></p>
<p style="top:433.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">rhBMP-2</span></p>
<p style="top:433.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:433.4pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:433.4pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">40</span></p>
<p style="top:433.4pt;left:259.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring (Uni)</span></p>
<p style="top:433.4pt;left:305.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Ligamentization</span></p>
<p style="top:433.4pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:433.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4 wks to</span></p>
<p style="top:439.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8 wks</span></p>
<p style="top:433.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical, </span></p>
<p style="top:439.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">imaging (microCT)</span></p>
<p style="top:433.4pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:433.4pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:433.4pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">7</span></p>
<p style="top:447.5pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Wang et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">111</span></sup></p>
<p style="top:447.5pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">BMP-transected </span></p>
<p style="top:453.5pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">cells</span></p>
<p style="top:447.5pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Gene therapy</span></p>
<p style="top:447.5pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:447.5pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">36</span></p>
<p style="top:447.5pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Extensor (Uni)</span></p>
<p style="top:447.5pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:453.5pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:447.5pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:447.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">1 wks to</span></p>
<p style="top:453.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:447.5pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC), biomechani-</span></p>
<p style="top:453.5pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">cal, imaging (MRI)</span></p>
<p style="top:447.5pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:447.5pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:447.5pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:461.4pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Shen et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">91</span></sup></p>
<p style="top:461.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">CaP ceramic</span></p>
<p style="top:461.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biomaterial</span></p>
<p style="top:461.4pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:461.4pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">30</span></p>
<p style="top:461.4pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring (Bi)</span></p>
<p style="top:461.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:467.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:461.4pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:461.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4 wks to</span></p>
<p style="top:467.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:461.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (HM)</span></p>
<p style="top:461.4pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:461.4pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">D</span></p>
<p style="top:461.4pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">5</span></p>
<p style="top:475.4pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Nakase et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">34</span></sup></p>
<p style="top:475.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">HGF</span></p>
<p style="top:475.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:475.4pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:475.4pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">50</span></p>
<p style="top:475.4pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Extensor (Bi)</span></p>
<p style="top:475.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:481.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:475.4pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:475.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to </span></p>
<p style="top:481.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:475.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical</span></p>
<p style="top:475.4pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:475.4pt;left:514.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:475.4pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:489.5pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Kawai et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">69</span></sup></p>
<p style="top:489.5pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Chitin coating</span></p>
<p style="top:489.5pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biomaterial</span></p>
<p style="top:489.5pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:489.5pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">20</span></p>
<p style="top:489.5pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Polyester (Uni)</span></p>
<p style="top:489.5pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Both</span></p>
<p style="top:489.5pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:489.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8 wks</span></p>
<p style="top:489.5pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical</span></p>
<p style="top:489.5pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:489.5pt;left:514.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:489.5pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">7</span></p>
<p style="top:497.4pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Wen et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">92</span></sup></p>
<p style="top:497.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">CaP cement</span></p>
<p style="top:497.4pt;left:167.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biomaterial</span></p>
<p style="top:497.4pt;left:208.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:497.4pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">28 (56)</span></p>
<p style="top:497.4pt;left:259.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Extensor (Bi)</span></p>
<p style="top:497.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:503.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:497.4pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:497.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6 wks to </span></p>
<p style="top:503.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:497.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical, </span></p>
<p style="top:503.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">imaging (microCT)</span></p>
<p style="top:497.4pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:497.4pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:497.4pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:511.4pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Papatheodorou et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">145</span></sup><span style="font-family:Univers55,serif;font-size:5.0pt">LIPUS</span></p>
<p style="top:511.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biophysical</span></p>
<p style="top:511.4pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:511.4pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">52</span></p>
<p style="top:511.4pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Extensor (Bi)</span></p>
<p style="top:511.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:517.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:511.4pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:511.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3 wks</span></p>
<p style="top:511.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (rtPCR)</span></p>
<p style="top:511.4pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:511.4pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">C</span></p>
<p style="top:511.4pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:525.5pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Pan et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">60</span></sup></p>
<p style="top:525.5pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">RBX</span></p>
<p style="top:525.5pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Bone substitute</span></p>
<p style="top:525.5pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:525.5pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">25 (50)</span></p>
<p style="top:525.5pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Extensor (Bi)</span></p>
<p style="top:525.5pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:531.5pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:525.5pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:525.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to</span></p>
<p style="top:531.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:525.5pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical, </span></p>
<p style="top:531.5pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">imaging (microCT)</span></p>
<p style="top:525.5pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:525.5pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:525.5pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">5</span></p>
<p style="top:539.4pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Lu et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">35</span></sup></p>
<p style="top:539.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">BMP2- releasing </span></p>
<p style="top:545.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interference screw</span></p>
<p style="top:539.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:539.4pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Sheep</span></p>
<p style="top:539.4pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">14 (28)</span></p>
<p style="top:539.4pt;left:259.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Extensor (Bi)</span></p>
<p style="top:539.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:545.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:539.4pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:539.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6 wks</span></p>
<p style="top:539.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical</span></p>
<p style="top:539.4pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:539.4pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:539.4pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:553.4pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Karaoglu et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">129</span></sup></p>
<p style="top:553.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Autogenous bone </span></p>
<p style="top:559.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">marrow aspirate, </span></p>
<p style="top:565.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">periosteum</span></p>
<p style="top:553.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Autologous</span></p>
<p style="top:559.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">tissue</span></p>
<p style="top:553.4pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:553.4pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">36</span></p>
<p style="top:553.4pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Extensor (Bi)</span></p>
<p style="top:553.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:559.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:553.4pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3</span></p>
<p style="top:553.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6 wks to </span></p>
<p style="top:559.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:553.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (HM) </span></p>
<p style="top:559.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical</span></p>
<p style="top:553.4pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:553.4pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:553.4pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:573.5pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Fan et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">105</span></sup></p>
<p style="top:573.5pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">MSCs</span></p>
<p style="top:573.5pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Stem cell</span></p>
<p style="top:573.5pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Pig</span></p>
<p style="top:573.5pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12</span></p>
<p style="top:573.5pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Silk (Uni)</span></p>
<p style="top:573.5pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Both</span></p>
<p style="top:573.5pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:573.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">24 wks</span></p>
<p style="top:573.5pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC), biomechani-</span></p>
<p style="top:579.5pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">cal, imaging (microCT)</span></p>
<p style="top:573.5pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:573.5pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:573.5pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:587.4pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Sasaki et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">36</span></sup></p>
<p style="top:587.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">G-CSF</span></p>
<p style="top:587.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:587.4pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Dog</span></p>
<p style="top:587.4pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">28 (56)</span></p>
<p style="top:587.4pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Flexor (Bi)</span></p>
<p style="top:587.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone </span></p>
<p style="top:593.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:587.4pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:587.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to</span></p>
<p style="top:593.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4 wks</span></p>
<p style="top:587.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical, </span></p>
<p style="top:593.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">imaging (microCT)</span></p>
<p style="top:587.4pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:587.4pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:587.4pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:601.5pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Gulotta et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">80</span></sup></p>
<p style="top:601.5pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Mg-based bone </span></p>
<p style="top:607.5pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">adhesive</span></p>
<p style="top:601.5pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Bone substitute</span></p>
<p style="top:601.5pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbits</span></p>
<p style="top:601.5pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">35 (70)</span></p>
<p style="top:601.5pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring (Bi)</span></p>
<p style="top:601.5pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone </span></p>
<p style="top:607.5pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:601.5pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:601.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3 wks to</span></p>
<p style="top:607.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6 wks</span></p>
<p style="top:601.5pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical, </span></p>
<p style="top:607.5pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">imaging (microCT)</span></p>
<p style="top:601.5pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:601.5pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:601.5pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">7</span></p>
<p style="top:615.5pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Fan et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">106</span></sup></p>
<p style="top:615.5pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">MSC</span></p>
<p style="top:615.5pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Stem cell</span></p>
<p style="top:615.5pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:615.5pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">48</span></p>
<p style="top:615.5pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Silk (Uni)</span></p>
<p style="top:615.5pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Both</span></p>
<p style="top:615.5pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:615.5pt;left:381.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8 wks to</span></p>
<p style="top:621.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">24 wks</span></p>
<p style="top:615.5pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical imag-</span></p>
<p style="top:621.5pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">ing (microCT)</span></p>
<p style="top:615.5pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:615.5pt;left:514.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:615.5pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">7</span></p>
<p style="top:629.4pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Yeh et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">141</span></sup></p>
<p style="top:629.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hyperbaric </span></p>
<p style="top:635.4pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">oxygen</span></p>
<p style="top:629.4pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Environmental</span></p>
<p style="top:629.4pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:629.4pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">40</span></p>
<p style="top:629.4pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring (Uni)</span></p>
<p style="top:629.4pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Both</span></p>
<p style="top:629.4pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:629.4pt;left:381.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6 wks to</span></p>
<p style="top:635.4pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">18 wks</span></p>
<p style="top:629.4pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical</span></p>
<p style="top:629.4pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:629.4pt;left:514.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:629.4pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8</span></p>
<p style="top:643.5pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Walsh et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">144</span></sup></p>
<p style="top:643.5pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">LIPUS</span></p>
<p style="top:643.5pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biophysical</span></p>
<p style="top:643.5pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Sheep</span></p>
<p style="top:643.5pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">89</span></p>
<p style="top:643.5pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Extensor (Uni)</span></p>
<p style="top:643.5pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone </span></p>
<p style="top:649.5pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:643.5pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:643.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3 wks to</span></p>
<p style="top:649.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">26 wks</span></p>
<p style="top:643.5pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical</span></p>
<p style="top:643.5pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:643.5pt;left:514.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:643.5pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8</span></p>
<p style="top:657.5pt;left:68.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Soon et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">107</span></sup></p>
<p style="top:657.5pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">MSC-coated </span></p>
<p style="top:663.5pt;left:122.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">allografts</span></p>
<p style="top:657.5pt;left:167.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Stem cell</span></p>
<p style="top:657.5pt;left:208.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:657.5pt;left:233.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">36 (72)</span></p>
<p style="top:657.5pt;left:259.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Achilles (Bi)</span></p>
<p style="top:657.5pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:663.5pt;left:306.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:657.5pt;left:349.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:657.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to </span></p>
<p style="top:663.5pt;left:381.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8 wks</span></p>
<p style="top:657.5pt;left:412.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical</span></p>
<p style="top:657.5pt;left:486.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:657.5pt;left:514.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:657.5pt;left:539.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">7</span></p>


<img style="position:absolute;transform:matrix(.3200452,0,-0,.31638713,47.153337,979.88009)" src="data:image/png;base64,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">
<p style="top:49.8pt;left:52.1pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">276</span></p>
<p style="top:49.8pt;left:203.2pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">A. T. HEXTER, T. THANGARAJAH, G. BLUNN, F. S. HADDAD</span></p>
<p style="top:753.5pt;left:70.0pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">Follow us @BoneJointJ</span></p>
<p style="top:753.5pt;left:447.7pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">THE BONE &amp; JOINT JOURNAL</span></p>
<p style="top:358.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">of PRP</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">48,56</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> or autologous serum.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">51</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> The majority of studies</span></p>
<p style="top:370.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">explicitly targeted both the graft and the tunnels with</span></p>
<p style="top:382.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">intraoperative application of a biological intervention</span></p>
<p style="top:394.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">(n = 12), whereas six studies specifically targeted the</span></p>
<p style="top:406.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">tunnels. </span></p>
<p style="top:418.3pt;left:62.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">Positive results were reported by nine of 20 studies;</span></p>
<p style="top:430.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">including seven studies of platelet concentrates, one study</span></p>
<p style="top:442.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">of calcium phosphate hybridized tendon, and one of ESWT.</span></p>
<p style="top:454.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">Two clinical studies, using remnant repair and bone</span></p>
<p style="top:466.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">substitutes, had mixed findings, reporting positive</span></p>
<p style="top:478.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">radiological outcomes, but no clinical differences. The</span></p>
<p style="top:490.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">remaining </span></p>
<p style="top:490.3pt;left:103.8pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">nine </span></p>
<p style="top:490.3pt;left:131.8pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">studies </span></p>
<p style="top:490.3pt;left:170.4pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">(eight </span></p>
<p style="top:490.3pt;left:204.4pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">studies </span></p>
<p style="top:490.3pt;left:243.0pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">of </span></p>
<p style="top:490.3pt;left:262.0pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">platelet</span></p>
<p style="top:502.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">concentrates and one study of bone marrow derived</span></p>
<p style="top:514.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">mesenchymal stem cells) reported no effect of the</span></p>
<p style="top:526.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">intervention.</span></p>
<p style="top:539.1pt;left:52.1pt;line-height:8.5pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:8.5pt;color:#424242">Study quality. </span></b><span style="font-family:Sabon,serif;font-size:9.5pt">A total of 15 studies were randomized</span></p>
<p style="top:550.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">controlled trials and five studies were non-randomized</span></p>
<p style="top:562.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">studies (three case control studies and two prospective</span></p>
<p style="top:574.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">cohort studies). The methodological quality scores for</span></p>
<p style="top:586.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">clinical studies were seen in the following frequency: one</span></p>
<p style="top:598.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">study had low levels of concern for methodological quality,</span></p>
<p style="top:610.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">there were moderate concerns in 17 (85%) and serious</span></p>
<p style="top:622.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">concerns in two studies (10%). Of the randomized studies,</span></p>
<p style="top:634.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">14/15 had moderate risk of bias either due to lack of clarity</span></p>
<p style="top:646.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">of blinding status, lack of clarity of the randomization</span></p>
<p style="top:658.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">process, or inadequate blinding of the operative surgeon.</span></p>
<p style="top:670.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">All observational studies had moderate risk of bias due to</span></p>
<p style="top:682.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">inadequate adjustment for potential confounders. Studies</span></p>
<p style="top:694.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">given a serious risk of bias also had potential bias in the</span></p>
<p style="top:706.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">selection of participants into the study. Acceptable inter-</span></p>
<p style="top:718.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">rater reliability was seen between the two authors (ICC</span></p>
<p style="top:730.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">0.734; 95% confidence interval 0.372 to 0.904).</span></p>
<p style="top:358.3pt;left:314.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">Out of the 14 studies evaluating PRP, none met the</span></p>
<p style="top:370.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">minimum reporting standards, with a median score of 12/</span></p>
<p style="top:382.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">23 (range 9 to 18). One study evaluated MSCs which had a</span></p>
<p style="top:394.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">score of 19/25 against the minimum reporting standards.</span></p>
<p style="top:417.9pt;left:304.1pt;line-height:10.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:10.0pt;color:#424242">Discussion</span></b></p>
<p style="top:430.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">A total of 24 different technologies were identified in the</span></p>
<p style="top:442.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">basic science literature, falling into seven broad categories.</span></p>
<p style="top:454.5pt;left:304.1pt;line-height:9.2pt"><span style="font-family:Sabon,serif;font-size:9.2pt">Of these 24, six have progressed to clinical studies, the</span></p>
<p style="top:466.5pt;left:304.1pt;line-height:9.2pt"><span style="font-family:Sabon,serif;font-size:9.2pt">majority of which (15/20) concern the use of PRP (Table IV).</span></p>
<p style="top:479.1pt;left:304.1pt;line-height:8.5pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:8.5pt;color:#424242">Growth factors. </span></b><span style="font-family:Sabon,serif;font-size:9.5pt">Most studies (39, of which 15 were clinical</span></p>
<p style="top:490.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">studies) concern growth factors, administered either as</span></p>
<p style="top:502.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">individual factors or as platelet concentrates.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">21-59</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> Growth</span></p>
<p style="top:514.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">factors studied in animals included bone morphogenetic</span></p>
<p style="top:526.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">growth proteins (BMPs)</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">30,35,37,60,61</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> basic fibroblast growth</span></p>
<p style="top:538.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">factor (bFGF),</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">12</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> epidermal growth factor (EGF),</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">40</span></sup></p>
<p style="top:550.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">granulocyte </span></p>
<p style="top:550.3pt;left:368.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">colony-stimulating </span></p>
<p style="top:550.3pt;left:461.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">factor </span></p>
<p style="top:550.3pt;left:502.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">(g-CSF),</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">36</span></sup></p>
<p style="top:562.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">hepatocyte growth factor (HGF),</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">34</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> transforming growth</span></p>
<p style="top:574.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">factor-</span><span style="font-family:Calibri,sans-serif;font-size:9.5pt">&#x3b2;</span><span style="font-family:Sabon,serif;font-size:9.5pt"> (TGF-</span><span style="font-family:Calibri,sans-serif;font-size:9.5pt">&#x3b2;</span><span style="font-family:Sabon,serif;font-size:9.5pt">),</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">39</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> and vascular endothelial growth factor</span></p>
<p style="top:586.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">(VEGF).</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">29,31,38</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> Platelet concentrates, which are sources of</span></p>
<p style="top:598.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">bioactive molecules and multiple growth factors such as</span></p>
<p style="top:610.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">platelet-derived growth factor (PDGF), TGF-</span><span style="font-family:Calibri,sans-serif;font-size:9.5pt">&#x3b2;</span><span style="font-family:Sabon,serif;font-size:9.5pt"> and VEGF,</span></p>
<p style="top:622.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">include PRP,</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">21,24,28,29,31,38,62</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> fibrin clot</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">23</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> and autologous</span></p>
<p style="top:634.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">conditioned serum.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">51</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> Growth factors are thought to</span></p>
<p style="top:646.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">enhance the healing process</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">63</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> and can be used to target</span></p>
<p style="top:658.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">graft healing; both on the graft-tunnel interface (n = 13</span></p>
<p style="top:670.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">studies), and to promote intra-articular ligamentization</span></p>
<p style="top:682.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">(n = 11 studies).</span></p>
<p style="top:694.3pt;left:314.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">In total 21 of the 24 animal studies that evaluated</span></p>
<p style="top:706.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">growth factors showed positive findings, but two animal</span></p>
<p style="top:718.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">studies showed no effect of growth factors, which included</span></p>
<p style="top:730.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">PDGF-coated sutures in sheep</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">41</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> and autologous blood</span></p>
<p style="top:75.7pt;left:56.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Table II. Animal studies (n = 92) (cont.)</span></p>
<p style="top:96.8pt;left:56.6pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Author</span></b></p>
<p style="top:90.8pt;left:102.5pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Biological</span></b></p>
<p style="top:96.8pt;left:102.5pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">modulation</span></b></p>
<p style="top:90.8pt;left:147.4pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Category of inter-</span></b></p>
<p style="top:96.8pt;left:147.4pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">vention</span></b></p>
<p style="top:90.8pt;left:192.4pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Animal </span></b></p>
<p style="top:96.8pt;left:192.4pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">model</span></b></p>
<p style="top:96.8pt;left:215.2pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">n</span></b></p>
<p style="top:96.8pt;left:240.6pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">ACLR graft (uni/bi) Site of action</span></b></p>
<p style="top:96.8pt;left:331.9pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Groups (n)</span></b></p>
<p style="top:90.8pt;left:361.1pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Follow-up </span></b></p>
<p style="top:96.8pt;left:361.1pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">min to max Outcome measures</span></b></p>
<p style="top:96.8pt;left:459.1pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Finding</span></b></p>
<p style="top:90.8pt;left:494.5pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Evidence </span></b></p>
<p style="top:96.8pt;left:494.5pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">level</span></b></p>
<p style="top:90.8pt;left:519.7pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Quality </span></b></p>
<p style="top:96.8pt;left:519.7pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">score</span></b></p>
<p style="top:106.0pt;left:56.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Ma et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">37</span></sup></p>
<p style="top:106.0pt;left:102.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">rhBMP-2</span></p>
<p style="top:106.0pt;left:147.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:106.0pt;left:192.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:106.0pt;left:215.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">60 (120)</span></p>
<p style="top:106.0pt;left:240.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring (Bi)</span></p>
<p style="top:106.0pt;left:287.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:112.0pt;left:287.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:106.0pt;left:331.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3</span></p>
<p style="top:106.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to </span></p>
<p style="top:112.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8 wks</span></p>
<p style="top:106.0pt;left:391.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (HM), </span></p>
<p style="top:112.0pt;left:391.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical</span></p>
<p style="top:106.0pt;left:459.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:106.0pt;left:494.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:106.0pt;left:519.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:120.0pt;left:56.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Li et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">117</span></sup></p>
<p style="top:120.0pt;left:102.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">MSC, PDGF-B </span></p>
<p style="top:126.0pt;left:102.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">transfected MSC</span></p>
<p style="top:120.0pt;left:147.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Gene therapy </span></p>
<p style="top:126.0pt;left:147.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(Stem cell)</span></p>
<p style="top:120.0pt;left:192.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:120.0pt;left:215.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">36 (72)</span></p>
<p style="top:120.0pt;left:240.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Achilles (Bi)</span></p>
<p style="top:120.0pt;left:287.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Ligamentization</span></p>
<p style="top:120.0pt;left:331.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:120.0pt;left:361.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3 wks to </span></p>
<p style="top:126.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:120.0pt;left:391.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology,</span></p>
<p style="top:120.0pt;left:459.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:120.0pt;left:494.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">E</span></p>
<p style="top:120.0pt;left:519.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4</span></p>
<p style="top:134.0pt;left:56.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Huangfu et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">93</span></sup></p>
<p style="top:134.0pt;left:102.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">TCP</span></p>
<p style="top:134.0pt;left:147.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biomaterial</span></p>
<p style="top:134.0pt;left:192.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Dog</span></p>
<p style="top:134.0pt;left:215.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">48 (96)</span></p>
<p style="top:134.0pt;left:240.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Flexor (Bi)</span></p>
<p style="top:134.0pt;left:287.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:140.0pt;left:287.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:134.0pt;left:331.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:134.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to </span></p>
<p style="top:140.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:134.0pt;left:391.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical</span></p>
<p style="top:134.0pt;left:459.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:134.0pt;left:494.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:134.0pt;left:519.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:148.0pt;left:56.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Yoshikawa et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">38</span></sup></p>
<p style="top:148.0pt;left:102.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">VEGF</span></p>
<p style="top:148.0pt;left:147.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:148.0pt;left:192.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Sheep</span></p>
<p style="top:148.0pt;left:215.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">18</span></p>
<p style="top:148.0pt;left:240.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring (Uni)</span></p>
<p style="top:148.0pt;left:287.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Ligamentization</span></p>
<p style="top:148.0pt;left:331.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:148.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:148.0pt;left:391.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Laxity histology</span></p>
<p style="top:154.0pt;left:391.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical</span></p>
<p style="top:148.0pt;left:459.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Negative</span></p>
<p style="top:148.0pt;left:494.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">A</span></p>
<p style="top:148.0pt;left:519.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8</span></p>
<p style="top:162.0pt;left:56.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Yamazaki et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">39</span></sup></p>
<p style="top:162.0pt;left:102.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">TGFb1</span></p>
<p style="top:162.0pt;left:147.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:162.0pt;left:192.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Dog</span></p>
<p style="top:162.0pt;left:215.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">21</span></p>
<p style="top:162.0pt;left:240.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Flexor (Uni)</span></p>
<p style="top:162.0pt;left:287.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone </span></p>
<p style="top:168.0pt;left:287.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:162.0pt;left:331.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3</span></p>
<p style="top:162.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3 wks</span></p>
<p style="top:162.0pt;left:391.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical</span></p>
<p style="top:162.0pt;left:459.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:162.0pt;left:494.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:162.0pt;left:519.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8</span></p>
<p style="top:176.0pt;left:56.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Wang et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">146</span></sup></p>
<p style="top:176.0pt;left:102.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Shock wave</span></p>
<p style="top:182.0pt;left:102.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">therapy</span></p>
<p style="top:176.0pt;left:147.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biophysical</span></p>
<p style="top:176.0pt;left:192.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:176.0pt;left:215.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">36</span></p>
<p style="top:176.0pt;left:240.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Extensor (Bi)</span></p>
<p style="top:176.0pt;left:287.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:182.0pt;left:287.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:176.0pt;left:331.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:176.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">1 wk to</span></p>
<p style="top:182.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">24 wks</span></p>
<p style="top:176.0pt;left:391.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (HM), </span></p>
<p style="top:182.0pt;left:391.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical</span></p>
<p style="top:176.0pt;left:459.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:176.0pt;left:494.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:176.0pt;left:519.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8</span></p>
<p style="top:190.0pt;left:56.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Demirag et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">135</span></sup></p>
<p style="top:190.0pt;left:102.5pt;line-height:5.0pt"><span style="font-family:Calibri,sans-serif;font-size:5.0pt">&#x3b1;</span><span style="font-family:Univers55,serif;font-size:3.5pt">2</span><span style="font-family:Univers55,serif;font-size:5.0pt">-macroglobulin </span></p>
<p style="top:196.0pt;left:102.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(MMP inhibitor)</span></p>
<p style="top:190.0pt;left:147.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Drug</span></p>
<p style="top:190.0pt;left:192.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:190.0pt;left:215.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">28 (56)</span></p>
<p style="top:190.0pt;left:240.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring (Bi)</span></p>
<p style="top:190.0pt;left:287.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone </span></p>
<p style="top:196.0pt;left:287.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:190.0pt;left:331.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:190.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to</span></p>
<p style="top:196.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">5 wks</span></p>
<p style="top:190.0pt;left:391.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical</span></p>
<p style="top:190.0pt;left:459.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:190.0pt;left:494.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:190.0pt;left:519.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">7</span></p>
<p style="top:204.0pt;left:56.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Yasuda et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">40</span></sup></p>
<p style="top:204.0pt;left:102.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">EGF and TGF </span><span style="font-family:Calibri,sans-serif;font-size:5.0pt">&#x3b2;</span></p>
<p style="top:204.0pt;left:147.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:204.0pt;left:192.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Dog</span></p>
<p style="top:204.0pt;left:215.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">20 (40)</span></p>
<p style="top:204.0pt;left:240.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Patella (Bi)</span></p>
<p style="top:204.0pt;left:287.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Ligamentization</span></p>
<p style="top:204.0pt;left:331.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4</span></p>
<p style="top:204.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:204.0pt;left:391.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical</span></p>
<p style="top:204.0pt;left:459.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:204.0pt;left:494.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:204.0pt;left:519.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">7</span></p>
<p style="top:212.0pt;left:56.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Weiler et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">41</span></sup></p>
<p style="top:212.0pt;left:102.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PDGF-coated </span></p>
<p style="top:218.0pt;left:102.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">sutures</span></p>
<p style="top:212.0pt;left:147.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:212.0pt;left:192.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Sheep</span></p>
<p style="top:212.0pt;left:215.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">48</span></p>
<p style="top:212.0pt;left:240.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Flexor (Uni)</span></p>
<p style="top:212.0pt;left:287.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Ligamentization</span></p>
<p style="top:212.0pt;left:331.8pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:212.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3 wks to</span></p>
<p style="top:218.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">24 wks</span></p>
<p style="top:212.0pt;left:391.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Laxity histology (IHC),</span></p>
<p style="top:218.0pt;left:391.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical</span></p>
<p style="top:212.0pt;left:459.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No</span></p>
<p style="top:218.0pt;left:459.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">difference</span></p>
<p style="top:212.0pt;left:494.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">A</span></p>
<p style="top:212.0pt;left:519.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:226.0pt;left:56.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Tien et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">94</span></sup></p>
<p style="top:226.0pt;left:102.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">CaP cement</span></p>
<p style="top:226.0pt;left:147.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biomaterial</span></p>
<p style="top:226.0pt;left:192.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:226.0pt;left:215.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">22 (44)</span></p>
<p style="top:226.0pt;left:240.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring (Bi)</span></p>
<p style="top:226.0pt;left:287.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:232.0pt;left:287.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:226.0pt;left:331.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:226.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">1 wk to</span></p>
<p style="top:232.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">24 wks</span></p>
<p style="top:226.0pt;left:391.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical</span></p>
<p style="top:226.0pt;left:459.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:226.0pt;left:494.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:226.0pt;left:519.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:240.0pt;left:56.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Mutsuzaki et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">95</span></sup></p>
<p style="top:240.0pt;left:102.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">CaP-hybridized </span></p>
<p style="top:246.0pt;left:102.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">tendon</span></p>
<p style="top:240.0pt;left:147.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biomaterial</span></p>
<p style="top:240.0pt;left:192.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:240.0pt;left:215.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">50 (100)</span></p>
<p style="top:240.0pt;left:240.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Flexor (Bi)</span></p>
<p style="top:240.0pt;left:287.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone </span></p>
<p style="top:246.0pt;left:287.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:240.0pt;left:331.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:240.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">1 wk to</span></p>
<p style="top:246.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3 wks</span></p>
<p style="top:240.0pt;left:391.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology</span></p>
<p style="top:240.0pt;left:459.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:240.0pt;left:494.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">D</span></p>
<p style="top:240.0pt;left:519.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4</span></p>
<p style="top:254.0pt;left:56.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Mihelic et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">43</span></sup></p>
<p style="top:254.0pt;left:102.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">BMP-7</span></p>
<p style="top:254.0pt;left:147.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:254.0pt;left:192.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Sheep</span></p>
<p style="top:254.0pt;left:215.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">30</span></p>
<p style="top:254.0pt;left:240.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Peroneal (Uni)</span></p>
<p style="top:254.0pt;left:287.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone </span></p>
<p style="top:260.0pt;left:287.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:254.0pt;left:331.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:254.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3 wks to</span></p>
<p style="top:260.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6 wks</span></p>
<p style="top:254.0pt;left:391.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (HM), </span></p>
<p style="top:260.0pt;left:391.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical</span></p>
<p style="top:254.0pt;left:459.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:254.0pt;left:494.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:254.0pt;left:519.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">7</span></p>
<p style="top:268.0pt;left:56.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Lim et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">108</span></sup></p>
<p style="top:268.0pt;left:102.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">MSC</span></p>
<p style="top:268.0pt;left:147.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Stem cell</span></p>
<p style="top:268.0pt;left:192.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:268.0pt;left:215.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">48 (96)</span></p>
<p style="top:268.0pt;left:240.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring (Bi)</span></p>
<p style="top:268.0pt;left:287.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:274.0pt;left:287.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:268.0pt;left:331.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:268.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to</span></p>
<p style="top:274.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8 wks</span></p>
<p style="top:268.0pt;left:391.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology (IHC), </span></p>
<p style="top:274.0pt;left:391.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical</span></p>
<p style="top:268.0pt;left:459.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:268.0pt;left:494.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:268.0pt;left:519.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">5</span></p>
<p style="top:282.0pt;left:56.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Martinek et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">110</span></sup></p>
<p style="top:282.0pt;left:102.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">BMP-2 genetically </span></p>
<p style="top:288.0pt;left:102.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">altered ST graft</span></p>
<p style="top:282.0pt;left:147.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Gene therapy</span></p>
<p style="top:282.0pt;left:192.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:282.0pt;left:215.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">48</span></p>
<p style="top:282.0pt;left:240.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring (Bi)</span></p>
<p style="top:282.0pt;left:287.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone </span></p>
<p style="top:288.0pt;left:287.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:282.0pt;left:331.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3</span></p>
<p style="top:282.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to </span></p>
<p style="top:288.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8 wks</span></p>
<p style="top:282.0pt;left:391.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, </span></p>
<p style="top:288.0pt;left:391.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical</span></p>
<p style="top:282.0pt;left:459.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:282.0pt;left:494.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:282.0pt;left:519.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6</span></p>
<p style="top:296.0pt;left:56.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Chen et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">130</span></sup></p>
<p style="top:296.0pt;left:102.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Autologous</span></p>
<p style="top:302.0pt;left:102.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">periosteum</span></p>
<p style="top:296.0pt;left:147.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Autologous</span></p>
<p style="top:302.0pt;left:147.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">tissue</span></p>
<p style="top:296.0pt;left:192.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:296.0pt;left:215.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">36 (72)</span></p>
<p style="top:296.0pt;left:240.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring (Bi)</span></p>
<p style="top:296.0pt;left:287.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone </span></p>
<p style="top:302.0pt;left:287.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:296.0pt;left:331.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:296.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4 wks to </span></p>
<p style="top:302.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 wks</span></p>
<p style="top:296.0pt;left:391.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, </span></p>
<p style="top:302.0pt;left:391.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">biomechanical</span></p>
<p style="top:296.0pt;left:459.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:296.0pt;left:494.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:296.0pt;left:519.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4</span></p>
<p style="top:310.0pt;left:56.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Anderson et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">42</span></sup></p>
<p style="top:310.0pt;left:102.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Bone-derived </span></p>
<p style="top:316.0pt;left:102.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">extract</span></p>
<p style="top:310.0pt;left:147.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:310.0pt;left:192.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rabbit</span></p>
<p style="top:310.0pt;left:215.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">70 (140)</span></p>
<p style="top:310.0pt;left:240.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring (Bi)</span></p>
<p style="top:310.0pt;left:287.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Graft-bone</span></p>
<p style="top:316.0pt;left:287.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">interface</span></p>
<p style="top:310.0pt;left:331.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:310.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 wks to</span></p>
<p style="top:316.0pt;left:361.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">8 wks</span></p>
<p style="top:310.0pt;left:391.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Histology, biomechanical, </span></p>
<p style="top:316.0pt;left:391.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">imaging (MRI)</span></p>
<p style="top:310.0pt;left:459.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:310.0pt;left:494.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">B</span></p>
<p style="top:310.0pt;left:519.6pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">7</span></p>


<p style="top:49.8pt;left:138.0pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">BIOLOGICAL AUGMENTATION OF GRAFT HEALING IN ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION</span></p>
<p style="top:49.8pt;left:549.0pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">277</span></p>
<p style="top:753.5pt;left:67.9pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">VOL. 100-B, No. 3, MARCH 2018</span></p>
<p style="top:646.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">applied to an extracellular matrix scaffold in pigs.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">27</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> The</span></p>
<p style="top:658.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">animal study where a negative effect was observed was a</span></p>
<p style="top:670.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">study where 18 sheep received semitendinosus grafts</span></p>
<p style="top:682.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">soaked in VEGF; while this promoted angiogenesis, it also</span></p>
<p style="top:694.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">led to reduced biomechanical strength and knee stability at</span></p>
<p style="top:706.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">12 weeks.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">38</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> Conversely in a separate study, the use of a</span></p>
<p style="top:718.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">sodium hyaluronate VEGF-releasing system increased</span></p>
<p style="top:730.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">ligamentization of patellar tendons in rabbits.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">29</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> </span></p>
<p style="top:646.3pt;left:329.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">In clinical trials, the most extensively studied biological</span></p>
<p style="top:658.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">intervention is PRP, which can be applied directly to the</span></p>
<p style="top:670.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">graft site (graft substance and graft-tunnel interface), or</span></p>
<p style="top:682.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">indirectly through intra-articular injection. A systematic</span></p>
<p style="top:694.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">review in 2015</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">64</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> suggested that PRP may promote</span></p>
<p style="top:706.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">ligamentization, but there is less evidence to suggest it</span></p>
<p style="top:718.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">enhances </span></p>
<p style="top:718.3pt;left:367.4pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">osseointegration. </span></p>
<p style="top:718.3pt;left:447.5pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">The </span></p>
<p style="top:718.3pt;left:473.8pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">largest </span></p>
<p style="top:718.3pt;left:511.4pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">randomized</span></p>
<p style="top:730.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">controlled trial (RCT) to date evaluated 150 patients with a</span></p>
<p style="top:85.0pt;left:69.4pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Table III. Clinical studies (n = 20)</span></p>
<p style="top:112.1pt;left:69.4pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Author</span></b></p>
<p style="top:106.1pt;left:127.7pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Biological</span></b></p>
<p style="top:112.1pt;left:127.7pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">modulation</span></b></p>
<p style="top:112.1pt;left:167.5pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Type</span></b></p>
<p style="top:106.1pt;left:207.2pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Site of action </span></b></p>
<p style="top:112.1pt;left:207.2pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">(and time)</span></b></p>
<p style="top:112.1pt;left:247.0pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Patients (n)</span></b></p>
<p style="top:106.1pt;left:279.5pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Surgery </span></b></p>
<p style="top:112.1pt;left:279.5pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">(graft)</span></b></p>
<p style="top:112.1pt;left:312.1pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Groups (n) </span></b></p>
<p style="top:106.1pt;left:338.7pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Follow-up </span></b></p>
<p style="top:112.1pt;left:338.7pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">min to max</span></b></p>
<p style="top:112.1pt;left:371.2pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Outcome measures</span></b></p>
<p style="top:112.1pt;left:436.9pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Finding</span></b></p>
<p style="top:112.1pt;left:465.4pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Study design</span></b></p>
<p style="top:100.1pt;left:498.5pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Reporting </span></b></p>
<p style="top:106.1pt;left:498.5pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">standards </span></b></p>
<p style="top:112.1pt;left:498.5pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">reached </span></b></p>
<p style="top:112.1pt;left:529.3pt;line-height:5.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:5.0pt">Risk of bias</span></b></p>
<p style="top:121.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Del Torto et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">45</span></sup></p>
<p style="top:121.3pt;left:127.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PRFM</span></p>
<p style="top:121.3pt;left:167.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:121.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Tunnel</span></p>
<p style="top:127.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(intraoperative)</span></p>
<p style="top:121.3pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">28</span></p>
<p style="top:121.3pt;left:279.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring</span></p>
<p style="top:121.3pt;left:312.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:121.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">1 y to 2 yrs</span></p>
<p style="top:121.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Laxity (rolimeter) Imaging </span></p>
<p style="top:127.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(MRI) Functional Score </span></p>
<p style="top:133.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(IKDC)</span></p>
<p style="top:121.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No</span></p>
<p style="top:127.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">difference</span></p>
<p style="top:121.3pt;left:465.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Non-RCT </span></p>
<p style="top:127.3pt;left:465.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(prospective)</span></p>
<p style="top:121.3pt;left:498.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No (13/23)</span></p>
<p style="top:121.3pt;left:529.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Moderate</span></p>
<p style="top:141.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Wang et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">147</span></sup></p>
<p style="top:141.3pt;left:127.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">ESWT</span></p>
<p style="top:141.3pt;left:167.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biophysical</span></p>
<p style="top:141.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Tunnel (single </span></p>
<p style="top:147.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">dose after </span></p>
<p style="top:153.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">wound closure)</span></p>
<p style="top:141.3pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">53</span></p>
<p style="top:141.3pt;left:279.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring</span></p>
<p style="top:141.3pt;left:312.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:141.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6 mths to</span></p>
<p style="top:147.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2 yrs</span></p>
<p style="top:141.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Laxity (arthrometer) Imag-</span></p>
<p style="top:147.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">ing (MRI) Functional Score </span></p>
<p style="top:153.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(Lysholme, IKDC)</span></p>
<p style="top:141.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:141.3pt;left:465.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">RCT</span></p>
<p style="top:141.3pt;left:498.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">N/A</span></p>
<p style="top:141.3pt;left:529.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Moderate</span></p>
<p style="top:161.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Valent&#xed; Azc&#xe1;rate et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">46</span></sup></p>
<p style="top:161.3pt;left:127.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PRP</span></p>
<p style="top:161.3pt;left:167.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:161.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Tunnel and graft </span></p>
<p style="top:167.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(intraoperative)</span></p>
<p style="top:161.3pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">150</span></p>
<p style="top:161.3pt;left:279.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Patella</span></p>
<p style="top:161.3pt;left:312.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3</span></p>
<p style="top:161.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3 mths to </span></p>
<p style="top:167.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 mths</span></p>
<p style="top:161.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Imaging (MRI) Functional </span></p>
<p style="top:167.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Score (IKDC)</span></p>
<p style="top:161.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No </span></p>
<p style="top:167.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">difference</span></p>
<p style="top:161.3pt;left:465.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">RCT</span></p>
<p style="top:161.3pt;left:498.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No (17/23)</span></p>
<p style="top:161.3pt;left:529.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Moderate</span></p>
<p style="top:175.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Silva et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">109</span></sup></p>
<p style="top:175.3pt;left:127.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">BMSC</span></p>
<p style="top:175.3pt;left:167.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Autologous </span></p>
<p style="top:181.3pt;left:167.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">MSCs</span></p>
<p style="top:175.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Tunnel and graft </span></p>
<p style="top:181.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(intraoperative)</span></p>
<p style="top:175.3pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">43</span></p>
<p style="top:175.3pt;left:279.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring</span></p>
<p style="top:175.3pt;left:312.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:175.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3 mths</span></p>
<p style="top:175.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Imaging (MRI)</span></p>
<p style="top:175.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No</span></p>
<p style="top:181.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">difference</span></p>
<p style="top:175.3pt;left:465.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">RCT</span></p>
<p style="top:175.3pt;left:498.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No (19/25)</span></p>
<p style="top:175.3pt;left:529.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Moderate</span></p>
<p style="top:189.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Matsumoto et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">127</span></sup></p>
<p style="top:189.3pt;left:127.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Augmented </span></p>
<p style="top:195.3pt;left:127.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">remnant repair</span></p>
<p style="top:189.3pt;left:167.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Autologous</span></p>
<p style="top:195.3pt;left:167.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">tissue</span></p>
<p style="top:189.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Tunnel and graft </span></p>
<p style="top:195.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(intraoperative)</span></p>
<p style="top:189.3pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">10</span></p>
<p style="top:189.3pt;left:279.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring</span></p>
<p style="top:189.3pt;left:312.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:189.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">1 y to 2 yrs</span></p>
<p style="top:189.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Laxity (arthrometer) Imag-</span></p>
<p style="top:195.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">ing (CT) Functional Score </span></p>
<p style="top:201.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(Lysholme, IKDC)</span></p>
<p style="top:189.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive </span></p>
<p style="top:195.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">radiologi-</span></p>
<p style="top:201.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">cally (no </span></p>
<p style="top:207.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">difference </span></p>
<p style="top:213.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">clinically)</span></p>
<p style="top:189.3pt;left:465.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">RCT</span></p>
<p style="top:189.3pt;left:498.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">N/A</span></p>
<p style="top:189.3pt;left:529.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Moderate</span></p>
<p style="top:221.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Vadal&#xe0; et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">47</span></sup></p>
<p style="top:221.3pt;left:127.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PRP</span></p>
<p style="top:221.3pt;left:167.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:221.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Tunnel and graft </span></p>
<p style="top:227.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(intraoperative)</span></p>
<p style="top:221.3pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">40</span></p>
<p style="top:221.3pt;left:279.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring</span></p>
<p style="top:221.3pt;left:312.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:221.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">10 mths to </span></p>
<p style="top:227.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">16 mths</span></p>
<p style="top:221.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Laxity (arthrometer) Imag-</span></p>
<p style="top:227.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">ing (CT) Functional Score </span></p>
<p style="top:233.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(Lysholme, Tegner, IKDC)</span></p>
<p style="top:221.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No differ-</span></p>
<p style="top:227.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">ence</span></p>
<p style="top:221.3pt;left:465.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">RCT</span></p>
<p style="top:221.3pt;left:498.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No (9/23)</span></p>
<p style="top:221.3pt;left:529.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Moderate</span></p>
<p style="top:241.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Seijas et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">48</span></sup></p>
<p style="top:241.3pt;left:127.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PRP</span></p>
<p style="top:241.3pt;left:167.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:241.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Tunnel and graft </span></p>
<p style="top:247.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(postoperative </span></p>
<p style="top:253.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">joint injection)</span></p>
<p style="top:241.3pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">98</span></p>
<p style="top:241.3pt;left:279.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Patella</span></p>
<p style="top:241.3pt;left:312.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:241.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4 mths to</span></p>
<p style="top:247.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 mths</span></p>
<p style="top:241.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Imaging (MRI)</span></p>
<p style="top:241.3pt;left:436.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:241.3pt;left:465.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">RCT</span></p>
<p style="top:241.3pt;left:498.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No (10/23)</span></p>
<p style="top:241.3pt;left:529.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Moderate</span></p>
<p style="top:261.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Rupreht et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">49</span></sup></p>
<p style="top:261.3pt;left:127.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PRP</span></p>
<p style="top:261.3pt;left:167.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:261.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Tunnel and graft </span></p>
<p style="top:267.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(intraoperative)</span></p>
<p style="top:261.3pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">50</span></p>
<p style="top:261.3pt;left:279.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring</span></p>
<p style="top:261.3pt;left:312.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:261.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6 mths</span></p>
<p style="top:261.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Imaging (MRI)</span></p>
<p style="top:261.3pt;left:436.9pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:261.3pt;left:465.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">RCT</span></p>
<p style="top:261.3pt;left:498.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No (12/23)</span></p>
<p style="top:261.3pt;left:529.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Moderate</span></p>
<p style="top:275.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Mirzatolooei et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">50</span></sup></p>
<p style="top:275.3pt;left:127.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PRP</span></p>
<p style="top:275.3pt;left:167.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:275.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Tunnel and graft </span></p>
<p style="top:281.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(Intraoperative)</span></p>
<p style="top:275.3pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">50</span></p>
<p style="top:275.3pt;left:279.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring</span></p>
<p style="top:275.3pt;left:312.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:275.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3 mths</span></p>
<p style="top:275.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Laxity (arthrometer) Imag-</span></p>
<p style="top:281.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">ing (CT) </span></p>
<p style="top:275.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No</span></p>
<p style="top:281.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">difference</span></p>
<p style="top:275.3pt;left:465.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">RCT</span></p>
<p style="top:275.3pt;left:498.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No (14/23)</span></p>
<p style="top:275.3pt;left:529.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Moderate</span></p>
<p style="top:289.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Iorio et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">85</span></sup></p>
<p style="top:289.3pt;left:127.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Nanohy-</span></p>
<p style="top:295.3pt;left:127.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">droxyapatite </span></p>
<p style="top:301.3pt;left:127.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">bone substitute</span></p>
<p style="top:289.3pt;left:167.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biomaterial</span></p>
<p style="top:289.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Tunnel and graft </span></p>
<p style="top:295.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(intraoperative)</span></p>
<p style="top:289.3pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">40</span></p>
<p style="top:289.3pt;left:279.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring</span></p>
<p style="top:289.3pt;left:312.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:289.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">30 days to </span></p>
<p style="top:295.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">180 days</span></p>
<p style="top:289.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Laxity (arthrometer) Imag-</span></p>
<p style="top:295.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">ing (MRI) Functional Score </span></p>
<p style="top:301.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(Lysholme, Tegner, IKDC)</span></p>
<p style="top:289.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive </span></p>
<p style="top:295.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">radiologi-</span></p>
<p style="top:301.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">cally (no </span></p>
<p style="top:307.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">difference </span></p>
<p style="top:313.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">clinically)</span></p>
<p style="top:289.3pt;left:465.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">RCT</span></p>
<p style="top:289.3pt;left:498.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">N/A</span></p>
<p style="top:289.3pt;left:529.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Moderate</span></p>
<p style="top:321.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Mutsuzaki et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">89</span></sup></p>
<p style="top:321.3pt;left:127.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">CaP-hybridized </span></p>
<p style="top:327.3pt;left:127.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">tendon graft</span></p>
<p style="top:321.3pt;left:167.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Biomaterial</span></p>
<p style="top:321.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Tunnel and graft </span></p>
<p style="top:327.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(intraoperative)</span></p>
<p style="top:321.3pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">64</span></p>
<p style="top:321.3pt;left:279.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring</span></p>
<p style="top:321.3pt;left:312.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:321.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">1 y to 2 yrs</span></p>
<p style="top:321.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Laxity (arthrometer) Imag-</span></p>
<p style="top:327.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">ing (MRI and CT) Arthros-</span></p>
<p style="top:333.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">copy Functional Score </span></p>
<p style="top:339.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(Lysholme, Tegner, IKDC)</span></p>
<p style="top:321.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:321.3pt;left:465.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">RCT</span></p>
<p style="top:321.3pt;left:498.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">N/A</span></p>
<p style="top:321.3pt;left:529.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Moderate</span></p>
<p style="top:347.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Darabos et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">51</span></sup></p>
<p style="top:347.3pt;left:127.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Autologous </span></p>
<p style="top:353.3pt;left:127.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">serum</span></p>
<p style="top:347.3pt;left:167.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:347.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Tunnel and graft </span></p>
<p style="top:353.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(4x postopera-</span></p>
<p style="top:359.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">tive joint </span></p>
<p style="top:365.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">injections)</span></p>
<p style="top:347.3pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">62</span></p>
<p style="top:347.3pt;left:279.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring</span></p>
<p style="top:347.3pt;left:312.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:347.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 mths</span></p>
<p style="top:347.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">IL-1</span><span style="font-family:Calibri,sans-serif;font-size:5.0pt">&#x3b2;</span><span style="font-family:Univers55,serif;font-size:5.0pt"> synovial fluid conc. </span></p>
<p style="top:353.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Imaging (CT) Functional </span></p>
<p style="top:359.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Score (WOMAC, IKDC)</span></p>
<p style="top:347.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:347.3pt;left:465.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">RCT</span></p>
<p style="top:347.3pt;left:498.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">N/A</span></p>
<p style="top:347.3pt;left:529.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Low</span></p>
<p style="top:373.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Vogrin et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">52</span></sup></p>
<p style="top:373.3pt;left:127.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PLG</span></p>
<p style="top:373.3pt;left:167.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:373.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Tunnel and graft </span></p>
<p style="top:379.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(intraoperative)</span></p>
<p style="top:373.3pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">50</span></p>
<p style="top:373.3pt;left:279.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring</span></p>
<p style="top:373.3pt;left:312.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:373.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3 mths to</span></p>
<p style="top:379.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6 mths</span></p>
<p style="top:373.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Laxity (arthrometer)</span></p>
<p style="top:373.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:373.3pt;left:465.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">RCT</span></p>
<p style="top:373.3pt;left:498.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No (12/23)</span></p>
<p style="top:373.3pt;left:529.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Moderate</span></p>
<p style="top:387.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">S&#xe1;nchez et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">53</span></sup></p>
<p style="top:387.3pt;left:127.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PRP</span></p>
<p style="top:387.3pt;left:167.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:387.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Tunnel and graft </span></p>
<p style="top:393.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(intraoperative)</span></p>
<p style="top:387.3pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">37</span></p>
<p style="top:387.3pt;left:279.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring</span></p>
<p style="top:387.3pt;left:312.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:387.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6 mths to</span></p>
<p style="top:393.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">24 mths</span></p>
<p style="top:387.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Arthroscopy Histology </span></p>
<p style="top:393.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(LTMI) </span></p>
<p style="top:387.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive </span></p>
<p style="top:387.3pt;left:465.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Non-RCT </span></p>
<p style="top:393.3pt;left:465.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(case con)</span></p>
<p style="top:387.3pt;left:498.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No (11/23)</span></p>
<p style="top:387.3pt;left:529.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Moderate</span></p>
<p style="top:401.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Radice et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">54</span></sup></p>
<p style="top:401.3pt;left:127.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PRP</span></p>
<p style="top:401.3pt;left:167.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:401.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Tunnel and graft </span></p>
<p style="top:407.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(Intraoperative)</span></p>
<p style="top:401.3pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">50</span></p>
<p style="top:401.3pt;left:279.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Ham-</span></p>
<p style="top:407.3pt;left:279.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">string,BTPB</span></p>
<p style="top:401.3pt;left:312.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:401.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3 mths to </span></p>
<p style="top:407.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">12 mths</span></p>
<p style="top:401.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Imaging (MRI)</span></p>
<p style="top:401.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:401.3pt;left:465.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Non-RCT </span></p>
<p style="top:407.3pt;left:465.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(case con)</span></p>
<p style="top:401.3pt;left:498.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No (9/13)</span></p>
<p style="top:401.3pt;left:529.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Serious</span></p>
<p style="top:415.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Figueroa et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">55</span></sup></p>
<p style="top:415.3pt;left:127.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">APC</span></p>
<p style="top:415.3pt;left:167.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:415.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Tunnel and graft </span></p>
<p style="top:421.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(intraoperative)</span></p>
<p style="top:415.3pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">50</span></p>
<p style="top:415.3pt;left:279.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring</span></p>
<p style="top:415.3pt;left:312.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:415.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6 mths</span></p>
<p style="top:415.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Imaging (MRI)</span></p>
<p style="top:415.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No </span></p>
<p style="top:421.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">difference</span></p>
<p style="top:415.3pt;left:465.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Non-RCT </span></p>
<p style="top:421.3pt;left:465.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(case con)</span></p>
<p style="top:415.3pt;left:498.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No (10)</span></p>
<p style="top:415.3pt;left:529.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Moderate</span></p>
<p style="top:429.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Silva et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">56</span></sup></p>
<p style="top:429.3pt;left:127.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PRP </span></p>
<p style="top:429.3pt;left:167.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:429.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Tunnel (intraop-</span></p>
<p style="top:435.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">erative applica-</span></p>
<p style="top:441.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">tion and </span></p>
<p style="top:447.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">postoperative </span></p>
<p style="top:453.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">injections)</span></p>
<p style="top:429.3pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">40</span></p>
<p style="top:429.3pt;left:279.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring</span></p>
<p style="top:429.3pt;left:312.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4</span></p>
<p style="top:429.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3 mths</span></p>
<p style="top:429.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Imaging (MRI)</span></p>
<p style="top:429.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No </span></p>
<p style="top:435.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">difference</span></p>
<p style="top:429.3pt;left:465.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Non-RCT </span></p>
<p style="top:435.3pt;left:465.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(prospective)</span></p>
<p style="top:429.3pt;left:498.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No (11/23)</span></p>
<p style="top:429.3pt;left:529.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Serious</span></p>
<p style="top:461.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Nin et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">57</span></sup></p>
<p style="top:461.3pt;left:127.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PRP</span></p>
<p style="top:461.3pt;left:167.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:461.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Tunnel and graft </span></p>
<p style="top:467.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(intraoperative)</span></p>
<p style="top:461.3pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">100</span></p>
<p style="top:461.3pt;left:279.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Patella</span></p>
<p style="top:461.3pt;left:312.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:461.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">18 mths to 36 </span></p>
<p style="top:467.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">mths</span></p>
<p style="top:461.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Laxity (arthrometer) </span></p>
<p style="top:467.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Imaging (MRI) Functional </span></p>
<p style="top:473.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Score (IKDC)</span></p>
<p style="top:461.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No </span></p>
<p style="top:467.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">difference</span></p>
<p style="top:461.3pt;left:465.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">RCT</span></p>
<p style="top:461.3pt;left:498.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No (18/23)</span></p>
<p style="top:461.3pt;left:529.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Moderate</span></p>
<p style="top:481.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Orrego et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">58</span></sup></p>
<p style="top:481.3pt;left:127.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">APC</span></p>
<p style="top:481.3pt;left:167.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:481.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Tunnel and graft </span></p>
<p style="top:487.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">(intraoperative)</span></p>
<p style="top:481.3pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">108</span></p>
<p style="top:481.3pt;left:279.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring</span></p>
<p style="top:481.3pt;left:312.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">4</span></p>
<p style="top:481.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">3 mths to 6 </span></p>
<p style="top:487.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">mths</span></p>
<p style="top:481.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Imaging (MRI)</span></p>
<p style="top:481.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No </span></p>
<p style="top:487.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">difference</span></p>
<p style="top:481.3pt;left:465.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">RCT</span></p>
<p style="top:481.3pt;left:498.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No (12/23)</span></p>
<p style="top:481.3pt;left:529.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Moderate</span></p>
<p style="top:495.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Ventura et al</span><sup><span style="font-family:Univers55,serif;font-size:3.5pt">59</span></sup></p>
<p style="top:495.3pt;left:127.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PRP</span></p>
<p style="top:495.3pt;left:167.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Growth factor</span></p>
<p style="top:495.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Tunnel (intraop-</span></p>
<p style="top:501.3pt;left:207.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">erative)</span></p>
<p style="top:495.3pt;left:247.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">20</span></p>
<p style="top:495.3pt;left:279.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Hamstring</span></p>
<p style="top:495.3pt;left:312.1pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">2</span></p>
<p style="top:495.3pt;left:338.7pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">6 mths</span></p>
<p style="top:495.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Laxity (arthrometer) </span></p>
<p style="top:501.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Imaging (CT) Functional </span></p>
<p style="top:507.3pt;left:371.2pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Score (Tegner, KOOS)</span></p>
<p style="top:495.3pt;left:437.0pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Positive</span></p>
<p style="top:495.3pt;left:465.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">RCT</span></p>
<p style="top:495.3pt;left:498.5pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">No (10/23)</span></p>
<p style="top:495.3pt;left:529.3pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">Moderate</span></p>
<p style="top:515.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">ACL, anterior cruciate ligament; ACLF. anterior cruciate ligament fibroblasts (ACLFs); AT, achilles tendon; Allo, allograft; APC, autologous platelet concentrate; ADSCs, adipose-derived stem cells; BMSCs, bone </span></p>
<p style="top:521.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">marrow derived mesenchymal stem cells; BMP-2, bone morphogenetic protein 2; bFGF, basic fibroblast growth factor; BMSC, bone marrow mesenchymal stem cells; Bio-scaffold, biologically active scaffold; Bi, </span></p>
<p style="top:527.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">bilateral reconstruction; BPTB, bone&#x2013;patellar tendon&#x2013;bone autograft; CAPP, ceramide-activated protein phosphatase; CaP, calcium phosphate; Case con, case control; DBM, demineralised bone matrix; DCB, </span></p>
<p style="top:533.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">demineralised cortical bone; DPB, deproteinized bone; DBP, demineralized bone protein; ESWT, extracorporeal shockwave therapy; EXT, extensor tendon; Extra, extra-articular; ECM, extracellular matrix; EGF, </span></p>
<p style="top:539.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">epidermal growth factor; Flex, flexor tendon; G-CSF, Granulocyte colony-stimulating factor; Gastroc, gastrocnemius; GF, growth factor; HT, hamstring; HM, Histomorphometric analysis.; hAT-MSCs, human adi-</span></p>
<p style="top:545.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">pose tissue; hiPSC-MSCs, induced pluripotent stemcells generated from human foreskin fibroblasts; HAP, hydroxyapatite; HGF, hepatocyte growth factor; hUCB-MSCs, human umbilical cord blood derived mes-</span></p>
<p style="top:551.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">enchymal stem cells; IFS, injected fibrin sealant; ICPC, injected calcium phosphate cement; IHC, immunohistochemistry; LARS, Ligament Advanced Reinforcement System; LIPUS, low-intensity pulsed </span></p>
<p style="top:557.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">ultrasound; LHA, low crystallinity hydroxyapatite; LTMI, ligament tissue maturity index; Mg, magnesium; MMP, matrix metalloproteinases; MSCs, mesenchymal stem cells; OPG, osteoprotegerin; PLGA, </span></p>
<p style="top:563.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">poly(d,l-lactide-</span><i><span style="font-family:Univers55,Italic,serif;font-size:5.0pt">co</span></i><span style="font-family:Univers55,serif;font-size:5.0pt">-glycolide); PCL/nHAp/Col, polycaprolactone/nanohydroxyapatite/collagen; PDGF, platelet-derived growth factor; PRFM, platelet-rich fibrin matrix; PLA, polylactide; PLG, Platelet-leucocyte gel; </span></p>
<p style="top:569.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">PCL, polycaprolactone; PET, polyethylene terephthalate; PRP, platelet-rich plasma; PolyNaSS , polystyrene sodium sulfonate; PT, patella tendon; PRFM, platelet rich fibrin matrix; PDGF, platelet-derived growth </span></p>
<p style="top:575.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">factor; PEEK, polyether ether ketone; PTH, parathyroid hormone; Peroneal, peroneus longus; PP, Partial patellectomy; PLG, platelet leucocyte gel; rhBMP-2, recombinant human bone morphogenetic protein-2; </span></p>
<p style="top:581.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">RBX, recombined bone xenograft; rtPCR, reverse transcription polymerase chain reaction; RCT, randomised controlled trial; ST, semitendinosus; siRNA, small interfering RNA; Sr-CPC, strontium-enriched cal-</span></p>
<p style="top:587.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">cium phosphate cement; sFLT1: soluble fms-like tyrosine kinase-1; SMDSC, skeletal muscle derived stem cells; Scaff, scaffold; ST, semitendinosis; STG, semitendinosus and gracilis grafts; Sr-CPC, strontium-</span></p>
<p style="top:593.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">enriched calcium phosphate cement; SIS, small intestine submucosa; TGF, transforming growth factor; TDSCs, Tendon-derived stem cells; Tib, tibialis anterior; TCP, tricalcium phosphate; TGF, transforming </span></p>
<p style="top:599.3pt;left:69.4pt;line-height:5.0pt"><span style="font-family:Univers55,serif;font-size:5.0pt">growth factor; TCP, tricalcium phosphate; Untra, untracduced; Uni, unilateral reconstruction; Xeno, xenogenic; VEGF, vascular endothelial growth factor</span></p>


<img style="position:absolute;transform:matrix(.3200452,0,-0,.31638713,47.153337,979.88009)" src="data:image/png;base64,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">
<p style="top:49.8pt;left:52.1pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">278</span></p>
<p style="top:49.8pt;left:203.2pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">A. T. HEXTER, T. THANGARAJAH, G. BLUNN, F. S. HADDAD</span></p>
<p style="top:753.5pt;left:70.0pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">Follow us @BoneJointJ</span></p>
<p style="top:753.5pt;left:447.7pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">THE BONE &amp; JOINT JOURNAL</span></p>
<p style="top:454.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">control group and two intervention groups with different</span></p>
<p style="top:466.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">concentrations of PRP and found no difference in</span></p>
<p style="top:478.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">radiological graft healing, or on clinical examination.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">46</span></sup></p>
<p style="top:490.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">Schippinger et al</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">65</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> showed PRP harvested from patients</span></p>
<p style="top:502.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">receiving non-steroidal anti-inflammatories had inferior</span></p>
<p style="top:514.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">platelet function and bioactivity compared with controls.</span></p>
<p style="top:527.1pt;left:52.1pt;line-height:8.5pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:8.5pt;color:#424242">Biomaterials. </span></b><span style="font-family:Sabon,serif;font-size:9.5pt">This group encompasses four separate</span></p>
<p style="top:538.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">technologies: biological fixation methods; biological</span></p>
<p style="top:550.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">coatings; </span></p>
<p style="top:550.3pt;left:106.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">biosynthetic </span></p>
<p style="top:550.3pt;left:174.4pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">bone </span></p>
<p style="top:550.3pt;left:212.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">substitutes; </span></p>
<p style="top:550.3pt;left:276.8pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">and</span></p>
<p style="top:562.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">osteoconductive materials. Two studies have demonstrated</span></p>
<p style="top:574.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">that magnesium-based interference screws can accelerate</span></p>
<p style="top:586.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">graft mineralization, promote bone formation in the</span></p>
<p style="top:598.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">periscrew region, and enhance osseointegration of extensor</span></p>
<p style="top:610.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">tendon in rabbit models of ACLR.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">66,67</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> The use</span></p>
<p style="top:622.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">biodegradable polylactide (PLA) bolts as the bone anchor</span></p>
<p style="top:634.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">and </span></p>
<p style="top:634.3pt;left:79.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">poly</span><span style="font-family:Sabon,serif;font-size:9.2pt">(d,l-lactide-co-glycolide) </span></p>
<p style="top:634.5pt;left:203.4pt;line-height:9.2pt"><span style="font-family:Sabon,serif;font-size:9.2pt">(PLGA) </span></p>
<p style="top:634.5pt;left:245.1pt;line-height:9.2pt"><span style="font-family:Sabon,serif;font-size:9.2pt">nanofibrous</span></p>
<p style="top:646.5pt;left:52.1pt;line-height:9.2pt"><span style="font-family:Sabon,serif;font-size:9.2pt">membrane at the graft-tunnel interface has been shown to</span></p>
<p style="top:658.5pt;left:52.1pt;line-height:9.2pt"><span style="font-family:Sabon,serif;font-size:9.2pt">enhance bone ingrowth and reduce peritunnel bone loss in</span></p>
<p style="top:670.5pt;left:52.1pt;line-height:9.2pt"><span style="font-family:Sabon,serif;font-size:9.2pt">rabbits.</span><sup><span style="font-family:Sabon,serif;font-size:6.5pt">68</span></sup><span style="font-family:Sabon,serif;font-size:9.2pt"> Studies have shown graft-tunnel interface healing of</span></p>
<p style="top:682.5pt;left:52.1pt;line-height:9.2pt"><span style="font-family:Sabon,serif;font-size:9.2pt">artificial grafts can be enhanced using coatings such as chitin,</span><sup><span style="font-family:Sabon,serif;font-size:6.5pt">69</span></sup></p>
<p style="top:694.5pt;left:52.1pt;line-height:9.2pt"><span style="font-family:Sabon,serif;font-size:9.2pt">bioglass,</span><sup><span style="font-family:Sabon,serif;font-size:6.5pt">70</span></sup><span style="font-family:Sabon,serif;font-size:9.2pt"> gelatin and hyaluronic acid,</span><sup><span style="font-family:Sabon,serif;font-size:6.5pt">71</span></sup><span style="font-family:Sabon,serif;font-size:9.2pt"> polystyrene sodium</span></p>
<p style="top:706.5pt;left:52.1pt;line-height:9.2pt"><span style="font-family:Sabon,serif;font-size:9.2pt">sulfonate</span><sup><span style="font-family:Sabon,serif;font-size:6.5pt">72</span></sup><span style="font-family:Sabon,serif;font-size:9.2pt"> and collagen matrix.</span><sup><span style="font-family:Sabon,serif;font-size:6.5pt">73,74</span></sup><span style="font-family:Sabon,serif;font-size:9.2pt"> Similar coatings have</span></p>
<p style="top:718.5pt;left:52.1pt;line-height:9.2pt"><span style="font-family:Sabon,serif;font-size:9.2pt">been used with tendon autograft; for instance the use of a</span></p>
<p style="top:730.5pt;left:52.1pt;line-height:9.2pt"><span style="font-family:Sabon,serif;font-size:9.2pt">hydroxyapatit</span><span style="font-family:Sabon,serif;font-size:9.5pt">e-doped </span></p>
<p style="top:730.3pt;left:160.6pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">polycaprolactone </span></p>
<p style="top:730.3pt;left:252.6pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">nanofiber</span></p>
<p style="top:454.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">membrane wrapped around autograft hamstring tendon in</span></p>
<p style="top:466.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">rabbits enhanced tissue integration and mechanical</span></p>
<p style="top:478.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">strength.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">75</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> </span></p>
<p style="top:478.3pt;left:358.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">Biosynthetic </span></p>
<p style="top:478.3pt;left:419.0pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">bone </span></p>
<p style="top:478.3pt;left:449.8pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">substitutes, </span></p>
<p style="top:478.3pt;left:506.4pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">such </span></p>
<p style="top:478.3pt;left:535.6pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">as</span></p>
<p style="top:490.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">demineralized bone matrix and recombinant bone</span></p>
<p style="top:502.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">xenograft, are promising biomaterials for enhancing graft-</span></p>
<p style="top:514.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">tunnel </span></p>
<p style="top:514.3pt;left:341.3pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">interface </span></p>
<p style="top:514.3pt;left:388.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">healing </span></p>
<p style="top:514.3pt;left:429.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">because </span></p>
<p style="top:514.3pt;left:472.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">they </span></p>
<p style="top:514.3pt;left:501.0pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">are </span></p>
<p style="top:514.3pt;left:525.0pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">both</span></p>
<p style="top:526.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">osteoinductive and osteoconductive, and they have been</span></p>
<p style="top:538.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">evaluated in eight animal studies, all with positive</span></p>
<p style="top:550.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">findings.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">26,30,62,76-80</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> Demineralized bone matrix (DBM) is</span></p>
<p style="top:562.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">manufactured by acid extraction of the mineral component</span></p>
<p style="top:574.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">of bone, which leaves collagen scaffold containing growth</span></p>
<p style="top:586.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">factors such as BMPs, and has shown the ability to enhance</span></p>
<p style="top:598.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">tendon-bone healing in animal models of rotator cuff</span></p>
<p style="top:610.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">pathology.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">81-84</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> When applied to the tendon-bone interface</span></p>
<p style="top:622.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">in ACLR, DBM can augment tendon-bone healing in</span></p>
<p style="top:634.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">rabbit</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">76</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> and rat</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">78</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> models of ACLR. In 2013, Iorio et al</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">85</span></sup></p>
<p style="top:646.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">reported the only clinical study to evaluate a bone</span></p>
<p style="top:658.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">substitute in graft healing when 40 patients were</span></p>
<p style="top:670.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">randomized to conventional ACLR with single-bundle</span></p>
<p style="top:682.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">hamstring reconstruction or nanohydroxyapatite bone-</span></p>
<p style="top:694.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">based graft, as well as ACLR. Whilst this was a short-term</span></p>
<p style="top:706.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">follow up, the intervention group showed superior</span></p>
<p style="top:718.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">radiological assessment of graft healing, at long-term</span></p>
<p style="top:730.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">follow up there was no difference between the groups in</span></p>
<p style="top:73.7pt;left:59.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Table IV. Categories of biological augmentation of anterior cruciate ligament reconstruction (ACLR)</span></p>
<p style="top:96.4pt;left:59.3pt;line-height:7.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:7.0pt">Category</span></b></p>
<p style="top:96.4pt;left:134.6pt;line-height:7.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:7.0pt">Intervention </span></b></p>
<p style="top:88.5pt;left:412.9pt;line-height:7.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:7.0pt">Comparative clinical </span></b></p>
<p style="top:96.4pt;left:412.9pt;line-height:7.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:7.0pt">trials (n) </span></b></p>
<p style="top:96.4pt;left:483.8pt;line-height:7.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:7.0pt">Clinical findings</span></b></p>
<p style="top:107.7pt;left:59.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Growth factors</span></p>
<p style="top:107.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Individual growth factors eg. bFGF, BMPs-2, VEGF</span></p>
<p style="top:107.7pt;left:412.8pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">0</span></p>
<p style="top:107.7pt;left:483.7pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">N/A</span></p>
<p style="top:117.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Blood/platelet concentrates eg. PRP, Fibrin clot</span></p>
<p style="top:117.7pt;left:412.9pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">15</span></p>
<p style="top:117.7pt;left:483.8pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Mixed</span></p>
<p style="top:127.7pt;left:59.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Biomaterials</span></p>
<p style="top:127.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Biological fixation eg. Magnesium interference screws, PLA bolts</span></p>
<p style="top:127.7pt;left:412.8pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">0</span></p>
<p style="top:127.7pt;left:483.7pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">N/A</span></p>
<p style="top:137.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Biological coatings e.g. Bio-active glass, Chitin, Collagen matrix, Gelatin and </span></p>
<p style="top:145.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">hyaluronic acid, Fibronectin, PLGA, PEEK, PLA, PolyNaSS</span></p>
<p style="top:137.7pt;left:412.9pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">0</span></p>
<p style="top:137.7pt;left:483.7pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">N/A</span></p>
<p style="top:155.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Biosynthetic bone substitutes e.g. Demineralised Bone Matrix, Recombined bone </span></p>
<p style="top:163.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">xenograft</span></p>
<p style="top:155.7pt;left:412.9pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">1</span></p>
<p style="top:155.7pt;left:483.7pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">No difference</span></p>
<p style="top:173.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Osteoconductive materials e.g. Calcium phosphate (CaP) and Strontium-enriched </span></p>
<p style="top:181.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">CaP, CaP-hybridised tendon</span></p>
<p style="top:173.7pt;left:412.9pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">1</span></p>
<p style="top:173.7pt;left:483.7pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Positive</span></p>
<p style="top:191.7pt;left:59.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Stem cells</span></p>
<p style="top:191.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">ACL-derived vascular stem cells (CD34+)</span></p>
<p style="top:191.7pt;left:412.8pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">0</span></p>
<p style="top:191.7pt;left:483.7pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">N/A</span></p>
<p style="top:201.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Adipose-derived stem cells </span></p>
<p style="top:201.7pt;left:412.9pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">1</span></p>
<p style="top:211.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Adult non-cultivated bone marrow stem cells</span></p>
<p style="top:211.7pt;left:412.8pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">0</span></p>
<p style="top:211.7pt;left:483.7pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Positive</span></p>
<p style="top:221.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Bone marrow derived mesenchymal stem cells (BMSC)</span></p>
<p style="top:221.7pt;left:412.9pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">0</span></p>
<p style="top:221.7pt;left:483.8pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">N/A</span></p>
<p style="top:231.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Induced pluripotent stem cells</span></p>
<p style="top:231.7pt;left:412.8pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">0</span></p>
<p style="top:231.7pt;left:483.7pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">N/A </span></p>
<p style="top:241.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Tendon-derived stem cells</span></p>
<p style="top:241.7pt;left:412.8pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">0</span></p>
<p style="top:241.7pt;left:483.7pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">N/A </span></p>
<p style="top:251.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Umbilical cord stem cells</span></p>
<p style="top:251.7pt;left:412.9pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">0</span></p>
<p style="top:261.7pt;left:59.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Autologous tissue</span></p>
<p style="top:261.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Periosteum </span></p>
<p style="top:261.7pt;left:412.9pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">0</span></p>
<p style="top:261.7pt;left:483.7pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">N/A</span></p>
<p style="top:271.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Remnant tissue eg. ACL, muscle</span></p>
<p style="top:271.7pt;left:412.9pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">1</span></p>
<p style="top:271.7pt;left:483.8pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Positive</span></p>
<p style="top:281.7pt;left:59.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Gene therapy</span></p>
<p style="top:281.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Based on stem cells eg. ACL CD34+ -BMP2 transfected, BMSC - bFGF/BMP2 </span></p>
<p style="top:289.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">transfected</span></p>
<p style="top:281.7pt;left:412.9pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">0</span></p>
<p style="top:281.7pt;left:483.7pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">N/A</span></p>
<p style="top:299.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Based on graft tissue eg. BMP-2 genetically altered semitendinosis graft</span></p>
<p style="top:299.7pt;left:412.9pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">0</span></p>
<p style="top:299.7pt;left:483.7pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">N/A</span></p>
<p style="top:309.7pt;left:59.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Pharmaceuticals</span></p>
<p style="top:309.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Bisphosphonates eg. Alendronate</span></p>
<p style="top:309.7pt;left:412.9pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">0</span></p>
<p style="top:309.7pt;left:483.7pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">N/A</span></p>
<p style="top:319.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Matrix metalloproteinases inhibitors eg. Alpha- 2-macroglobulin</span></p>
<p style="top:319.7pt;left:412.8pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">0</span></p>
<p style="top:319.7pt;left:483.7pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">N/A</span></p>
<p style="top:329.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Parathyroid hormone</span></p>
<p style="top:329.7pt;left:412.9pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">0</span></p>
<p style="top:329.7pt;left:483.7pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">N/A</span></p>
<p style="top:339.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Simvastatin</span></p>
<p style="top:339.7pt;left:412.9pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">0</span></p>
<p style="top:339.7pt;left:483.7pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">N/A</span></p>
<p style="top:349.7pt;left:59.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Biophysical and </span></p>
<p style="top:357.7pt;left:59.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">environmental</span></p>
<p style="top:349.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Extracorporeal shockwave therapy </span></p>
<p style="top:349.7pt;left:412.9pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">1</span></p>
<p style="top:349.7pt;left:483.8pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Positive</span></p>
<p style="top:367.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Low-intensity pulsed ultrasound, LIPUS</span></p>
<p style="top:367.7pt;left:412.8pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">0</span></p>
<p style="top:367.7pt;left:483.7pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">N/A</span></p>
<p style="top:377.7pt;left:134.6pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">Hyperbaric oxygen</span></p>
<p style="top:377.7pt;left:412.9pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">0</span></p>
<p style="top:377.7pt;left:483.8pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">N/A</span></p>
<p style="top:387.7pt;left:59.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">bFGF, basic fibroblast growth factor;BMP-2, bone morphogenetic protein 2; VEGF, vascular endothelial growth factor; PRP, platelet-rich plasma; PLA, </span></p>
<p style="top:395.7pt;left:59.3pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">polylactide; PLGA, poly(d,l-lactide-</span><i><span style="font-family:Univers55,Italic,serif;font-size:7.0pt">co</span></i><span style="font-family:Univers55,serif;font-size:7.0pt">-glycolide); PEEK, polyether ether ketone; PolyNaSS , polystyrene sodium sulfonate; N/A, not applicable</span></p>


<p style="top:49.8pt;left:138.0pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">BIOLOGICAL AUGMENTATION OF GRAFT HEALING IN ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION</span></p>
<p style="top:49.8pt;left:549.0pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">279</span></p>
<p style="top:753.5pt;left:67.9pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">VOL. 100-B, No. 3, MARCH 2018</span></p>
<p style="top:70.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">terms of radiological and clinical outcome measures.</span></p>
<p style="top:82.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">Calcium </span></p>
<p style="top:82.3pt;left:114.0pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">phosphate </span></p>
<p style="top:82.3pt;left:168.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">(CaP) </span></p>
<p style="top:82.3pt;left:203.2pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">is </span></p>
<p style="top:82.3pt;left:221.4pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">a </span></p>
<p style="top:82.3pt;left:238.0pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">resorbable </span></p>
<p style="top:82.3pt;left:292.6pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">and</span></p>
<p style="top:94.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">osteoconductive biomaterial that has shown positive results</span></p>
<p style="top:106.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">in 12 animal studies which evaluated graft healing.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">25,32,86-95</span></sup></p>
<p style="top:118.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">There is evidence that CaP materials and cements can</span></p>
<p style="top:130.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">enhance tendon-bone healing in rabbit</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">32,91,92,94</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> and dog</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">93</span></sup></p>
<p style="top:142.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">animal models, an effect which is enhanced with</span></p>
<p style="top:154.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">incorporation of strontium.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">87,88</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> Mutsuzaki et al</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">86</span></sup></p>
<p style="top:166.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">investigated a CaP-hybridized flexor tendon in a goat</span></p>
<p style="top:178.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">model (n = 10) and after six months, animals treated with</span></p>
<p style="top:190.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">the CaP-hybridized tendon showed superior knee stability</span></p>
<p style="top:202.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">and increased osseointegration at the graft-tunnel interface.</span></p>
<p style="top:214.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">A randomized controlled trial</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">89</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> was carried out in humans</span></p>
<p style="top:226.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">involving 64 patients, who were randomized to receive</span></p>
<p style="top:238.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">conventional hamstring ACLR or CaP-hybridized graft</span></p>
<p style="top:250.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">reconstruction where tendon graft was hybridized</span></p>
<p style="top:262.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">intraoperatively with CaP at both ends of the graft. When</span></p>
<p style="top:274.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">compared with the control group, the hybridized-group</span></p>
<p style="top:286.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">showed reduced tunnel enlargement at one year and</span></p>
<p style="top:298.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">superior anterior knee stability and Lysholm scores at two-</span></p>
<p style="top:310.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">year follow-up.</span></p>
<p style="top:323.1pt;left:67.9pt;line-height:8.5pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:8.5pt;color:#424242">Stem cells. </span></b><span style="font-family:Sabon,serif;font-size:9.5pt">Multiple stem cell types have been shown to</span></p>
<p style="top:334.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">enhance graft-tunnel interface healing in animal models.</span></p>
<p style="top:346.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">Cells can be isolated at the time of surgery</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">109</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> using bone</span></p>
<p style="top:358.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">marrow aspirate, or cells can be culture-expanded prior to</span></p>
<p style="top:370.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">the surgical procedure. Cells that have been culture</span></p>
<p style="top:382.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">expanded include adipose-derived stem cells (ADSCs),</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">96-98</span></sup></p>
<p style="top:394.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">bone marrow derived stem cells (BMSCs),</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">99,100</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> induced</span></p>
<p style="top:406.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">pluripotent stem cells (iPSCs),</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">97</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> umbilical cord-derived</span></p>
<p style="top:418.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">mesenchymal stem cells,</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">101</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> tendon-derived stem cells</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">102</span></sup></p>
<p style="top:430.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">and CD34+ ACL-derived stem cells.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">103,104</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> Stem cells have</span></p>
<p style="top:442.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">been seeded on scaffold,</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">96,99,100,105-107</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> in the form of</span></p>
<p style="top:454.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">sheets</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">102,103</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> or applied locally to grafts.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">108</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> Li et al</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">99</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> found</span></p>
<p style="top:466.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">that a BMSC-seeded silk scaffold implanted in rabbits led</span></p>
<p style="top:478.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">to enhanced osseointegration at 24 weeks confirmed by</span></p>
<p style="top:490.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">biomechanical </span></p>
<p style="top:490.3pt;left:139.2pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">testing, </span></p>
<p style="top:490.3pt;left:181.0pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">micro-CT </span></p>
<p style="top:490.3pt;left:233.4pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">and </span></p>
<p style="top:490.3pt;left:261.0pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">histological</span></p>
<p style="top:502.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">assessment. Kosaka et al</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">98</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> found that a coating</span></p>
<p style="top:514.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">semitendinosus graft with ADSCs mixed in a fibrin glue</span></p>
<p style="top:526.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">carrier in a rabbit model led to higher ultimate failure load</span></p>
<p style="top:538.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">and enhanced histological remodelling by 12 weeks. In a rat</span></p>
<p style="top:550.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">model, Mifune et al</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">103</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> found that wrapping a tendon graft</span></p>
<p style="top:562.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">in an ACL-derived CD34+ cell sheet demonstrated</span></p>
<p style="top:574.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">increased biomechanical strength. The CD34 antigen is</span></p>
<p style="top:586.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">expressed on haematopoietic stem and progenitor cells.</span></p>
<p style="top:598.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">Immunohistochemistry confirmed that cells derived from</span></p>
<p style="top:610.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">the cell sheets had integrated within the tendon graft and</span></p>
<p style="top:622.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">the graft-tunnel interface.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">103</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> Intracapsular administration</span></p>
<p style="top:634.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">of ACL-derived CD34+ cells in a rat model led to</span></p>
<p style="top:646.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">recruitment of the transplanted cells into the perigraft site,</span></p>
<p style="top:658.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">with </span></p>
<p style="top:658.3pt;left:101.6pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">enhanced </span></p>
<p style="top:658.3pt;left:155.4pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">angiogenesis, </span></p>
<p style="top:658.3pt;left:224.5pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">osteogenesis, </span></p>
<p style="top:658.3pt;left:292.6pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">and</span></p>
<p style="top:670.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">biomechanical strength.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">104</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> </span></p>
<p style="top:682.3pt;left:77.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">The only clinical study evaluating stem cells in tendon-</span></p>
<p style="top:694.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">bone healing was a RCT of 44 patients where adult non-</span></p>
<p style="top:706.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">cultivated bone marrow stem cells were obtained</span></p>
<p style="top:718.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">intraoperatively.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">109</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> Bone marrow harvested from the iliac</span></p>
<p style="top:730.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">crest was centrifuged and 3 ml of marrow stem cell</span></p>
<p style="top:70.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">concentrate was obtained, which was applied to the</span></p>
<p style="top:82.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">femoral side of the graft and the femoral osseous tunnel.</span></p>
<p style="top:94.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">MRI assessment of tendon-bone healing found no</span></p>
<p style="top:106.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">difference between intervention and control groups at three</span></p>
<p style="top:118.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">months.</span></p>
<p style="top:131.1pt;left:319.9pt;line-height:8.5pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:8.5pt;color:#424242">Gene therapy. </span></b><span style="font-family:Sabon,serif;font-size:9.5pt">Martinek et al</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">110</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> reported the first study to</span></p>
<p style="top:142.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">evaluate gene therapy on the graft-tunnel interface after</span></p>
<p style="top:154.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">ACLR. A rabbit model of ACLR injury was used, and</span></p>
<p style="top:166.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">rabbits either received an untreated semitendinosus tendon,</span></p>
<p style="top:178.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">or semitendinosus tendon infected </span><i><span style="font-family:Sabon,Italic,serif;font-size:9.5pt">in vitro</span></i><span style="font-family:Sabon,serif;font-size:9.5pt"> with adenovirus-</span></p>
<p style="top:190.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">BMP-2 (AdBMP-2). Infection was accomplished by</span></p>
<p style="top:202.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">culturing the semitendinosus tendon with the adenovirus</span></p>
<p style="top:214.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">prior to the operation. The number of infected cells was</span></p>
<p style="top:226.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">stable during the eight-week study. Improved integration of</span></p>
<p style="top:238.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">semitendinosus tendon grafts within the bone tunnels was</span></p>
<p style="top:250.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">observed with associated improvements in biomechanical</span></p>
<p style="top:262.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">strength. In a rabbit extensor tendon model, Wang et al</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">111</span></sup></p>
<p style="top:274.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">applied BMP-2 gene-transfected normal rat kidney cells at</span></p>
<p style="top:286.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">the tendon-bone interface. After 12 weeks the study group</span></p>
<p style="top:298.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">had superior biomechanical strength and histological</span></p>
<p style="top:310.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">assessment showed greater integration between tendon and</span></p>
<p style="top:322.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">bone compared with controls with higher expressions of</span></p>
<p style="top:334.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">BMP-2 and VEGR on immunohistochemistry. Besides the</span></p>
<p style="top:346.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">previous two studies, all other gene therapy approaches to</span></p>
<p style="top:358.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">enhance graft healing has been based on stem cells.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">31,112-117</span></sup></p>
<p style="top:370.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">By transfecting stem cells with growth factors such as</span></p>
<p style="top:382.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">BMP2, PDGF-B and TGF-</span><span style="font-family:Calibri,sans-serif;font-size:9.5pt">&#x3b2;</span><span style="font-family:Sabon,serif;font-size:9.5pt">, a stable continuous</span></p>
<p style="top:394.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">concentration of these agents would be delivered to the</span></p>
<p style="top:406.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">graft healing site.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">118</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> Unlike local application of growth</span></p>
<p style="top:418.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">factors intraoperatively, genetic modification of stem cells</span></p>
<p style="top:430.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">offers the benefits of a strong and sustained effect of growth</span></p>
<p style="top:442.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">factors. Chen et al</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">114</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> found that implantation of genetically</span></p>
<p style="top:454.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">modified MSCs with bFGF and BMP2 at the graft-tunnel</span></p>
<p style="top:466.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">interface in rabbit model of ACLR led to improved</span></p>
<p style="top:478.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">cellularity, enhanced new bone formation, and conferred</span></p>
<p style="top:490.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">superior mechanical properties. Furthermore, the co-</span></p>
<p style="top:502.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">application of these two genes was more powerful and</span></p>
<p style="top:514.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">efficient than either single gene therapy.</span></p>
<p style="top:527.1pt;left:319.9pt;line-height:8.5pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:8.5pt;color:#424242">Autologous tissue. </span></b><span style="font-family:Sabon,serif;font-size:9.5pt">When the ACL ruptures, CD34+</span></p>
<p style="top:538.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">vascular stem cells released locally are thought to</span></p>
<p style="top:550.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">contribute to healing at the site of rupture.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">119</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> An advantage</span></p>
<p style="top:562.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">of using autologous tissue over cultured stem cells is the</span></p>
<p style="top:574.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">ability to deliver a source of regenerative cells without the</span></p>
<p style="top:586.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">risk of rejection and malignancy. Attachment of the ACL</span></p>
<p style="top:598.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">remnant </span></p>
<p style="top:598.3pt;left:365.6pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">to </span></p>
<p style="top:598.3pt;left:385.6pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">the </span></p>
<p style="top:598.3pt;left:409.6pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">graft </span></p>
<p style="top:598.3pt;left:440.6pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">is </span></p>
<p style="top:598.3pt;left:458.4pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">intended </span></p>
<p style="top:598.3pt;left:505.2pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">to </span></p>
<p style="top:598.3pt;left:525.2pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">promote</span></p>
<p style="top:610.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">ligamentization. Six animal studies have been carried out</span></p>
<p style="top:622.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">evaluating the effect of remnant repair on graft healing,</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">120-</span></sup></p>
<p style="top:632.8pt;left:319.9pt;line-height:6.6pt"><span style="font-family:Sabon,serif;font-size:6.6pt">125</span><span style="font-family:Sabon,serif;font-size:9.5pt"> with positive findings in four studies and no difference</span></p>
<p style="top:646.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">in two. Song et al</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">125</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> found no difference in biomechanical</span></p>
<p style="top:658.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">strength, revascularization status, and proprioceptive</span></p>
<p style="top:670.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">recovery potential between 30 rabbits who underwent</span></p>
<p style="top:682.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">remnant-preserving ACLR and 30 rabbits who underwent</span></p>
<p style="top:694.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">conventional ACLR. Conversely, in a study of 42 sheep,</span></p>
<p style="top:706.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">Takahashi et al</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">124</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> found that remnant-preserving ACLR</span></p>
<p style="top:718.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">enhanced </span></p>
<p style="top:718.3pt;left:372.6pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">revascularization </span></p>
<p style="top:718.3pt;left:456.6pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">and </span></p>
<p style="top:718.3pt;left:486.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">regeneration </span></p>
<p style="top:718.3pt;left:551.5pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">of</span></p>
<p style="top:730.3pt;left:319.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">proprioceptive organs compared with conventional ACLR,</span></p>


<img style="position:absolute;transform:matrix(.3200452,0,-0,.31638713,47.153337,979.88009)" src="data:image/png;base64,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">
<p style="top:49.8pt;left:52.1pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">280</span></p>
<p style="top:49.8pt;left:203.2pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">A. T. HEXTER, T. THANGARAJAH, G. BLUNN, F. S. HADDAD</span></p>
<p style="top:753.5pt;left:70.0pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">Follow us @BoneJointJ</span></p>
<p style="top:753.5pt;left:447.7pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">THE BONE &amp; JOINT JOURNAL</span></p>
<p style="top:70.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">leading to reduced anteroposterior laxity on clinical</span></p>
<p style="top:82.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">examination. However, there was no improvement in</span></p>
<p style="top:94.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">biomechanical strength. Matsumoto et al</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">126</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> found that</span></p>
<p style="top:106.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">autologous ruptured ACL tissue sutured to the tibial side of</span></p>
<p style="top:118.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">the graft enhanced maturation of bone-tendon integration</span></p>
<p style="top:130.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">in a canine model of ACLR at four weeks and compared</span></p>
<p style="top:142.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">with an untreated-control group, and was associated with</span></p>
<p style="top:154.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">smaller tibial bone tunnels and greater ultimate tensile</span></p>
<p style="top:166.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">strength. </span></p>
<p style="top:178.3pt;left:62.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">The effect of remnant preservation was examined in</span></p>
<p style="top:190.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">humans by Matsumoto et al</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">127</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> in 2014. In this study, five</span></p>
<p style="top:202.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">patients underwent conventional double-bundle ACLR and</span></p>
<p style="top:214.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">five patients underwent ACLR with suturing of the</span></p>
<p style="top:226.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">ruptured tissue to hamstring graft. After two years, CT</span></p>
<p style="top:238.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">scans demonstrated smaller tunnel volumes in the remnant-</span></p>
<p style="top:250.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">preserving ACLR, but no difference was detected clinically</span></p>
<p style="top:262.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">in terms of knee laxity and Lysholm score. This study was</span></p>
<p style="top:274.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">limited by follow-up occurring at different timepoints and</span></p>
<p style="top:286.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">longer-term studies are required to investigate the effects of</span></p>
<p style="top:298.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">remnant-preserving ACLR better. </span></p>
<p style="top:310.3pt;left:62.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">The periosteum is also a source of regenerative cells</span></p>
<p style="top:322.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">capable of promoting osteogenesis and chondrogenesis and</span></p>
<p style="top:334.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">in theory the use of periosteal cell graft healing may</span></p>
<p style="top:346.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">recreate a fibrocartilaginous direct-type enthesis.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">128,129</span></sup></p>
<p style="top:358.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">Chen et al</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">130</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> first investigated the benefit of periosteum in</span></p>
<p style="top:370.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">36 rabbits who underwent bilateral ACLR using extensor</span></p>
<p style="top:382.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">tendons bilaterally, with one side wrapped in periosteum.</span></p>
<p style="top:394.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">After 12 weeks histologically, there was enhanced tendon-</span></p>
<p style="top:406.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">bone integration with the periosteum-enveloped tendon</span></p>
<p style="top:418.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">and associated improvements biomechanically with higher</span></p>
<p style="top:430.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">maximal pull-out forces. Improved osseointegration has</span></p>
<p style="top:442.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">also been observed when synthetic grafts are wrapped in</span></p>
<p style="top:454.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">periosteum in a goat animal model.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">131</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> One group has</span></p>
<p style="top:466.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">reported clinical studies, albeit with no control group,</span></p>
<p style="top:478.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">which show minimal tunnel widening when hamstring</span></p>
<p style="top:490.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">tendons were enveloped in periosteum.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">132-134</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> </span></p>
<p style="top:503.1pt;left:52.1pt;line-height:8.5pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:8.5pt;color:#424242">Pharmaceuticals. </span></b><span style="font-family:Sabon,serif;font-size:9.5pt">Four different pharmaceuticals have been</span></p>
<p style="top:514.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">studied in animal models to modulate the inflammatory</span></p>
<p style="top:526.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">response present after ACL injury and augment graft</span></p>
<p style="top:538.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">healing. Demirag et al</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">135</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> investigated the effect of metal</span></p>
<p style="top:550.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">matrix metalloproteinase (MMP) inhibitors on graft</span></p>
<p style="top:562.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">healing in 28 rabbits undergoing bilateral ACLR by</span></p>
<p style="top:574.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">injecting the MMP-inhibitor alpha-2-macroglobulin into</span></p>
<p style="top:586.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">one knee. After five weeks knees that received MMP</span></p>
<p style="top:598.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">blockade showed a more mature graft-tunnel interface,</span></p>
<p style="top:610.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">reduced MMPs in the synovial fluid and better</span></p>
<p style="top:622.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">biomechanical strength.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">135</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> In 2013 two studies</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">136,137</span></sup></p>
<p style="top:634.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">investigated </span></p>
<p style="top:634.3pt;left:115.0pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">the </span></p>
<p style="top:634.3pt;left:142.0pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">effect </span></p>
<p style="top:634.3pt;left:178.5pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">of </span></p>
<p style="top:634.3pt;left:201.3pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">bisphosphonates </span></p>
<p style="top:634.3pt;left:283.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">of</span></p>
<p style="top:646.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">osseointegration after ACLR in a rat model of ACLR.</span></p>
<p style="top:658.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">Local</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">136</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> or systemic</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">137</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> administration of alendronate</span></p>
<p style="top:670.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">resulted in improved bone tunnel mineralization, reduced</span></p>
<p style="top:682.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">peritunnel bone loss and enhanced graft-tunnel integration</span></p>
<p style="top:694.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">after six weeks. A study comparing rats receiving daily</span></p>
<p style="top:706.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">subcutaneous parathyroid hormone showed enhanced</span></p>
<p style="top:718.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">thickness and microarchitecture of trabecular bone on CT</span></p>
<p style="top:730.3pt;left:52.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">compared with rats that received saline injections.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">138</span></sup></p>
<p style="top:70.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">Simvastatin has been shown to promote bone formation.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">139</span></sup></p>
<p style="top:82.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">In 2016, Zhang et al</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">140</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> investigated the effect of statins on</span></p>
<p style="top:94.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">osseointegration in 36 rabbits undergoing ACLR with a</span></p>
<p style="top:106.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">PET artificial ligament. Rabbits in which the graft was</span></p>
<p style="top:118.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">coated with collagen-containing low-dose simvastatin</span></p>
<p style="top:130.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">polycaprolactone </span></p>
<p style="top:130.3pt;left:396.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">microspheres </span></p>
<p style="top:130.3pt;left:472.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">had </span></p>
<p style="top:130.3pt;left:510.3pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">superior</span></p>
<p style="top:142.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">biomechanical strength and better histological findings at</span></p>
<p style="top:154.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">eight weeks, with immunohistochemistry demonstrating</span></p>
<p style="top:166.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">enhanced angiogenesis and osteogenesis. </span></p>
<p style="top:179.1pt;left:304.1pt;line-height:8.5pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:8.5pt;color:#424242">Biophysical and environmental. </span></b><span style="font-family:Sabon,serif;font-size:9.5pt">Yeh et al</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">141</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> studied the use</span></p>
<p style="top:190.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">of hyperbaric oxygen (HBO) on graft neovascularization in</span></p>
<p style="top:202.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">a rabbit model (n = 40). Animals receiving HBO treatment</span></p>
<p style="top:214.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">showed superior neovascularization, osseointegration and</span></p>
<p style="top:226.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">biomechanical properties. Low intensity pulsed ultrasound</span></p>
<p style="top:238.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">(LIPUS) has been used in two animal studies with positive</span></p>
<p style="top:250.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">results.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">142,143</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> A study of 89 sheep investigating the effect of</span></p>
<p style="top:262.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">daily LIPUS found that the LIPUS group demonstrated</span></p>
<p style="top:274.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">better </span></p>
<p style="top:274.3pt;left:340.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">histological </span></p>
<p style="top:274.3pt;left:399.3pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">osseointegration </span></p>
<p style="top:274.3pt;left:478.6pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">and </span></p>
<p style="top:274.3pt;left:506.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">increased</span></p>
<p style="top:286.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">mechanical strength 26 weeks after surgery.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">142</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> A</span></p>
<p style="top:298.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">subsequent study in rabbits found that LIPUS-treated</span></p>
<p style="top:310.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">animals had improved ligamentization, which was</span></p>
<p style="top:322.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">attributed to upregulation of genes such as TGF-1.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">143</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> Wang</span></p>
<p style="top:334.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">et al</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">144</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> reported that ESWT applied to the tibial tunnel</span></p>
<p style="top:346.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">immediately after ACLR in rabbits improved healing at the</span></p>
<p style="top:358.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">graft-tunnel </span></p>
<p style="top:358.3pt;left:369.5pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">interface </span></p>
<p style="top:358.3pt;left:421.7pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">both </span></p>
<p style="top:358.3pt;left:457.6pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">histologically </span></p>
<p style="top:358.3pt;left:528.8pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">and</span></p>
<p style="top:370.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">biomechanically at eight and 24 weeks. </span></p>
<p style="top:382.3pt;left:314.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">A clinical RCT of 53 patients undergoing single-bundle</span></p>
<p style="top:394.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">ACLR with hamstring autograft found that patients</span></p>
<p style="top:406.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">randomized to receive ESWT on the day of surgery had</span></p>
<p style="top:418.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">significantly superior Lysholm scores and reduced tibial</span></p>
<p style="top:430.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">peritunnel bone loss than the control group at two years.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">145</span></sup></p>
<p style="top:443.1pt;left:304.1pt;line-height:8.5pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:8.5pt;color:#424242">Clinical translation and future research. </span></b><span style="font-family:Sabon,serif;font-size:9.5pt">This </span></p>
<p style="top:442.3pt;left:501.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">systematic</span></p>
<p style="top:454.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">review demonstrates the large amount of preclinical</span></p>
<p style="top:466.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">research in the biological augmentation of ACLR.</span></p>
<p style="top:478.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">Nevertheless, the impact of the research is limited by the</span></p>
<p style="top:490.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">fact the majority of studies have used small animal models</span></p>
<p style="top:502.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">(n = 67, 60%), and only 10% of studies have used</span></p>
<p style="top:514.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">quantitative clinically useful outcome measures (as</span></p>
<p style="top:526.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">determined by rank A in Table II). We believe future</span></p>
<p style="top:538.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">research should use larger animal models as this lends itself</span></p>
<p style="top:550.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">to clinically useful outcomes such as joint laxity and gait</span></p>
<p style="top:562.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">analysis. The median follow-up of animal research is 12</span></p>
<p style="top:574.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">weeks, but this is likely to be inadequate to assess</span></p>
<p style="top:586.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">ligamentization and the development of osteoarthritis. It is</span></p>
<p style="top:598.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">thought the poor capacity of the ACL to heal is due to the</span></p>
<p style="top:610.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">fact that the synovial fluid environment can disrupt the</span></p>
<p style="top:622.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">healing scaffold,</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">146</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> and future research should show that</span></p>
<p style="top:634.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">interventions are capable of remaining at the graft interface</span></p>
<p style="top:646.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">by using tracking methods such as quantum dot</span></p>
<p style="top:658.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">labelling.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">147</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> In terms of clinical studies, 75% have</span></p>
<p style="top:670.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">evaluated PRP but currently there is a lack of evidence to</span></p>
<p style="top:682.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">support its efficacy and most clinical studies fall short of the</span></p>
<p style="top:694.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">minimum reporting standards. Biomaterials are the most</span></p>
<p style="top:706.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">investigated category of biological therapy in animal</span></p>
<p style="top:718.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">studies, but represent just 10% (n = 2) of clinical studies.</span></p>
<p style="top:730.3pt;left:304.1pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">Future clinical studies investigating biomaterials are</span></p>


<p style="top:49.8pt;left:138.0pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">BIOLOGICAL AUGMENTATION OF GRAFT HEALING IN ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION</span></p>
<p style="top:49.8pt;left:549.0pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">281</span></p>
<p style="top:753.5pt;left:67.9pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">VOL. 100-B, No. 3, MARCH 2018</span></p>
<p style="top:70.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">required, especially materials currently in use in clinical</span></p>
<p style="top:82.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">practice such as DBM, which has shown efficacy in animal</span></p>
<p style="top:94.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">studies.</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">148</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> To date, one stem cell study</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">109</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> has been</span></p>
<p style="top:106.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">performed in the context of ACLR, but with the current</span></p>
<p style="top:118.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">enthusiasm for MSC-based therapies in the treatment of</span></p>
<p style="top:130.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">musculoskeletal conditions, and the development of</span></p>
<p style="top:142.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">methods to harvest and intraoperatively deliver adult non-</span></p>
<p style="top:154.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">cultivated bone marrow stem cells, this is set to increase.</span></p>
<p style="top:166.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">There is no current clinical evidence to support the use of</span></p>
<p style="top:178.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">stem cells in ACLR, but it is possible that techniques where</span></p>
<p style="top:190.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">stem cells are delivered in higher concentrations will lead to</span></p>
<p style="top:202.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">a clinically detectable effect. Other autologous sources of</span></p>
<p style="top:214.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">stem cells requiring further evaluation in clinical studies</span></p>
<p style="top:226.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">include enhancement of the graft with the native graft</span></p>
<p style="top:238.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">remnant</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">119-122</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> and periosteum,</span><sup><span style="font-family:Sabon,serif;font-size:6.6pt">130,131</span></sup><span style="font-family:Sabon,serif;font-size:9.5pt"> which have been</span></p>
<p style="top:250.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">shown to be effective in animal studies. Future research is</span></p>
<p style="top:262.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">needed to delineate the exact mechanisms of the</span></p>
<p style="top:274.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">interventions and determine whether a combination of</span></p>
<p style="top:286.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">different therapies is of benefit in the clinical setting.</span></p>
<p style="top:298.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">Despite promising results in animal studies, gene therapy</span></p>
<p style="top:310.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">remains experimental and risks such as mutagenesis and</span></p>
<p style="top:322.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">malignancy need to be addressed before clinical studies are</span></p>
<p style="top:334.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">performed. </span></p>
<p style="top:346.3pt;left:77.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">This study has highlighted the diversity of biological</span></p>
<p style="top:358.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">therapies and of methods of delivery. To facilitate robust</span></p>
<p style="top:370.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">critical appraisal future clinical studies should comply by</span></p>
<p style="top:382.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">the published minimum standards of reporting. Relatively</span></p>
<p style="top:394.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">few clinical studies (9/20) have evaluated clinical outcome</span></p>
<p style="top:406.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">measures (knee laxity, functional scores) with imaging of</span></p>
<p style="top:418.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">the graft-bone interfaces (CT or MRI). In order to evaluate</span></p>
<p style="top:430.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">the clinical efficacy of biological studies, clinical studies</span></p>
<p style="top:442.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">should ideally include 3D imaging of the bone tunnels and</span></p>
<p style="top:454.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">the graft as well as clinical assessment of joint function,</span></p>
<p style="top:466.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">including examination of laxity and clinical functional</span></p>
<p style="top:478.3pt;left:67.9pt;line-height:9.5pt"><span style="font-family:Sabon,serif;font-size:9.5pt">scores.</span></p>
<p style="top:490.1pt;left:77.9pt;line-height:9.7pt"><span style="font-family:Sabon,serif;font-size:9.7pt">In conclusion, this systematic review has summarized</span></p>
<p style="top:502.1pt;left:67.9pt;line-height:9.7pt"><span style="font-family:Sabon,serif;font-size:9.7pt">a significant body of literature on biological modulation</span></p>
<p style="top:514.1pt;left:67.9pt;line-height:9.7pt"><span style="font-family:Sabon,serif;font-size:9.7pt">of ACLR across human and animal models in clinical</span></p>
<p style="top:526.1pt;left:67.9pt;line-height:9.7pt"><span style="font-family:Sabon,serif;font-size:9.7pt">and experimental settings. As a result, there is a</span></p>
<p style="top:538.1pt;left:67.9pt;line-height:9.7pt"><span style="font-family:Sabon,serif;font-size:9.7pt">significant amount of heterogeneity amongst the</span></p>
<p style="top:550.1pt;left:67.9pt;line-height:9.7pt"><span style="font-family:Sabon,serif;font-size:9.7pt">subgroups and treatment modalities, which makes meta-</span></p>
<p style="top:562.1pt;left:67.9pt;line-height:9.7pt"><span style="font-family:Sabon,serif;font-size:9.7pt">analysis inappropriate. Nevertheless, this study adds</span></p>
<p style="top:574.1pt;left:67.9pt;line-height:9.7pt"><span style="font-family:Sabon,serif;font-size:9.7pt">important knowledge to the field. When compared with</span></p>
<p style="top:586.1pt;left:67.9pt;line-height:9.7pt"><span style="font-family:Sabon,serif;font-size:9.7pt">the most recent systematic review (n = 60 studies),</span><sup><span style="font-family:Sabon,serif;font-size:6.8pt">20</span></sup><span style="font-family:Sabon,serif;font-size:9.7pt"> this</span></p>
<p style="top:598.1pt;left:67.9pt;line-height:9.7pt"><span style="font-family:Sabon,serif;font-size:9.7pt">study has reported a further 62 studies. Unlike the</span></p>
<p style="top:610.1pt;left:67.9pt;line-height:9.7pt"><span style="font-family:Sabon,serif;font-size:9.7pt">previous review, this study focuses exclusively on ACLR</span></p>
<p style="top:622.1pt;left:67.9pt;line-height:9.7pt"><span style="font-family:Sabon,serif;font-size:9.7pt">and has excluded bioenhanced repair. In addition, for</span></p>
<p style="top:634.1pt;left:67.9pt;line-height:9.7pt"><span style="font-family:Sabon,serif;font-size:9.7pt">the first time this study has specifically reported the</span></p>
<p style="top:646.1pt;left:67.9pt;line-height:9.7pt"><span style="font-family:Sabon,serif;font-size:9.7pt">target site and timing of biological therapies and has</span></p>
<p style="top:658.1pt;left:67.9pt;line-height:9.7pt"><span style="font-family:Sabon,serif;font-size:9.7pt">critiqued clinical studies against the minimum reporting</span></p>
<p style="top:670.1pt;left:67.9pt;line-height:9.7pt"><span style="font-family:Sabon,serif;font-size:9.7pt">standards.</span></p>
<p style="top:682.1pt;left:77.9pt;line-height:9.7pt"><span style="font-family:Sabon,serif;font-size:9.7pt">Further clinical studies that meet the minimum</span></p>
<p style="top:694.1pt;left:67.9pt;line-height:9.7pt"><span style="font-family:Sabon,serif;font-size:9.7pt">standards of reporting are required to determine</span></p>
<p style="top:706.1pt;left:67.9pt;line-height:9.7pt"><span style="font-family:Sabon,serif;font-size:9.7pt">whether current and emerging biological strategies will</span></p>
<p style="top:718.1pt;left:67.9pt;line-height:9.7pt"><span style="font-family:Sabon,serif;font-size:9.7pt">provide tangible benefits in patients undergoing ACLR.</span></p>
<p style="top:70.3pt;left:357.1pt;line-height:9.5pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:9.5pt;color:#919191">Take home message:</span></b></p>
<p style="top:82.6pt;left:357.1pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">-The outcome of ACL reconstruction depends on a biological</span></p>
<p style="top:91.6pt;left:357.1pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">healing response, called &#x201c;Graft Healing&#x201d;.</span></p>
<p style="top:100.6pt;left:319.9pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">-We have systematically reviewed biological augmentation of ACL</span></p>
<p style="top:109.6pt;left:319.9pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">reconstruction.</span></p>
<p style="top:120.3pt;left:319.9pt;line-height:7.0pt"><span style="font-family:Univers55,serif;font-size:7.0pt">-We have identified seven categories of biological intervention.</span></p>
<p style="top:141.9pt;left:319.9pt;line-height:10.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:10.0pt;color:#424242">Twitter</span></b></p>
<p style="top:155.5pt;left:319.9pt;line-height:8.0pt"><span style="font-family:Univers55,serif;font-size:8.0pt">Follow A. T. Hexter @HexterAdam</span></p>
<p style="top:177.9pt;left:319.9pt;line-height:10.0pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:10.0pt;color:#424242">References</span></b></p>
<p style="top:190.2pt;left:324.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">1. Prodromos CC, Han Y, Rogowski J, Joyce B, Shi K.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> A meta-analysis of the</span></p>
<p style="top:198.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">incidence of anterior cruciate ligament tears as a function of gender, sport, and a knee</span></p>
<p style="top:206.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">injury&#x2013;reduction regimen. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Arthroscopy</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2007;23:1320&#x2013;1325.</span></p>
<p style="top:217.2pt;left:324.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">2. Linko E, Harilainen A, Malmivaara A, Seitsalo S.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Surgical versus conservative</span></p>
<p style="top:225.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">interventions for anterior cruciate ligament ruptures in adults. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Cochrane Database</span></i></p>
<p style="top:233.2pt;left:331.9pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Syst Rev</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2005;2:CD001356.</span></p>
<p style="top:244.2pt;left:324.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">3. Wasserstein D, Sheth U, Cabrera A, Spindler KP.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> A systematic review of failed</span></p>
<p style="top:252.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">anterior cruciate ligament reconstruction with autograft compared with allograft in</span></p>
<p style="top:260.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">young patients. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Sports Health</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2015;7:207&#x2013;216.</span></p>
<p style="top:271.2pt;left:324.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">4. Grassi A, Nitri M, Moulton SG, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Does the type of graft affect the outcome of</span></p>
<p style="top:279.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">revision anterior cruciate ligament reconstruction? a meta-analysis of 32 studies.</span></p>
<p style="top:287.2pt;left:331.9pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Bone Joint J</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2017;99-B:714&#x2013;723.</span></p>
<p style="top:298.2pt;left:324.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">5.</span></b><b><span style="font-family:Calibri,Bold,sans-serif;font-size:7.5pt"> &#x15a;</span></b><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">migielski R</span></b><b><span style="font-family:Univers47CondensedLight,,serif;font-size:6.5pt">, </span></b><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Zdanowicz U</span></b><b><span style="font-family:Univers47CondensedLight,,serif;font-size:6.5pt">, </span></b><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Drwi</span></b><b><span style="font-family:Calibri,Bold,sans-serif;font-size:7.5pt">&#x119;</span></b><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">ga M</span></b><b><span style="font-family:Univers47CondensedLight,,serif;font-size:6.5pt">, </span></b><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Ciszek B</span></b><b><span style="font-family:Univers47CondensedLight,,serif;font-size:6.5pt">, </span></b><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Williams A</span></b><b><span style="font-family:Univers47CondensedLight,,serif;font-size:6.5pt">.</span></b><span style="font-family:Times New Roman,serif;font-size:12.0pt"> </span><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">The anatomy of</span></p>
<p style="top:306.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">the anterior cruciate ligament and its relevance to the technique of reconstruction.</span></p>
<p style="top:314.2pt;left:331.9pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Bone Joint J</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2016;98-B:1020&#x2013;1026.</span></p>
<p style="top:325.2pt;left:324.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">6. Boddu C, Arif SK, Hussain MM, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Prevention of graft-tunnel mismatch during</span></p>
<p style="top:333.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">anatomical anterior cruciate ligament reconstruction using a bone-patellar tendon-</span></p>
<p style="top:341.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">bone graft. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Bone Joint J</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2015;97-B:324&#x2013;328.</span></p>
<p style="top:352.2pt;left:324.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">7. Shah VM, Andrews JR, Fleisig GS, McMichael CS, Lemak LJ.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Return to play</span></p>
<p style="top:360.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">after anterior cruciate ligament reconstruction in National Football League athletes.</span></p>
<p style="top:368.2pt;left:331.9pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Am J Sports Med</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2010;38:2233&#x2013;2239.</span></p>
<p style="top:379.2pt;left:324.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">8. Paterno MV, Rauh MJ, Schmitt LC, Ford KR, Hewett TE.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Incidence of second ACL</span></p>
<p style="top:387.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">injuries 2 years after primary ACL reconstruction and return to sport. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Am J Sports Med</span></i></p>
<p style="top:395.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2014;42:1567&#x2013;1573.</span></p>
<p style="top:406.2pt;left:324.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">9. Ahmed I, Salmon L, Roe J, Pinczewski L.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> The long-term clinical and radiological</span></p>
<p style="top:414.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">outcomes in patients who suffer recurrent injuries to the anterior cruciate ligament</span></p>
<p style="top:422.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">after reconstruction. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Bone Joint J</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2017;99-B:337&#x2013;343.</span></p>
<p style="top:433.2pt;left:321.6pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">10. Kur&#x161;umovi</span></b><b><span style="font-family:Calibri,Bold,sans-serif;font-size:7.5pt">&#x107;</span></b><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt"> K, Charalambous C.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Graft salvage following infected anterior cruciate</span></p>
<p style="top:441.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">ligament reconstruction: a systematic review and meta-analysis. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Bone Joint J</span></i></p>
<p style="top:449.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2016;98-B:608&#x2013;615.</span></p>
<p style="top:460.2pt;left:321.6pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">11. von Porat A, Roos EM, Roos H.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> High prevalence of osteoarthritis 14 years after an</span></p>
<p style="top:468.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">anterior cruciate ligament tear in male soccer players: a study of radiographic and</span></p>
<p style="top:476.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">patient relevant outcomes. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Ann Rheum Dis</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2004;63:269&#x2013;273.</span></p>
<p style="top:487.2pt;left:321.6pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">12. Gulotta LV, Rodeo SA.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Biology of autograft and allograft healing in anterior cruciate</span></p>
<p style="top:495.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">ligament reconstruction. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Clin Sports Med</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2007;26:509&#x2013;524.</span></p>
<p style="top:506.2pt;left:321.6pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">13. Benjamin M, Toumi H, Ralphs J, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Where tendons and ligaments meet bone:</span></p>
<p style="top:514.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">attachment sites (&#x2018;entheses&#x2019;) in relation to exercise and/or mechanical load. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">J Anat</span></i></p>
<p style="top:522.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2006;208:471&#x2013;490.</span></p>
<p style="top:533.2pt;left:321.6pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">14. Lazarides AL, Eward WC, Green K, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Histological Evaluation of Tendon-Bone</span></p>
<p style="top:541.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">Healing of an Anterior Cruciate Ligament Hamstring Graft in a 14-Year-Old Boy. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Am J</span></i></p>
<p style="top:549.2pt;left:331.9pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Sports Med</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2015;43:1935&#x2013;1940.</span></p>
<p style="top:560.2pt;left:321.6pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">15. LaPrade RF, Dragoo JL, Koh JL, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> AAOS Research Symposium Updates and</span></p>
<p style="top:568.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">Consensus: Biologic Treatment of Orthopaedic Injuries. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">J Am Acad Orthop Surg</span></i></p>
<p style="top:576.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2016;24:62&#x2013;78.</span></p>
<p style="top:587.2pt;left:321.6pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">16. Murray IR, Geeslin AG, Goudie EB, Petrigliano FA, LaPrade RF.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Minimum</span></p>
<p style="top:595.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">Information for Studies Evaluating Biologics in Orthopaedics (MIBO): Platelet-Rich</span></p>
<p style="top:603.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">Plasma and Mesenchymal Stem Cells. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">J Bone Joint Surg [Am]</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2017;99-A:809&#x2013;819.</span></p>
<p style="top:614.2pt;left:321.6pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">17. No authors listed.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> The Cochrane Risk of Bias 2.0 Tool. A revised tool to assess risk</span></p>
<p style="top:622.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">of bias in randomized trials (RoB 2.0). http://training.cochrane.org/resource/rob-20-</span></p>
<p style="top:630.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">webinar (date last accessed 22 January 2017).</span></p>
<p style="top:641.2pt;left:321.6pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">18. Sterne JA, Hern&#xe1;n MA, Reeves BC, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> ROBINS-I: a tool for assessing risk of</span></p>
<p style="top:649.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">bias in non-randomised studies of interventions. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">BMJ</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2016;355:4919.</span></p>
<p style="top:660.2pt;left:321.6pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">19. Hooijmans CR, Leenaars M, Ritskes-Hoitinga M.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> A gold standard publication</span></p>
<p style="top:668.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">checklist to improve the quality of animal studies, to fully integrate the Three Rs, and</span></p>
<p style="top:676.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">to make systematic reviews more feasible. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Altern Lab Anim</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2010;38:167&#x2013;182.</span></p>
<p style="top:687.2pt;left:321.6pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">20. Fu SC, Cheuk YC, Yung SH, Rolf CG, Chan KM.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Systematic review of biological</span></p>
<p style="top:695.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">modulation of healing in anterior cruciate ligament reconstruction. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Orthop J Sports</span></i></p>
<p style="top:703.2pt;left:331.9pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Med</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2014;2:2325967114526687.</span></p>
<p style="top:714.2pt;left:321.6pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">21. Teng C, Zhou CH, Xu D, Bi F.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Combination of platelet-rich plasma and bone marrow</span></p>
<p style="top:722.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">mesenchymal stem cells enhances tendon-bone healing in a rabbit model of anterior</span></p>
<p style="top:730.2pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">cruciate ligament reconstruction. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">J Orthop Surg</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2016;11:96.</span></p>


<img style="position:absolute;transform:matrix(.3200452,0,-0,.31638713,47.153337,979.88009)" src="data:image/png;base64,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">
<p style="top:49.8pt;left:52.1pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">282</span></p>
<p style="top:49.8pt;left:203.2pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">A. T. HEXTER, T. THANGARAJAH, G. BLUNN, F. S. HADDAD</span></p>
<p style="top:753.5pt;left:70.0pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">Follow us @BoneJointJ</span></p>
<p style="top:753.5pt;left:447.7pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">THE BONE &amp; JOINT JOURNAL</span></p>
<p style="top:71.9pt;left:53.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">22. Leong NL, Kabir N, Arshi A, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Evaluation of polycaprolactone scaffold with</span></p>
<p style="top:79.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">basic fibroblast growth factor and fibroblasts in an athymic rat model for anterior</span></p>
<p style="top:87.8pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">cruciate ligament reconstruction. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Tissue Eng Part A</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2015;21:1859&#x2013;1868.</span></p>
<p style="top:98.9pt;left:53.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">23. Hensler D, Illingworth KD, Musahl V, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Does fibrin clot really enhance graft</span></p>
<p style="top:106.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">healing after double-bundle ACL reconstruction in a caprine model? </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Knee Surg Sports</span></i></p>
<p style="top:114.8pt;left:64.1pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Traumatol Arthrosc</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2015;23:669&#x2013;679.</span></p>
<p style="top:125.9pt;left:53.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">24. Fleming BC, Proffen BL, Vavken P, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Increased platelet concentration does</span></p>
<p style="top:133.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">not improve functional graft healing in bio-enhanced ACL reconstruction. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Knee Surg</span></i></p>
<p style="top:141.8pt;left:64.1pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Sports Traumatol Arthrosc</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2015;23:1161&#x2013;1170.</span></p>
<p style="top:152.9pt;left:53.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">25. Li X, He JK, Bian W, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> A novel silk-based artificial ligament and tricalcium</span></p>
<p style="top:160.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">phosphate/polyether ether ketone anchor for anterior cruciate ligament</span></p>
<p style="top:168.8pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">reconstruction - safety and efficacy in a porcine model. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Acta Biomater</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2014;10:3696&#x2013;</span></p>
<p style="top:176.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">3704.</span></p>
<p style="top:187.9pt;left:53.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">26. Weimin P, Dan L, Yiyong W, Yunyu H, Li Z.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Tendon-to-bone healing using an</span></p>
<p style="top:195.8pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">injectable calcium phosphate cement combined with bone xenograft/BMP composite.</span></p>
<p style="top:203.9pt;left:64.1pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Biomaterials</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2013;34:9926&#x2013;9936.</span></p>
<p style="top:214.9pt;left:53.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">27. Murray MM, Fleming BC.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Use of a bioactive scaffold to stimulate anterior cruciate</span></p>
<p style="top:222.8pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">ligament healing also minimizes posttraumatic osteoarthritis after surgery. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Am J</span></i></p>
<p style="top:230.9pt;left:64.1pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Sports Med </span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2013;41:1762&#x2013;1770.</span></p>
<p style="top:241.9pt;left:53.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">28. Lee AJ, Chung WH, Kim DH, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Anterior cruciate ligament reconstruction in a</span></p>
<p style="top:249.8pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">rabbit model using canine small intestinal submucosa and autologous platelet-rich</span></p>
<p style="top:257.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">plasma. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">J Surg Res</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2012;178:206&#x2013;215.</span></p>
<p style="top:268.9pt;left:53.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">29. Chen J, Yang L, Guo L, Duan X.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Sodium hyaluronate as a drug-release system for</span></p>
<p style="top:276.8pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">VEGF 165 improves graft revascularization in anterior cruciate ligament</span></p>
<p style="top:284.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">reconstruction in a rabbit model. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Exp Ther Med</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2012;4:430&#x2013;434.</span></p>
<p style="top:295.9pt;left:53.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">30. Zhang W, Pan W, Zhang M, Wei Y.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> In vivo evaluation of two types of bioactive</span></p>
<p style="top:303.8pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">scaffold used for tendon-bone interface healing in the reconstruction of anterior</span></p>
<p style="top:311.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">cruciate ligament. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Biotechnol Lett</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2011;33:837&#x2013;844.</span></p>
<p style="top:322.9pt;left:53.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">31. Wei X, Mao Z, Hou Y, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Local administration of TGF</span><span style="font-family:Calibri,sans-serif;font-size:7.5pt">&#x3b2;</span><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">-1/VEGF165 gene-</span></p>
<p style="top:330.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">transduced bone mesenchymal stem cells for Achilles allograft replacement of the</span></p>
<p style="top:338.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">anterior cruciate ligament in rabbits. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Biochem Biophys Res Commun </span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2011;406:204&#x2013;</span></p>
<p style="top:346.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">210.</span></p>
<p style="top:357.9pt;left:53.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">32. Pan W, Wei Y, Zhou L, Li D.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Comparative in vivo study of injectable biomaterials</span></p>
<p style="top:365.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">combined with BMP for enhancing tendon graft osteointegration for anterior cruciate</span></p>
<p style="top:373.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">ligament reconstruction. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">J Orthop Res </span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2011;29:1015&#x2013;1021.</span></p>
<p style="top:384.9pt;left:53.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">33. Hashimoto Y, Naka Y, Fukunaga K, Nakamura H, Takaoka K.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> ACL</span></p>
<p style="top:392.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">reconstruction using bone-tendon-bone graft engineered from the semitendinosus</span></p>
<p style="top:400.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">tendon by injection of recombinant BMP-2 in a rabbit model. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">J Orthop Res</span></i></p>
<p style="top:408.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2011;29:1923&#x2013;1930.</span></p>
<p style="top:419.9pt;left:53.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">34. Nakase J, Kitaoka K, Matsumoto K, Tomita K.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Facilitated tendon-bone healing by</span></p>
<p style="top:427.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">local delivery of recombinant hepatocyte growth factor in rabbits. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Arthroscopy</span></i></p>
<p style="top:435.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2010;26:84&#x2013;90.</span></p>
<p style="top:446.9pt;left:53.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">35. Lu Y, Markel MD, Nemke B, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Influence of hydroxyapatite-coated and growth</span></p>
<p style="top:454.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">factor-releasing interference screws on tendon-bone healing in an ovine model.</span></p>
<p style="top:462.9pt;left:64.1pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Arthroscopy</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2009;25:1427&#x2013;1434.</span></p>
<p style="top:473.9pt;left:53.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">36. Sasaki K, Kuroda R, Ishida K, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Enhancement of tendon-bone osteointegration</span></p>
<p style="top:481.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">of anterior cruciate ligament graft using granulocyte colony-stimulating factor. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Am J</span></i></p>
<p style="top:489.9pt;left:64.1pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Sports Med</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2008;36:1519&#x2013;1527.</span></p>
<p style="top:500.9pt;left:53.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">37. Ma CB, Kawamura S, Deng XH, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Bone morphogenetic proteins-signaling</span></p>
<p style="top:508.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">plays a role in tendon-to-bone healing: a study of rhBMP-2 and noggin. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Am J Sports</span></i></p>
<p style="top:516.9pt;left:64.1pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Med</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2007;35:597&#x2013;604.</span></p>
<p style="top:527.9pt;left:53.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">38. Yoshikawa T, Tohyama H, Katsura T, Kondo E, Kotani Y, Matsumoto H, et al.</span></b></p>
<p style="top:535.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">Effects of local administration of vascular endothelial growth factor on mechanical</span></p>
<p style="top:543.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">characteristics of the semitendinosus tendon graft after anterior cruciate ligament</span></p>
<p style="top:551.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">reconstruction in sheep. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Am J Sports Med</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2006;34:1918&#x2013;1925.</span></p>
<p style="top:562.9pt;left:53.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">39. Yamazaki S, Yasuda K, Tomita F, Tohyama H, Minami A.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> The effect of</span></p>
<p style="top:570.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">transforming growth factor-beta1 on intraosseous healing of flexor tendon autograft</span></p>
<p style="top:578.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">replacement of anterior cruciate ligament in dogs. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Arthroscopy </span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2005;21:1034&#x2013;1041.</span></p>
<p style="top:589.9pt;left:53.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">40. Yasuda K, Tomita F, Yamazaki S, Minami A, Tohyama H.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> The effect of growth</span></p>
<p style="top:597.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">factors on biomechanical properties of the bone-patellar tendon-bone graft after</span></p>
<p style="top:605.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">anterior cruciate ligament reconstruction: a canine model study. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Am J Sports Med</span></i></p>
<p style="top:613.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2004;32:870&#x2013;880.</span></p>
<p style="top:624.9pt;left:53.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">41. Weiler A, F&#xf6;rster C, Hunt P, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> The influence of locally applied platelet-derived</span></p>
<p style="top:632.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">growth factor-BB on free tendon graft remodeling after anterior cruciate ligament</span></p>
<p style="top:640.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">reconstruction. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Am J Sports Med</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2004;32:881&#x2013;891.</span></p>
<p style="top:651.9pt;left:53.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">42. Anderson K, Seneviratne AM, Izawa K, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Augmentation of tendon healing in</span></p>
<p style="top:659.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">an intraarticular bone tunnel with use of a bone growth factor. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Am J Sports Med</span></i></p>
<p style="top:667.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2001;29:689&#x2013;698.</span></p>
<p style="top:678.9pt;left:53.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">43. Mihelic R, Pecina M, Jelic M, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Bone morphogenetic protein-7 (osteogenic</span></p>
<p style="top:686.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">protein-1) promotes tendon graft integration in anterior cruciate ligament</span></p>
<p style="top:694.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">reconstruction in sheep. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Am J Sports Med</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2004;32:1619&#x2013;1625.</span></p>
<p style="top:705.9pt;left:53.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">44. Li H, Chen C, Ge Y, Chen S.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Spray-painted human fibronectin coating as an effective</span></p>
<p style="top:713.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">strategy to enhance graft ligamentization of a polyethylene terephthalate artificial</span></p>
<p style="top:721.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">ligament. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Biotechnol Lett</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2014;36:1079&#x2013;1088.</span></p>
<p style="top:71.9pt;left:305.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">45. Del Torto M, Enea D, Panfoli N, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Hamstrings anterior cruciate ligament</span></p>
<p style="top:79.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">reconstruction with and without platelet rich fibrin matrix. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Knee Surg Sports</span></i></p>
<p style="top:87.8pt;left:316.1pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Traumatol Arthrosc</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2015;23:3614&#x2013;3622.</span></p>
<p style="top:98.9pt;left:305.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">46. Valent&#xed; Azc&#xe1;rate A, Lamo-Espinosa J, Aquerreta Beola JD, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Comparison</span></p>
<p style="top:106.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">between two different platelet-rich plasma preparations and control applied during</span></p>
<p style="top:114.8pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">anterior cruciate ligament reconstruction. Is there any evidence to support their use?</span></p>
<p style="top:122.9pt;left:316.1pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Injury</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2014;45(Suppl 4):S36&#x2013;S41.</span></p>
<p style="top:133.9pt;left:305.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">47. Vadal&#xe0; A, Iorio R, De Carli A, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Platelet-rich plasma: does it help reduce tunnel</span></p>
<p style="top:141.8pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">widening after ACL reconstruction? </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Knee Surg Sports Traumatol Arthrosc</span></i></p>
<p style="top:149.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2013;21:824&#x2013;829.</span></p>
<p style="top:160.9pt;left:305.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">48. Seijas R, Ares O, Catala J, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Magnetic resonance imaging evaluation of</span></p>
<p style="top:168.8pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">patellar tendon graft remodelling after anterior cruciate ligament reconstruction with</span></p>
<p style="top:176.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">or without platelet-rich plasma. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">J Orthop Surg (Hong Kong)</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2013;21:10&#x2013;14.</span></p>
<p style="top:187.9pt;left:305.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">49. Rupreht M, Vogrin M, Hussein M.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> MRI evaluation of tibial tunnel wall cortical</span></p>
<p style="top:195.8pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">bone formation after platelet-rich plasma applied during anterior cruciate ligament</span></p>
<p style="top:203.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">reconstruction. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Radiol Oncol</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2013;47:119&#x2013;124.</span></p>
<p style="top:214.9pt;left:305.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">50. Mirzatolooei F, Alamdari MT, Khalkhali HR.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> The impact of platelet-rich plasma</span></p>
<p style="top:222.8pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">on the prevention of tunnel widening in anterior cruciate ligament reconstruction</span></p>
<p style="top:230.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">using quadrupled autologous hamstring tendon: a randomised clinical trial. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Bone</span></i></p>
<p style="top:238.9pt;left:316.1pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Joint J</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2013;95-B:65&#x2013;69.</span></p>
<p style="top:249.8pt;left:305.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">51. Darabos N, Haspl M, Moser C, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Intraarticular application of autologous</span></p>
<p style="top:257.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">conditioned serum (ACS) reduces bone tunnel widening after ACL reconstructive</span></p>
<p style="top:265.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">surgery in a randomized controlled trial. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Knee Surg Sports Traumatol Arthrosc</span></i></p>
<p style="top:273.8pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2011;19(Suppl 1):S36&#x2013;S46.</span></p>
<p style="top:284.9pt;left:305.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">52. Vogrin M, Rupreht M, Crnjac A, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> The effect of platelet-derived growth factors</span></p>
<p style="top:292.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">on knee stability after anterior cruciate ligament reconstruction: a prospective</span></p>
<p style="top:300.8pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">randomized clinical study. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Wien Klin Wochenschr</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2010;122(Suppl 2):91&#x2013;95.</span></p>
<p style="top:311.9pt;left:305.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">53. S&#xe1;nchez M, Anitua E, Azofra J, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Ligamentization of tendon grafts treated</span></p>
<p style="top:319.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">with an endogenous preparation rich in growth factors: gross morphology and</span></p>
<p style="top:327.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">histology. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Arthroscopy</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2010;26:470&#x2013;480.</span></p>
<p style="top:338.9pt;left:305.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">54. Radice F, Y&#xe1;nez R, Guti&#xe9;rrez V, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Comparison of magnetic resonance imaging</span></p>
<p style="top:346.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">findings in anterior cruciate ligament grafts with and without autologous platelet-</span></p>
<p style="top:354.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">derived growth factors. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Arthroscopy </span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2010;26:50&#x2013;57.</span></p>
<p style="top:365.9pt;left:305.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">55. Figueroa D, Melean P, Calvo R, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Magnetic resonance imaging evaluation of</span></p>
<p style="top:373.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">the integration and maturation of semitendinosus-gracilis graft in anterior cruciate</span></p>
<p style="top:381.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">ligament reconstruction using autologous platelet concentrate. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Arthroscopy</span></i></p>
<p style="top:389.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2010;26:1318&#x2013;1325.</span></p>
<p style="top:400.9pt;left:305.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">56. Silva A, Sampaio R.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Anatomic ACL reconstruction: does the platelet-rich plasma</span></p>
<p style="top:408.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">accelerate tendon healing? </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Knee Surg Sports Traumatol Arthrosc</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2009;17:676&#x2013;682.</span></p>
<p style="top:419.9pt;left:305.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">57. Nin JR, Gasque GM, Azc&#xe1;rate AV, Beola JD, Gonzalez MH.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Has platelet-rich</span></p>
<p style="top:427.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">plasma any role in anterior cruciate ligament allograft healing? </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Arthroscopy</span></i></p>
<p style="top:435.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2009;25:1206&#x2013;1213.</span></p>
<p style="top:446.9pt;left:305.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">58. Orrego M, Larrain C, Rosales J, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Effects of platelet concentrate and a bone</span></p>
<p style="top:454.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">plug on the healing of hamstring tendons in a bone tunnel. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Arthroscopy</span></i></p>
<p style="top:462.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2008;24:1373&#x2013;1380.</span></p>
<p style="top:473.9pt;left:305.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">59. Ventura A, Terzaghi C, Borgo E, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Use of growth factors in ACL surgery:</span></p>
<p style="top:481.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">Preliminary study. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">J Orthop Traumatol</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2005;6:76&#x2013;79.</span></p>
<p style="top:492.9pt;left:305.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">60. Pan W, Hu Y, Wei Y, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Recombined bone xenografts enhance tendon graft</span></p>
<p style="top:500.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">osteointegration of anterior cruciate ligament reconstruction. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Int Orthop</span></i></p>
<p style="top:508.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2009;33:1761&#x2013;1768.</span></p>
<p style="top:519.9pt;left:305.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">61. Jin SK, Lee JH, Hong JH, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Enhancement of Osseointegration of Artificial</span></p>
<p style="top:527.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">Ligament by Nano-Hydroxyapatite and Bone Morphogenic Protein-2 into the Rabbit</span></p>
<p style="top:535.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">Femur. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Tissue Eng Regen Med</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2016;13:284&#x2013;296.</span></p>
<p style="top:546.9pt;left:305.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">62. Zhai W, Lv C, Zheng Y, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Weak link of tendon-bone healing and a control</span></p>
<p style="top:554.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">experiment to promote healing. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Arch Orthop Trauma Surg</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2013;133:1533&#x2013;1541.</span></p>
<p style="top:565.9pt;left:305.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">63. Sun X, Liu W, Cheng G, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> The influence of connective tissue growth factor on</span></p>
<p style="top:573.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">rabbit ligament injury repair. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Bone Joint Res</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2017;6:399&#x2013;404.</span></p>
<p style="top:584.9pt;left:305.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">64. Andriolo L, Di Matteo B, Kon E, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> PRP Augmentation for ACL reconstruction.</span></p>
<p style="top:592.9pt;left:316.1pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">BioMed Res Int</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2015;2015:371746.</span></p>
<p style="top:603.9pt;left:305.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">65. Schippinger G, Pr&#xfc;ller F, Divjak M, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Autologous platelet-rich plasma</span></p>
<p style="top:611.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">preparations: influence of nonsteroidal anti-inflammatory drugs on platelet function.</span></p>
<p style="top:619.9pt;left:316.1pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Orthop J Sports Med</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2015;3:2325967115588896.</span></p>
<p style="top:630.9pt;left:305.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">66. Wang J, Xu J, Fu W, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Biodegradable magnesium screws accelerate fibrous</span></p>
<p style="top:638.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">tissue mineralization at the tendon-bone insertion in anterior cruciate ligament</span></p>
<p style="top:646.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">reconstruction model of rabbit. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Sci Rep</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2017;7:40369.</span></p>
<p style="top:657.9pt;left:305.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">67. Cheng P, Han P, Zhao C, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Magnesium inference screw supports early graft</span></p>
<p style="top:665.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">incorporation with inhibition of graft degradation in anterior cruciate ligament</span></p>
<p style="top:673.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">reconstruction. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Sci Rep</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2016;6:26434.</span></p>
<p style="top:684.9pt;left:305.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">68. Chou YC, Yeh WL, Chao CL, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Enhancement of tendon-bone healing via the</span></p>
<p style="top:692.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">combination of biodegradable collagen-loaded nanofibrous membranes and a three-</span></p>
<p style="top:700.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">dimensional printed bone-anchoring bolt. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Int J Nanomedicine</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2016;11:4173&#x2013;4186.</span></p>
<p style="top:711.9pt;left:305.8pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">69. Kawai T, Yamada T, Yasukawa A, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Anterior cruciate ligament reconstruction</span></p>
<p style="top:719.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">using chitin-coated fabrics in a rabbit model. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Artif Org</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2010;34:55&#x2013;64.</span></p>


<p style="top:49.8pt;left:138.0pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">BIOLOGICAL AUGMENTATION OF GRAFT HEALING IN ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION</span></p>
<p style="top:49.8pt;left:549.0pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">283</span></p>
<p style="top:753.5pt;left:67.9pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">VOL. 100-B, No. 3, MARCH 2018</span></p>
<p style="top:71.9pt;left:69.5pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">70. Li H, Chen S, Wu Y, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Enhancement of the osseointegration of a polyethylene</span></p>
<p style="top:79.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">terephthalate artificial ligament graft in a bone tunnel using 58S bioglass. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Int Orthop</span></i></p>
<p style="top:87.8pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2012;36:191&#x2013;197.</span></p>
<p style="top:98.9pt;left:69.5pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">71. Cho S, Li H, Chen C, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Cationised gelatin and hyaluronic acid coating enhances</span></p>
<p style="top:106.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">polyethylene terephthalate artificial ligament graft osseointegration in porcine bone</span></p>
<p style="top:114.8pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">tunnels. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Int Orthop</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2013;37:507&#x2013;513.</span></p>
<p style="top:125.9pt;left:69.5pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">72. Vaquette C, Viateau V, Gu&#xe9;rard S, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> The effect of polystyrene sodium</span></p>
<p style="top:133.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">sulfonate grafting on polyethylene terephthalate artificial ligaments on in vitro</span></p>
<p style="top:141.8pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">mineralisation and in vivo bone tissue integration. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Biomaterials </span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2013;34:7048&#x2013;7063.</span></p>
<p style="top:152.9pt;left:69.5pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">73. Bi F, Shi Z, Liu A, Guo P, Yan S.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Anterior cruciate ligament reconstruction in a rabbit</span></p>
<p style="top:160.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">model using silk-collagen scaffold and comparison with autograft. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">PLoS One</span></i></p>
<p style="top:168.8pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2015;10:0125900.</span></p>
<p style="top:179.9pt;left:69.5pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">74. Shen W, Chen X, Hu Y, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Long-term effects of knitted silk-collagen sponge</span></p>
<p style="top:187.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">scaffold on anterior cruciate ligament reconstruction and osteoarthritis prevention.</span></p>
<p style="top:195.8pt;left:79.9pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Biomaterials </span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2014;35:8154&#x2013;8163.</span></p>
<p style="top:206.9pt;left:69.5pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">75. Han F, Zhang P, Sun Y, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Hydroxyapatite-doped polycaprolactone nanofiber</span></p>
<p style="top:214.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">membrane improves tendon-bone interface healing for anterior cruciate ligament</span></p>
<p style="top:222.8pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">reconstruction. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Int J Nanomedicine</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2015;10:7333&#x2013;7343.</span></p>
<p style="top:233.9pt;left:69.5pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">76. Hsu SL, Wang CJ.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> The use of demineralized bone matrix for anterior cruciate</span></p>
<p style="top:241.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">ligament reconstruction: a radiographic, histologic, and immunohistochemical study</span></p>
<p style="top:249.8pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">in rabbits. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">J Surg Res</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2014;187:219&#x2013;224.</span></p>
<p style="top:260.9pt;left:69.5pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">77. Weimin P, Dan L, Yiyong W, Yunyu H, Li Z.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Tendon-to-bone healing using an</span></p>
<p style="top:268.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">injectable calcium phosphate cement combined with bone xenograft/BMP composite.</span></p>
<p style="top:276.8pt;left:79.9pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Biomaterials </span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2013;34:9926&#x2013;9936.</span></p>
<p style="top:287.9pt;left:69.5pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">78. Lovric V, Chen D, Yu Y, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Effects of demineralized bone matrix on tendon-bone</span></p>
<p style="top:295.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">healing in an intra-articular rodent model. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Am J Sports Med</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2012;40:2365&#x2013;2374.</span></p>
<p style="top:306.8pt;left:69.5pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">79. Kadonishi Y, Deie M, Takata T, Ochi M.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Acceleration of tendon-bone healing in</span></p>
<p style="top:314.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">anterior cruciate ligament reconstruction using an enamel matrix derivative in a rat</span></p>
<p style="top:322.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">model. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">J Bone Joint Surg [Br]</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2012;94-B:205&#x2013;209.</span></p>
<p style="top:333.9pt;left:69.5pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">80. Gulotta LV, Kovacevic D, Ying L, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Augmentation of tendon-to-bone healing</span></p>
<p style="top:341.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">with a magnesium-based bone adhesive. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Am J Sports Med</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2008;36:1290&#x2013;1297.</span></p>
<p style="top:352.9pt;left:69.5pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">81. Elnikety S, Pendegrass CJ, de Godoy RF, Holden C, Blunn GW.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Augmentation</span></p>
<p style="top:360.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">and repair of tendons using demineralised cortical bone. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">BMC Musculoskelet Disord</span></i></p>
<p style="top:368.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2016;17:483.</span></p>
<p style="top:379.9pt;left:69.5pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">82. Sundar S, Pendegrass CJ, Blunn GW.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Tendon bone healing can be enhanced by</span></p>
<p style="top:387.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">demineralized bone matrix: a functional and histological study. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">J Biomed Mater Res B</span></i></p>
<p style="top:395.9pt;left:79.9pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Appl Biomater</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2009;88:115&#x2013;122.</span></p>
<p style="top:406.9pt;left:69.5pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">83. Thangarajah T, Henshaw F, Sanghani-Kerai A, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> The effectiveness of</span></p>
<p style="top:414.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">demineralized cortical bone matrix in a chronic rotator cuff tear model. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">J Shoulder</span></i></p>
<p style="top:422.9pt;left:79.9pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Elbow Surg</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2017;26:619&#x2013;626.</span></p>
<p style="top:433.9pt;left:69.5pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">84. Thangarajah T, Shahbazi S, Pendegrass CJ, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Tendon Reattachment to Bone</span></p>
<p style="top:441.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">in an Ovine Tendon Defect Model of Retraction Using Allogenic and Xenogenic</span></p>
<p style="top:449.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">Demineralised Bone Matrix Incorporated with Mesenchymal Stem Cells. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">PloS One</span></i></p>
<p style="top:457.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2016;11:0161473.</span></p>
<p style="top:468.9pt;left:69.5pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">85. Iorio R, Di Sanzo V, Vadal&#xe0; A, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Nanohydroxyapatite-based bone graft</span></p>
<p style="top:476.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">substitute in tunnel enlargement after ACL surgery: RMN study. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Clin Ter</span></i></p>
<p style="top:484.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2013;164:101&#x2013;106.</span></p>
<p style="top:495.9pt;left:69.5pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">86. Mutsuzaki H, Fujie H, Nakajima H, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Effect of calcium phosphate-hybridized</span></p>
<p style="top:503.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">tendon graft in anatomic single-bundle ACL reconstruction in goats. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Orth J Sports</span></i></p>
<p style="top:511.9pt;left:79.9pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Med</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2016;4:2325967116662653.</span></p>
<p style="top:522.9pt;left:69.5pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">87. Kuang GM, Yau WP, Lu WW, Chiu KY.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Local application of strontium in a calcium</span></p>
<p style="top:530.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">phosphate cement system accelerates healing of soft tissue tendon grafts in anterior</span></p>
<p style="top:538.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">cruciate ligament reconstruction experiment using a rabbit model. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Am J Sports Med</span></i></p>
<p style="top:546.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2014;42:2996&#x2013;3002.</span></p>
<p style="top:557.9pt;left:69.5pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">88. Kuang GM, Yau WP, Lu WW, Chiu KY.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Use of a strontium-enriched calcium</span></p>
<p style="top:565.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">phosphate cement in accelerating the healing of soft-tissue tendon graft within the</span></p>
<p style="top:573.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">bone tunnel in a rabbit model of anterior cruciate ligament reconstruction. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Bone Joint</span></i></p>
<p style="top:581.9pt;left:79.9pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">J</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2013;95-B:923&#x2013;928.</span></p>
<p style="top:592.9pt;left:69.5pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">89. Mutsuzaki H, Kanamori A, Ikeda K, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Effect of calcium phosphate-hybridized</span></p>
<p style="top:600.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">tendon graft in anterior cruciate ligament reconstruction: a randomized controlled</span></p>
<p style="top:608.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">trial. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Am J Sports Med</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2012;40:1772&#x2013;1780.</span></p>
<p style="top:619.9pt;left:69.5pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">90. Mutsuzaki H, Sakane M, Fujie H, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Effect of calcium phosphate-hybridized</span></p>
<p style="top:627.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">tendon graft on biomechanical behavior in anterior cruciate ligament reconstruction</span></p>
<p style="top:635.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">in a goat model: novel technique for improving tendon-bone healing. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Am J Sports</span></i></p>
<p style="top:643.9pt;left:79.9pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Med</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2011;39:1059&#x2013;1066.</span></p>
<p style="top:654.9pt;left:69.5pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">91. Shen H, Qiao G, Cao H, Jiang Y.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> An histological study of the influence of</span></p>
<p style="top:662.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">osteoinductive calcium phosphate ceramics on tendon healing pattern in a bone</span></p>
<p style="top:670.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">tunnel with suspensory fixation. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Int Orthop</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2010;34:917&#x2013;924.</span></p>
<p style="top:681.9pt;left:69.5pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">92. Wen CY, Qin L, Lee KM, Chan KM.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> The use of brushite calcium phosphate cement</span></p>
<p style="top:689.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">for enhancement of bone-tendon integration in an anterior cruciate ligament</span></p>
<p style="top:697.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">reconstruction rabbit model. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">J Biomed Mater Res B Appl Biomater</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2009;89:466&#x2013;474.</span></p>
<p style="top:708.9pt;left:69.5pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">93. Huangfu X, Zhao J.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Tendon-bone healing enhancement using injectable tricalcium</span></p>
<p style="top:716.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">phosphate in a dog anterior cruciate ligament reconstruction model. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Arthroscopy</span></i></p>
<p style="top:724.9pt;left:79.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2007;23:455&#x2013;462.</span></p>
<p style="top:71.9pt;left:321.6pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">94. Tien YC, Chih TT, Lin JHC, Ju CP, Lin SD.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Augmentation of tendon-bone healing by</span></p>
<p style="top:79.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">the use of calcium-phosphate cement. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">J Bone Joint Surg [Br]</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2004;86-B:1072&#x2013;1076.</span></p>
<p style="top:90.8pt;left:321.6pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">95. Mutsuzaki H, Sakane M, Nakajima H, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Calcium-phosphate-hybridized</span></p>
<p style="top:98.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">tendon directly promotes regeneration of tendon-bone insertion. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">J Biomed Mater Res</span></i></p>
<p style="top:106.9pt;left:331.9pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">A</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2004;70:319&#x2013;327.</span></p>
<p style="top:117.8pt;left:321.6pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">96. Teuschl A, Heimel P, N&#xfc;rnberger S, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> A Novel Silk Fiber-Based Scaffold for</span></p>
<p style="top:125.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">Regeneration of the Anterior Cruciate Ligament: Histological Results From a Study in</span></p>
<p style="top:133.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">Sheep. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Am J Sports Med</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2016;44:1547&#x2013;1557.</span></p>
<p style="top:144.8pt;left:321.6pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">97. Kouroupis D, Kyrkou A, Triantafyllidi E, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Generation of stem cell-based</span></p>
<p style="top:152.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">bioartificial anterior cruciate ligament (ACL) grafts for effective ACL rupture repair.</span></p>
<p style="top:160.9pt;left:331.9pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Stem Cell Res (Amst)</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2016;17:448&#x2013;457.</span></p>
<p style="top:171.8pt;left:321.6pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">98. Kosaka M, Nakase J, Hayashi K, Tsuchiya H.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Adipose-Derived Regenerative</span></p>
<p style="top:179.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">Cells Promote Tendon-Bone Healing in a Rabbit Model. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Arthroscopy</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2016;32:851&#x2013;</span></p>
<p style="top:187.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">859.</span></p>
<p style="top:198.8pt;left:321.6pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">99. Li H, Fan J, Sun L, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Functional regeneration of ligament-bone interface using a</span></p>
<p style="top:206.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">triphasic silk-based graft. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Biomaterials</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2016;106:180&#x2013;192.</span></p>
<p style="top:217.9pt;left:319.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">100.Zhu JX, Zhang X, Shao ZX, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> In vivo study of ligament-bone healing after</span></p>
<p style="top:225.8pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">anterior cruciate ligament reconstruction using autologous tendons with</span></p>
<p style="top:233.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">mesenchymal stem cells affinity peptide conjugated electrospun nanofibrous</span></p>
<p style="top:241.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">scaffold. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">J Nanomaterials</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2013.</span></p>
<p style="top:252.8pt;left:319.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">101.Jang KM, Lim HC, Jung WY, Moon SW, Wang JH.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Efficacy and safety of human</span></p>
<p style="top:260.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">umbilical cord blood-derived mesenchymal stem cells in anterior cruciate ligament</span></p>
<p style="top:268.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">reconstruction of a rabbit model: new strategy to enhance tendon graft healing.</span></p>
<p style="top:276.8pt;left:331.9pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Arthroscopy</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2015;31:1530&#x2013;1539.</span></p>
<p style="top:287.9pt;left:319.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">102.Lui PPY, Wong OT, Lee YW.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Application of tendon-derived stem cell sheet for the</span></p>
<p style="top:295.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">promotion of graft healing in anterior cruciate ligament reconstruction. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Am J Sports</span></i></p>
<p style="top:303.8pt;left:331.9pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Med</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2014;42:681&#x2013;689.</span></p>
<p style="top:314.9pt;left:319.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">103.Mifune Y, Matsumoto T, Takayama K, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Tendon graft revitalization using adult</span></p>
<p style="top:322.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">anterior cruciate ligament (ACL)-derived CD34+ cell sheets for ACL reconstruction.</span></p>
<p style="top:330.9pt;left:331.9pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Biomaterials</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2013;34:5476&#x2013;5487.</span></p>
<p style="top:341.9pt;left:319.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">104.Mifune Y, Matsumoto T, Ota S, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Therapeutic potential of anterior cruciate</span></p>
<p style="top:349.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">ligament-derived stem cells for anterior cruciate ligament reconstruction. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Cell</span></i></p>
<p style="top:357.9pt;left:331.9pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Transplant</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2012;21:1651&#x2013;1665.</span></p>
<p style="top:368.9pt;left:319.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">105.Fan H, Liu H, Toh SL, Goh JC.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Anterior cruciate ligament regeneration using</span></p>
<p style="top:376.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">mesenchymal stem cells and silk scaffold in large animal model. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Biomaterials</span></i></p>
<p style="top:384.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2009;30:4967&#x2013;4977.</span></p>
<p style="top:395.9pt;left:319.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">106.Fan H, Liu H, Wong EJW, Toh SL, Goh JCH.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> In vivo study of anterior cruciate</span></p>
<p style="top:403.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">ligament regeneration using mesenchymal stem cells and silk scaffold. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Biomaterials</span></i></p>
<p style="top:411.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2008;29:3324&#x2013;3337.</span></p>
<p style="top:422.9pt;left:319.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">107.Soon MY, Hassan A, Hui JH, Goh JC, Lee E.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> An analysis of soft tissue allograft</span></p>
<p style="top:430.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">anterior cruciate ligament reconstruction in a rabbit model: a short-term study of the</span></p>
<p style="top:438.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">use of mesenchymal stem cells to enhance tendon osteointegration. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Am J Sports</span></i></p>
<p style="top:446.9pt;left:331.9pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Med</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2007;35:962&#x2013;971.</span></p>
<p style="top:457.9pt;left:319.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">108.Lim JK, Hui J, Li L, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Enhancement of tendon graft osteointegration using</span></p>
<p style="top:465.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">mesenchymal stem cells in a rabbit model of anterior cruciate ligament</span></p>
<p style="top:473.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">reconstruction. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Arthroscopy</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2004;20:899&#x2013;910.</span></p>
<p style="top:484.9pt;left:319.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">109.Silva A, Sampaio R, Fernandes R, Pinto E.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Is there a role for adult non-cultivated</span></p>
<p style="top:492.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">bone marrow stem cells in ACL reconstruction? </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Knee Surg Sports Traumatol Arthrosc</span></i></p>
<p style="top:500.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2014;22:66&#x2013;71.</span></p>
<p style="top:511.9pt;left:319.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">110.Martinek V, Latterman C, Usas A, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Enhancement of tendon-bone integration</span></p>
<p style="top:519.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">of anterior cruciate ligament grafts with bone morphogenetic protein-2 gene transfer:</span></p>
<p style="top:527.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">a histological and biomechanical study. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">J Bone Joint Surg [Am]</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2002;84-A:1123&#x2013;</span></p>
<p style="top:535.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">1131.</span></p>
<p style="top:546.9pt;left:319.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">111.Wang CJ, Weng LH, Hsu SL, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> pCMV-BMP-2-transfected cell-mediated gene</span></p>
<p style="top:554.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">therapy in anterior cruciate ligament reconstruction in rabbits. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Arthroscopy</span></i></p>
<p style="top:562.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2010;26:968&#x2013;976.</span></p>
<p style="top:573.9pt;left:319.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">112.Zhang X, Ma Y, Fu X, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Runx2-Modified Adipose-Derived Stem Cells Promote</span></p>
<p style="top:581.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">Tendon Graft Integration in Anterior Cruciate Ligament Reconstruction. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Sci Rep</span></i></p>
<p style="top:589.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2016;6:19073.</span></p>
<p style="top:600.9pt;left:319.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">113.Kawakami Y, Takayama K, Matsumoto T, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Anterior cruciate ligament-</span></p>
<p style="top:608.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">derived stem cells transduced with BMP2 accelerate graft-bone integration after ACL</span></p>
<p style="top:616.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">reconstruction. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Am J Sports Med</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2017;45:584&#x2013;597.</span></p>
<p style="top:627.9pt;left:319.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">114.Chen BA, Li B, Qi YJ, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Enhancement of tendon-to-bone healing after anterior</span></p>
<p style="top:635.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">cruciate ligament reconstruction using bone marrow-derived mesenchymal stem cells</span></p>
<p style="top:643.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">genetically modified with bFGF/BMP2. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Sci Rep</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2016;6:25940.</span></p>
<p style="top:654.9pt;left:319.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">115.Takayama K, Kawakami Y, Mifune Y, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> The effect of blocking angiogenesis on</span></p>
<p style="top:662.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">anterior cruciate ligament healing following stem cell transplantation. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Biomaterials</span></i></p>
<p style="top:670.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2015;60:9&#x2013;19.</span></p>
<p style="top:681.9pt;left:319.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">116.Dong Y, Zhang Q, Li Y, Jiang J, Chen S.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Enhancement of tendon-bone healing for</span></p>
<p style="top:689.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">anterior cruciate ligament (ACL) reconstruction using bone marrow-derived</span></p>
<p style="top:697.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">mesenchymal stem cells infected with BMP-2. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Int J Mol Sci</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2012;13:13605&#x2013;13620.</span></p>
<p style="top:708.9pt;left:319.9pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">117.Li F, Jia H, Yu C.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> ACL reconstruction in a rabbit model using irradiated Achilles</span></p>
<p style="top:716.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">allograft seeded with mesenchymal stem cells or PDGF-B gene-transfected</span></p>
<p style="top:724.9pt;left:331.9pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">mesenchymal stem cells. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Knee Surg Sports Traumatol Arthrosc</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2007;15:1219&#x2013;1227.</span></p>


<img style="position:absolute;transform:matrix(.3200452,0,-0,.31638713,47.153337,979.88009)" src="data:image/png;base64,
iVBORw0KGgoAAAANSUhEUgAAADsAAAA+CAIAAAAaivRXAAAACXBIWXMAAA7EAAAO
xAGVKw4bAAADrElEQVR4nO2ZiU4iQRCGff8H2lURwQNEULlUBBQvQORQdOOBF/tJ
rWR2EaZ6ZnqNyVQ6BuPQ83V11d9V7dzwu9ncVwMYW0hs30Ji+xYS27eQ2L6FxPYt
JLZv/4P49fX1st05KFdyhWI2X9wvlS9araenp08ffnt7mz2biphXGmN+GKyp9FYk
GltcWuanfGAkkql6o+kEbbUuWczz87NfYubKF3c73a4H3NOz86XlOJTR2Mo/QxZQ
qR5dXfePasfpzPb84lLt5NR1TndiZoxE46vryf7NjREuPuOLEE/iyhgt5v0B6H8u
RHayec207sRn5/WFSBR/rCdTeujBYMC+AzQN1zl4bDube3x8vO73ed3swHAnrh7W
IJZ9XFlLtC7bGmLigec1uPg4trJGUhIY/OoMbo/EhJoQj5wR4wWswTUX8RnEPDwj
KsbEMjNxfBxIHOOtMbHsICj4AxGY9hWUK7GxqQwJgWZocFXEvavrsScc3OhUHHFt
d7qTCnp/f0+mKokF9+T0TIOrIgYIj04GpcgWWJuZLeQJSRlnDB/0acc8y/FVci4w
4uFIpyQop2S6nA5xIiGbK5QOKodHtbXEhhExOxkYsWx6uXooaTdTXGPjs8014Zxf
RO1vbm8DI2bHKQl6vSv8Z4SiHHI8PTw8BEaMlv2YX2TjmDcQxMkk3tjMuBZABsSo
mLg2cO/KIIqoW5S4KmISP5lKf1rNTDrMw0DslUqsJcbO640ZWuE/QvRCoSXGCsU9
TtHAidk6NlAfxAbEFEAkn764UcYME3Jw6nENiLFut0dSBytwzNa8aNkiJgUpGJBn
zrNAoEXXXl5ebBHL2UvThuIHQkxIUL8b4ZoR04BIh/OFDjYjHo5ObBTDP7F0eMp2
xhcxRoMubZ8fYmbYKx14wPVCjFF9U2PItYO+0XCGLyX1tBsWK8QYfS8HIX6icjcK
EnBZ7e2vX97e651YjEBcV/cakm1040ZncmDEvJV+XbomZz7N9i7Lo7nyg2tGjBKx
mygonb2c2NMQJyrgOKnGt+7u7nziuhBToNQbzfcLyVyB9yGfbKpRUyRXBZw4yKKf
60Yt8XB0q9loXpDayDBDL2riV2B390p+8syYeGztTre4uz+6hYh96Np7EP89/vwJ
t1JDlitVfb8ZPLEYooY+0FfvZPMUGEgblQbpT0qBmM5sU0bTUJCXHo5fK8ROI8oH
gwE9MAUdK3G9qQ7Kwv+D2LeQ2L6FxPYtJLZvIbF9C4nt2/cj/g0Tj1V7sEk/ggAA
AABJRU5ErkJggg==">
<p style="top:49.8pt;left:52.1pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">284</span></p>
<p style="top:49.8pt;left:203.2pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">A. T. HEXTER, T. THANGARAJAH, G. BLUNN, F. S. HADDAD</span></p>
<p style="top:753.5pt;left:70.0pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">Follow us @BoneJointJ</span></p>
<p style="top:753.5pt;left:447.7pt;line-height:6.5pt"><span style="font-family:Sabon,serif;font-size:6.5pt">THE BONE &amp; JOINT JOURNAL</span></p>
<p style="top:71.9pt;left:52.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">118.Hao ZC, Wang SZ, Zhang XJ, Lu J.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Stem cell therapy: a promising biological</span></p>
<p style="top:79.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">strategy for tendon-bone healing after anterior cruciate ligament reconstruction. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Cell</span></i></p>
<p style="top:87.8pt;left:64.1pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Prolif</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2016;49:154&#x2013;162.</span></p>
<p style="top:98.9pt;left:52.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">119.Matsumoto T, Ingham SM, Mifune Y, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Isolation and characterization of</span></p>
<p style="top:106.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">human anterior cruciate ligament-derived vascular stem cells. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Stem Cells Dev</span></i></p>
<p style="top:114.8pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2012;21:859&#x2013;872.</span></p>
<p style="top:125.9pt;left:52.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">120.Li H, Chen J, Chen S.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Remnant Repair-enhanced Polyethylene Terepthalate Artificial</span></p>
<p style="top:133.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">Ligament Graft Ligamentization. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Int J Sports Med</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2015;36:1015&#x2013;1020.</span></p>
<p style="top:144.8pt;left:52.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">121.Song GY, Zhang J, Li X, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Acute anterior cruciate ligament reconstruction with</span></p>
<p style="top:152.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">an augmented remnant repair: a comparative macroscopic and biomechanical study</span></p>
<p style="top:160.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">in an animal model. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Arthroscopy</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2014;30:344&#x2013;351.</span></p>
<p style="top:171.8pt;left:52.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">122.Sun L, Wu B, Tian M, Liu BC, Luo Y.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Comparison of graft healing in anterior</span></p>
<p style="top:179.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">cruciate ligament reconstruction with and without a preserved remnant in rabbits.</span></p>
<p style="top:187.9pt;left:64.1pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Knee</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2013;20:537&#x2013;544.</span></p>
<p style="top:198.8pt;left:52.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">123.Sun L, Hou C, Wu B, Tian M, Zhou X.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Effect of muscle preserved on tendon graft on</span></p>
<p style="top:206.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">intra-articular healing in anterior cruciate ligament reconstruction. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Knee Surg Sports</span></i></p>
<p style="top:214.9pt;left:64.1pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Traumatol Arthrosc</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2013;21:1862&#x2013;1868.</span></p>
<p style="top:225.8pt;left:52.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">124.Takahashi T, Kondo E, Yasuda K, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Effects of remnant tissue preservation on</span></p>
<p style="top:233.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">the tendon graft in anterior cruciate ligament reconstruction: a biomechanical and</span></p>
<p style="top:241.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">histological study. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Am J Sports Med</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2016;44:1708&#x2013;1716.</span></p>
<p style="top:252.8pt;left:52.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">125.Song GY, Zhang J, Li X, Li Y, Feng H.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Biomechanical and biological findings</span></p>
<p style="top:260.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">between acute anterior cruciate ligament reconstruction with and without an</span></p>
<p style="top:268.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">augmented remnant repair: a comparative in vivo animal study. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Arthroscopy</span></i></p>
<p style="top:276.8pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2016;32:307&#x2013;319.</span></p>
<p style="top:287.9pt;left:52.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">126.Matsumoto T, Kubo S, Sasaki K, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Acceleration of tendon-bone healing of</span></p>
<p style="top:295.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">anterior cruciate ligament graft using autologous ruptured tissue. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Am J Sports Med</span></i></p>
<p style="top:303.8pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2012;40:1296&#x2013;1302.</span></p>
<p style="top:314.9pt;left:52.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">127.Matsumoto T, Kuroda R, Matsushita T, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Reduction of tunnel enlargement</span></p>
<p style="top:322.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">with use of autologous ruptured tissue in anterior cruciate ligament reconstruction: a</span></p>
<p style="top:330.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">pilot clinical trial. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Arthroscopy</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2014;30:468&#x2013;474.</span></p>
<p style="top:341.9pt;left:52.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">128.Uddstr&#xf6;mer L, Ritsil&#xe4; V.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Osteogenic capacity of periosteal grafts: a qualitative and</span></p>
<p style="top:349.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">quantitative study of membranous and tubular bone periosteum in young rabbits.</span></p>
<p style="top:357.9pt;left:64.1pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Scand J Plast</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 1978;12:207&#x2013;214.</span></p>
<p style="top:368.9pt;left:52.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">129.Karaoglu S, Celik C, Korkusuz P.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> The effects of bone marrow or periosteum on</span></p>
<p style="top:376.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">tendon-to-bone tunnel healing in a rabbit model. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Knee Surg Sports Traumatol</span></i></p>
<p style="top:384.9pt;left:64.1pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Arthrosc</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2009;17:170&#x2013;178.</span></p>
<p style="top:395.9pt;left:52.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">130.Chen CH, Chen WJ, Shih CH.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Enveloping of periosteum on the hamstring tendon</span></p>
<p style="top:403.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">graft in anterior cruciate ligament reconstruction. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Arthroscopy</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2002;18:27E.</span></p>
<p style="top:414.9pt;left:52.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">131.Dai Z, Bao W, Li S, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Enhancement of polyethylene terephthalate artificial</span></p>
<p style="top:422.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">ligament graft osseointegration using a periosteum patch in a goat model. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Int J Sports</span></i></p>
<p style="top:430.9pt;left:64.1pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Med</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2016;37:493&#x2013;499.</span></p>
<p style="top:441.9pt;left:52.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">132.Chen C- H, Chang C- H, Su C- I, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Arthroscopic single-bundle anterior cruciate</span></p>
<p style="top:449.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">ligament reconstruction with periosteum-enveloping hamstring tendon graft: clinical</span></p>
<p style="top:457.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">outcome at 2 to 7 years. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Arthroscopy</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2010;26:907&#x2013;917.</span></p>
<p style="top:468.9pt;left:52.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">133.Chen C- H, Chen W- J, Shih C- H, Chou S- W.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Arthroscopic anterior cruciate</span></p>
<p style="top:476.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">ligament reconstruction with periosteum-enveloping hamstring tendon graft. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Knee</span></i></p>
<p style="top:484.9pt;left:64.1pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Surg Sports Traumatol Arthrosc</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2004;12:398&#x2013;405.</span></p>
<p style="top:495.9pt;left:52.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">134.Chen C- H, Chen W- J, Shih C- H.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Enveloping of periosteum on the hamstring</span></p>
<p style="top:503.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">tendon graft in anterior cruciate ligament reconstruction. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Arthroscopy</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2002;18:27E.</span></p>
<p style="top:514.9pt;left:52.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">135.Demirag B, Sarisozen B, Ozer O, Kaplan T, Ozturk C.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Enhancement of tendon-</span></p>
<p style="top:522.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">bone healing of anterior cruciate ligament grafts by blockage of matrix</span></p>
<p style="top:530.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">metalloproteinases. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">J Bone Joint Surg [Am]</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2005;87-A:2401&#x2013;2410.</span></p>
<p style="top:541.9pt;left:52.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">136.Lui PPY, Lee YW, Mok TY, Cheuk YC.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Local administration of alendronate reduced</span></p>
<p style="top:549.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">peri-tunnel bone loss and promoted graft-bone tunnel healing with minimal systemic</span></p>
<p style="top:557.9pt;left:64.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">effect on bone in contralateral knee. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">J Orthop Res</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2013;31:1897&#x2013;1906.</span></p>
<p style="top:71.9pt;left:304.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">137.Lui PP, Lee YW, Mok TY, Cheuk YC, Chan KM.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Alendronate reduced peri-tunnel</span></p>
<p style="top:80.2pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">bone loss and enhanced tendon graft to bone tunnel healing in anterior cruciate</span></p>
<p style="top:88.4pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">ligament reconstruction. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Eur Cell Mater</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2013;25:78&#x2013;96.</span></p>
<p style="top:99.8pt;left:304.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">138.Bi F, Shi Z, Jiang S, Guo P, Yan S.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Intermittently administered parathyroid hormone</span></p>
<p style="top:108.1pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">[1-34] promotes tendon-bone healing in a rat model. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Int J Mol Sci</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2014;15:17366&#x2013;</span></p>
<p style="top:116.3pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">17379.</span></p>
<p style="top:127.7pt;left:304.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">139.Oka S, Matsumoto T, Kubo S, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Local administration of low-dose simvastatin-</span></p>
<p style="top:136.0pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">conjugated gelatin hydrogel for tendon&#x2013;bone healing in anterior cruciate ligament</span></p>
<p style="top:144.2pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">reconstruction. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Tissue Eng Part A</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2013;19:1233&#x2013;1243.</span></p>
<p style="top:155.6pt;left:304.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">140.Zhang P, Han F, Li Y, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Local delivery of controlled-release simvastatin to</span></p>
<p style="top:163.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">improve the biocompatibility of polyethylene terephthalate artificial ligaments for</span></p>
<p style="top:172.1pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">reconstruction of the anterior cruciate ligament. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Int J Nanomedicine</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2016;11:465&#x2013;</span></p>
<p style="top:180.5pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">478.</span></p>
<p style="top:191.8pt;left:304.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">141.Yeh WL, Lin SS, Yuan LJ, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Effects of hyperbaric oxygen treatment on tendon</span></p>
<p style="top:200.0pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">graft and tendon-bone integration in bone tunnel: biochemical and histological</span></p>
<p style="top:208.4pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">analysis in rabbits. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">J Orthop Res</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2007;25:636&#x2013;645.</span></p>
<p style="top:219.7pt;left:304.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">142.Walsh WR, Stephens P, Vizesi F, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Effects of low-intensity pulsed ultrasound</span></p>
<p style="top:227.9pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">on tendon-bone healing in an intra-articular sheep knee model. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Arthroscopy</span></i></p>
<p style="top:236.3pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2007;23:197&#x2013;204.</span></p>
<p style="top:247.6pt;left:304.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">143.Papatheodorou LK, Malizos KN, Poultsides LA, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Effect of transosseous</span></p>
<p style="top:255.8pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">application of low-intensity ultrasound at the tendon graft-bone interface healing:</span></p>
<p style="top:264.2pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">gene expression and histological analysis in rabbits. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Ultrasound Med Biol</span></i></p>
<p style="top:272.5pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2009;35:576&#x2013;584.</span></p>
<p style="top:283.7pt;left:304.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">144.Wang CJ, Wang FS, Yang KD, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> The effect of shock wave treatment at the</span></p>
<p style="top:292.1pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">tendon-bone interface-an histomorphological and biomechanical study in rabbits. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">J</span></i></p>
<p style="top:300.4pt;left:316.1pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Orthop Res</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2005;23:274&#x2013;280.</span></p>
<p style="top:311.6pt;left:304.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">145.Wang CJ, Ko JY, Chou WY, et al.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Shockwave therapy improves anterior cruciate</span></p>
<p style="top:320.0pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">ligament reconstruction. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">J Surg Res</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2014;188:110&#x2013;118.</span></p>
<p style="top:331.3pt;left:304.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">146.Kiapour A, Murray M.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Basic science of anterior cruciate ligament injury and repair.</span></p>
<p style="top:339.6pt;left:316.1pt;line-height:7.5pt"><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Bone Joint Res</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2014;3:20&#x2013;31.</span></p>
<p style="top:350.9pt;left:304.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">147.Muller-Borer BJ, Collins MC, Gunst PR, Cascio WE, Kypson AP.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Quantum dot</span></p>
<p style="top:359.2pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">labeling of mesenchymal stem cells. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">J Nanobiotechnology</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2007;5:9.</span></p>
<p style="top:370.5pt;left:304.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">148.Hexter AT, Pendegrass C, Haddad F, Blunn G.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Demineralized bone matrix to</span></p>
<p style="top:378.8pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">augment tendon-bone healing: a systematic review. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Orthop J Sports Med</span></i></p>
<p style="top:387.1pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">2017;5:2325967117734517.</span></p>
<p style="top:398.4pt;left:304.1pt;line-height:7.5pt"><b><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">149.Pan W, Cao Z, Li D, Zhang M.</span></b><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> Evaluation of the potential application of three</span></p>
<p style="top:406.7pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">different biomaterials combined with bone morphological proteins for enhancing</span></p>
<p style="top:415.0pt;left:316.1pt;line-height:7.5pt"><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt">tendon-bone integration. </span><i><span style="font-family:Univers47CondensedLight,,serif;font-size:7.5pt">Injury</span></i><span style="font-family:Univers47CondensedLight,serif;font-size:7.5pt"> 2013;44:550&#x2013;557.</span></p>
<p style="top:439.4pt;left:307.7pt;line-height:6.5pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:6.5pt">Author contributions:</span></b></p>
<p style="top:447.4pt;left:307.7pt;line-height:6.5pt"><span style="font-family:Univers55,serif;font-size:6.5pt">A. T. Hexter: Wrote the manuscript. Data extraction and measurement of</span></p>
<p style="top:456.4pt;left:307.7pt;line-height:6.5pt"><span style="font-family:Univers55,serif;font-size:6.5pt">methodological quality</span></p>
<p style="top:465.4pt;left:307.7pt;line-height:6.5pt"><span style="font-family:Univers55,serif;font-size:6.5pt">T. Thangarajah: Data extraction and measurement of methodological quality</span></p>
<p style="top:474.4pt;left:307.7pt;line-height:6.5pt"><span style="font-family:Univers55,serif;font-size:6.5pt">G. Blunn: Helped write the manuscript and helped with the literature search</span></p>
<p style="top:483.4pt;left:307.7pt;line-height:6.5pt"><span style="font-family:Univers55,serif;font-size:6.5pt">F. S. Haddad: Senior author, Supervision of the planning and writing of the</span></p>
<p style="top:492.4pt;left:307.7pt;line-height:6.5pt"><span style="font-family:Univers55,serif;font-size:6.5pt">manuscript, Reviewed the manuscript prior to submission.</span></p>
<p style="top:506.4pt;left:307.7pt;line-height:6.5pt"><b><span style="font-family:Univers45Light,Bold,serif;font-size:6.5pt">Funding statement:</span></b></p>
<p style="top:514.4pt;left:307.7pt;line-height:6.5pt"><span style="font-family:Univers55,serif;font-size:6.5pt">No benefits in any form have been received or will be received from a</span></p>
<p style="top:523.4pt;left:307.7pt;line-height:6.5pt"><span style="font-family:Univers55,serif;font-size:6.5pt">commercial party related directly or indirectly to the subject of this article. </span></p>
<p style="top:539.4pt;left:307.7pt;line-height:6.5pt"><span style="font-family:Univers55,serif;font-size:6.5pt">This article was primary edited by A. D. Liddle and first proof edited by</span></p>
<p style="top:548.4pt;left:307.7pt;line-height:6.5pt"><span style="font-family:Univers55,serif;font-size:6.5pt">G. Scott.</span></p>

</div>
